\r\n\tThis book aims to explore the issues around the rheology of polymers, with an emphasis on biopolymers as well as the modification of polymers using reactive extrusion.
",isbn:null,printIsbn:"979-953-307-X-X",pdfIsbn:null,doi:null,price:0,priceEur:0,priceUsd:0,slug:null,numberOfPages:0,isOpenForSubmission:!1,hash:"5bc21841d2b87388ad498bc09910944b",bookSignature:"Dr. Casparus Johannes Verbeek and Dr. Velram Mohan",publishedDate:null,coverURL:"https://cdn.intechopen.com/books/images_new/8880.jpg",keywords:"Extrusion, Injection Moulding, Thermoplastics, Natural Polymers, Biomass, Polymer Modification, Polymer Blends, Compatibilization, Processing Challenges, Reactive Compounding, Screw Design, Process Design",numberOfDownloads:null,numberOfWosCitations:0,numberOfCrossrefCitations:0,numberOfDimensionsCitations:0,numberOfTotalCitations:0,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"September 6th 2019",dateEndSecondStepPublish:"September 27th 2019",dateEndThirdStepPublish:"November 26th 2019",dateEndFourthStepPublish:"February 14th 2020",dateEndFifthStepPublish:"April 14th 2020",remainingDaysToSecondStep:"a year",secondStepPassed:!0,currentStepOfPublishingProcess:5,editedByType:null,kuFlag:!1,biosketch:null,coeditorOneBiosketch:null,coeditorTwoBiosketch:null,coeditorThreeBiosketch:null,coeditorFourBiosketch:null,coeditorFiveBiosketch:null,editors:[{id:"102391",title:"Dr.",name:"Casparus",middleName:"Johannes",surname:"Verbeek",slug:"casparus-verbeek",fullName:"Casparus Verbeek",profilePictureURL:"https://mts.intechopen.com/storage/users/102391/images/system/102391.jpeg",biography:"Dr Verbeek is a Chemical Engineer, currently an associate professor at the School of Engineering at the University of Waikato and is also the R&D manager for Aduro Biopolymers. He has 20 years experience in waste and by-product valorisation with an emphasis on renewable materials and biological products. Since his tertiary studies, Johan’s knowledge in the engineering field of sustainable products has led to a number of innovative developments in the engineering industry. His research area covers a wide range of topics, such as polymer extrusion, rheology, material properties, protein analysis, chemical modification of proteins as well as protein composites and nano-composites.",institutionString:"University of Auckland",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"0",totalChapterViews:"0",totalEditedBooks:"1",institution:{name:"University of Auckland",institutionURL:null,country:{name:"New Zealand"}}}],coeditorOne:{id:"294363",title:"Dr.",name:"Velram",middleName:null,surname:"Mohan",slug:"velram-mohan",fullName:"Velram Mohan",profilePictureURL:"https://mts.intechopen.com/storage/users/294363/images/system/294363.jpeg",biography:null,institutionString:"University of Auckland",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"0",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"University of Auckland",institutionURL:null,country:{name:"New Zealand"}}},coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"6",title:"Biochemistry, Genetics and Molecular Biology",slug:"biochemistry-genetics-and-molecular-biology"}],chapters:null,productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},personalPublishingAssistant:{id:"300344",firstName:"Danijela",lastName:"Pintur",middleName:null,title:"Ms.",imageUrl:"https://mts.intechopen.com/storage/users/300344/images/8496_n.png",email:"danijela.p@intechopen.com",biography:null}},relatedBooks:[{type:"book",id:"1332",title:"Products and Applications of Biopolymers",subtitle:null,isOpenForSubmission:!1,hash:"8dee78e87e2f654541d4285e7cdd5212",slug:"products-and-applications-of-biopolymers",bookSignature:"Casparus Johannes Reinhard Verbeek",coverURL:"https://cdn.intechopen.com/books/images_new/1332.jpg",editedByType:"Edited by",editors:[{id:"102391",title:"Dr.",name:"Casparus",surname:"Verbeek",slug:"casparus-verbeek",fullName:"Casparus Verbeek"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6694",title:"New Trends in Ion Exchange Studies",subtitle:null,isOpenForSubmission:!1,hash:"3de8c8b090fd8faa7c11ec5b387c486a",slug:"new-trends-in-ion-exchange-studies",bookSignature:"Selcan Karakuş",coverURL:"https://cdn.intechopen.com/books/images_new/6694.jpg",editedByType:"Edited by",editors:[{id:"206110",title:"Dr.",name:"Selcan",surname:"Karakuş",slug:"selcan-karakus",fullName:"Selcan Karakuş"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1591",title:"Infrared Spectroscopy",subtitle:"Materials Science, Engineering and Technology",isOpenForSubmission:!1,hash:"99b4b7b71a8caeb693ed762b40b017f4",slug:"infrared-spectroscopy-materials-science-engineering-and-technology",bookSignature:"Theophile Theophanides",coverURL:"https://cdn.intechopen.com/books/images_new/1591.jpg",editedByType:"Edited by",editors:[{id:"37194",title:"Dr.",name:"Theophanides",surname:"Theophile",slug:"theophanides-theophile",fullName:"Theophanides Theophile"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3161",title:"Frontiers in Guided Wave Optics and Optoelectronics",subtitle:null,isOpenForSubmission:!1,hash:"deb44e9c99f82bbce1083abea743146c",slug:"frontiers-in-guided-wave-optics-and-optoelectronics",bookSignature:"Bishnu Pal",coverURL:"https://cdn.intechopen.com/books/images_new/3161.jpg",editedByType:"Edited by",editors:[{id:"4782",title:"Prof.",name:"Bishnu",surname:"Pal",slug:"bishnu-pal",fullName:"Bishnu Pal"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3092",title:"Anopheles mosquitoes",subtitle:"New insights into malaria vectors",isOpenForSubmission:!1,hash:"c9e622485316d5e296288bf24d2b0d64",slug:"anopheles-mosquitoes-new-insights-into-malaria-vectors",bookSignature:"Sylvie Manguin",coverURL:"https://cdn.intechopen.com/books/images_new/3092.jpg",editedByType:"Edited by",editors:[{id:"50017",title:"Prof.",name:"Sylvie",surname:"Manguin",slug:"sylvie-manguin",fullName:"Sylvie Manguin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"371",title:"Abiotic Stress in Plants",subtitle:"Mechanisms and Adaptations",isOpenForSubmission:!1,hash:"588466f487e307619849d72389178a74",slug:"abiotic-stress-in-plants-mechanisms-and-adaptations",bookSignature:"Arun Shanker and B. Venkateswarlu",coverURL:"https://cdn.intechopen.com/books/images_new/371.jpg",editedByType:"Edited by",editors:[{id:"58592",title:"Dr.",name:"Arun",surname:"Shanker",slug:"arun-shanker",fullName:"Arun Shanker"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"72",title:"Ionic Liquids",subtitle:"Theory, Properties, New Approaches",isOpenForSubmission:!1,hash:"d94ffa3cfa10505e3b1d676d46fcd3f5",slug:"ionic-liquids-theory-properties-new-approaches",bookSignature:"Alexander Kokorin",coverURL:"https://cdn.intechopen.com/books/images_new/72.jpg",editedByType:"Edited by",editors:[{id:"19816",title:"Prof.",name:"Alexander",surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"314",title:"Regenerative Medicine and Tissue Engineering",subtitle:"Cells and Biomaterials",isOpenForSubmission:!1,hash:"bb67e80e480c86bb8315458012d65686",slug:"regenerative-medicine-and-tissue-engineering-cells-and-biomaterials",bookSignature:"Daniel Eberli",coverURL:"https://cdn.intechopen.com/books/images_new/314.jpg",editedByType:"Edited by",editors:[{id:"6495",title:"Dr.",name:"Daniel",surname:"Eberli",slug:"daniel-eberli",fullName:"Daniel Eberli"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"57",title:"Physics and Applications of Graphene",subtitle:"Experiments",isOpenForSubmission:!1,hash:"0e6622a71cf4f02f45bfdd5691e1189a",slug:"physics-and-applications-of-graphene-experiments",bookSignature:"Sergey Mikhailov",coverURL:"https://cdn.intechopen.com/books/images_new/57.jpg",editedByType:"Edited by",editors:[{id:"16042",title:"Dr.",name:"Sergey",surname:"Mikhailov",slug:"sergey-mikhailov",fullName:"Sergey Mikhailov"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1373",title:"Ionic Liquids",subtitle:"Applications and Perspectives",isOpenForSubmission:!1,hash:"5e9ae5ae9167cde4b344e499a792c41c",slug:"ionic-liquids-applications-and-perspectives",bookSignature:"Alexander Kokorin",coverURL:"https://cdn.intechopen.com/books/images_new/1373.jpg",editedByType:"Edited by",editors:[{id:"19816",title:"Prof.",name:"Alexander",surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},chapter:{item:{type:"chapter",id:"41310",title:"Laminopathies",doi:"10.5772/53793",slug:"laminopathies",body:'
1. Introduction
1.1. The nuclear envelope
The nucleus is the defining characteristic organelle of the eukaryotes, and contains the nuclear genome. It is segregated from the cellular cytoplasm by the bilayer nuclear envelope (Figure 1), which consists of concentric inner and outer nuclear membranes, between which lies the perinuclear space. The outer nuclear membrane is contiguous with the rough endoplasmic reticulum, like which it is studded with protein producing ribosomes, and the perinuclear space is contiguous with the lumen of the endoplasmic reticulum. Transport across the nuclear envelope is accommodated by nuclear pore complexes (NPCs). The NPCs are the site where the inner and outer nuclear membranes are connected, as their shared lipid bilayers are united at that point. These NPCs are large, complex and heterogeneous protein structures, made up of multiple copies of approximately 30 different proteins, called nucleoporins [1]. NPCs span the inner and outer nuclear membranes, and allow the regulated relocation of molecules between the nucleoplasm and cytoplasm. While smaller molecules, such as small metabolites or proteins under 40 kDa, are passively transported through the NPCs, larger molecules such as mRNAs, tRNAs, ribosomes and signalling molecules can be actively transported from the nucleus, while signalling molecules, proteins, lipids and carbohydrates are actively transported both into and out of the nucleus [2,3].
Figure 1.
Structure of the nuclear envelope and associated proteins. The nuclear A-type and B-type lamins underlay the nucleoplasmic side of the inner nuclear membrane, and provide stability to the nucleus, an organisational binding platform for chromatin, and facilitate localisation and binding of nuclear pore complexes as well as a large family of nuclear envelope proteins. ONM, outer nuclear membrane; PNS, perinuclear space; INM, Inner nuclear membrane; NE, Nuclear envelope; NPC, Nuclear pore complex; ER, Endoplasmic reticulum, The structures on the ER represent ribosomes.
The inner nuclear membrane is embedded by various inner nuclear membrane proteins, such as LAP1, LAP2 and MAN1, which are involved in cell cycle control, linking the nucleus to the cytoskeleton and chromatin organisation [4,5]. Underlying and connected by various nuclear envelope proteins to the inner nuclear membrane are the nuclear lamina, a thin (30-100nm) and densely woven fibrillar mesh of intermediate filaments, composed of evolutionarily conserved lamins A, B1, B2 and C, and lamin associated proteins. These proteins are closely associated with the NPCs (Figure 1). This assembly of outer nuclear membrane, inner nuclear membrane, NPCs, and the lamina can be thought of as complex interface, coupling the nuclear genome to the rest of the cell, allowing for a sophisticated means of regulated traffic between inner and outer nuclear space, while compartmentalising DNA replication, RNA transcription and mRNA editing from translation at the ribosomes [3].
The nuclear lamins are type V intermediate filaments (IFs), and are closely related to the cytoplasmic intermediate filaments (types I-IV, which include the keratins), differing by the presence of a nuclear localisation signal (NLS) located in the initial section of the tail domain [6]. Physically, these lamins have the characteristic tripartite assemblage of intermediate filaments; a short globular N-terminal head domain and a long C-terminal tail domain containing an immunoglobin-like domain, separated by a conserved central alpha-helical rod domain (Figure 4). Coiled-coil homodimers of A- and B-type lamins are formed by interaction between adjacent heptad hydrophobic repeats on the central rod domain, and charged residues along the centre of this dimer promote further assembly between dimers, leading to assembly of filamentous fibrils, whereas the N and C terminal endings facilitate head-to-tail polymerisation [6-8]. The nuclear lamina has been shown to have a major role in nuclear structure, heterochromatin organisation and gene regulation [8-11].
1.2. The lamins
The LMNA gene (Online inheritance in man: 150330) is located on chromosome 1q21.2-q21.3 and is composed of 12 exons. Exon 1 codes the N-terminal head domain, exons 1-6 code the central rod domain, and exons 7-9 code the C-terminal tail domains. Exon 7 also contains the 6 amino acid NLS, necessary for importation of the protein into the nucleus by nuclear transport through NPCs [6,12,13]. Exons 11 and 12 specifically code lamin A, and the CaaX motif of prelamin A (the immature form of lamin A) is located in exon 12. The CaaX motif is a series of four amino acids at the C-terminus of a protein, consisting of a cysteine, two of any aliphatic amino acid, and a terminal amino acid. It is important for the post-translational processing including farnesylation. The motif is identified by the prenyltransferases, farnesyltransferase, or geranylgeranyltransferase-I, and is modified and removed during maturation of lamin A [14]. Lamin C does not contain a CaaX motif, and terminates in an alternative six amino-acid C-terminal end (VSGSRR) (Figure 4).
LMNA produces the major lamin A and C proteins (Figure 4), and the minor A∆10 and C2 proteins by alternative splicing within exon 10, and they are differentially expressed in a developmentally and tissue specific way [13,15]. Lamin A∆10 is identical to lamin A, except exon 10 is absent [16], and lamin C2 (which is expressed exclusively in germ cells) is identical to lamin C, except an alternative exon, 1C2, located in intron 1 of LMNA, codes for the N-terminal head domain [17,18]. A TATA-like promotor sequence (TATTA) for RNA polymerase attachment, and a CAT-box for RNA transcription factor attachment, lie 236 and 297 base pairs upstream of the ATG initiation codon [6,13].
A-type lamins are expressed only in differentiated cells, suggesting that they have a role in stabilising differential gene expression [15,16,19,20]. The main products in somatic cells are lamins A and C, with C2 and AΔ10 being less common isoforms, lamin C2 being specific to the testes [6,13,16,21]. The first 566 amino acids of lamins A and C are identical. However, at the C-terminals lamin A has 98 unique amino acids, and as with lamin B1 and B2, ends in a CaaX box motif, whilst lamin C has 6 unique terminal amino acids.
The second family of lamins, the B-type lamins, consist of lamin B1 encoded by the LMNB1 gene, and lamin B2 and B3, encoded by the LMNB2 gene. At least one of these B-type lamins are expressed in all cell types [13,22-25]. Lamin B3 is a minor variant, arising from differential splicing and alternative polyadenylation of LMNB2 and is expressed in male germ cells [24]. B-type lamins have a CAAX motif and are constitutively farnesylated, whereas lamin A loses its farnesyl group once targeted to the lamina [26].
The maturation process for lamin A, lamin B1 and B2 is detailed below, with these post-translational modifications taking place in the nucleus [27].
Prenylation: A farnesyl or geranylgeranyl isoprenoid group is covalently attached to the cysteine of the CaaX motif of prelamin A, lamin B1 and B2 by farnesyltransferase or geranylgeranyltransferase-I, respectively.
Cleavage: The terminal -aaX amino acids are removed by RCE1 and FACE1 for prelamin A, and by RCE1 alone for lamin B1 and B2.
Methylation: The now exposed C-terminal farnesylcysteine undergoes a methylation step, performed by a carboxymethyltransferase, isoprenylcysteine carboxyl methyltransferase (ICMT) [28]. This is the final post-translational step for B-type lamins, therefore they retain the farnesylcysteine α-methyl ester at the C-terminus.
Second cleavage (for prelamin A only): FACE1 cleaves the carboxy-terminal 15 amino acids, including the farnesylcysteine methyl ester group, at the NM [29]. This final modification step completes the post-translational modification of prelamin A to mature lamin A. This maturation is thought to aid localisation of lamin A to the nuclear rim [30,31].
2. Laminopathies
Diseases caused by mutations in the LMNA gene are collectively known as primary laminopathies [32], whereas mutations in genes coding for B-type lamins (LMNB1 and LMNB2), prelamin A processing proteins (such as ZMPSTE24), or lamin-binding proteins (such as EMD, TMPO, LBR and LEMD3) are known as secondary laminopathies [33,34]. At present, 458 different mutations from 2,206 individuals have been identified in the LMNA gene (www.umd.be/LMNA/). These mutations can be de novo or heritable, with a gain- or loss-of-function effect, and with severity ranging from minor arrhythmia arising in adolescence to a neonatally lethal tight skin condition [35]. Unlike with the LMNA gene, there are only a few mutations found affecting B-type lamins [36]. This is most likely due to the wide-ranging and non-redundant functions of lamin B1 in early growth and development [29].
Laminopathies are caused by a heterogeneous set of pleiotropic mutations affecting universally expressed genes. However, their effects can be tissue specific to a degree, allowing for categorisation into five groups (Table 1). Striated muscles are affected in muscular dystrophies, peripheral nerves are affected in neuropathies, adipose tissue in lipodystophies, several tissues affected with premature development of multiple markers of senescence in segmental progeriod diseases, and finally diseases displaying symptoms from more than one category are known as overlapping syndromes.
2.1. Muscular dystrophies
Within this following section, selected muscular dystrophies will be detailed, while Table 2 shows a complete listing of known muscular dystrophy laminopathies, at the time of writing.
2.1.1. Emery-dreifuss muscular dystrophy
Emery-Dreifuss muscular dystrophy (EDMD), first described in 1955 [37], is the most prevalent laminopathy, affecting 1 in 100,000 births. It is also a prototypical laminopathy, occurring both as a primary and secondary laminopathy. The most commonly occurring form is autosomal dominant (AD-EDMD). It also occurs as an autosomal recessive (AR-EDMD) or X-linked (XL-EDMD) form [38,39]. Mutations in the emerin gene are responsible for XL-EDMD [40-43], while mutations in the LMNA gene have been found to cause AD-EDMD, AR-EDMD and sporadic EDMD [44-47]. It most commonly occurs with nonsense mutations, although there has also been a report of at least one case with a premature stop codon in exon 1 of LMNA resulting in loss-of-function and haploinsufficiency as the genetic mechanism (Figure 4). The similarities in the clinical features of EDMD irrespective of whether the causative mutation is affecting emerin or lamin A/C indicates a close functional relationship between these proteins. Emerin mediates linkage between membranes and the cytoskeleton, and is closely linked to lamins [40].
\n\t\t
\n\t\t
\n\t\t
\n\t\t
\n\t\t
\n\t\t
\n\t\t\t
\n\t\t\t\tLaminopathy\n\t\t\t
\n\t\t\t
\n\t\t\t\tAcronym\n\t\t\t
\n\t\t\t
\n\t\t\t\tOMIM\n\t\t\t
\n\t\t\t
\n\t\t\t\tLocus\n\t\t\t
\n\t\t\t
\n\t\t\t\tGene\n\t\t\t
\n\t\t
\n\t\t
\n\t\t\t
\n\t\t\t\tMuscular dystrophy\n\t\t\t
\n\t\t
\n\t\t
\n\t\t\t
Cardiomyopathy, dilated, 1A
\n\t\t\t
CMD1A
\n\t\t\t
115200
\n\t\t\t
1q22
\n\t\t\t
\n\t\t\t\tLMNA\n\t\t\t
\n\t\t
\n\t\t
\n\t\t\t
Emery-Dreifuss muscular dystrophy 1, X-linked
\n\t\t\t
EDMD1
\n\t\t\t
310300
\n\t\t\t
Xq28
\n\t\t\t
\n\t\t\t\tEMD\n\t\t\t
\n\t\t
\n\t\t
\n\t\t\t
Emery-Dreifuss muscular dystrophy 2, AD
\n\t\t\t
EDMD2
\n\t\t\t
181350
\n\t\t\t
1q22
\n\t\t\t
\n\t\t\t\tLMNA\n\t\t\t
\n\t\t
\n\t\t
\n\t\t\t
Emery-Dreifuss muscular dystrophy 3, AR
\n\t\t\t
EDMD2
\n\t\t\t
181350
\n\t\t\t
1q22
\n\t\t\t
\n\t\t\t\tLMNA\n\t\t\t
\n\t\t
\n\t\t
\n\t\t\t
Emery-Dreifuss muscular dystrophy 4, AD
\n\t\t\t
EDMD4
\n\t\t\t
612998
\n\t\t\t
6q25.1-q25.2
\n\t\t\t
\n\t\t\t\tSYNE1\n\t\t\t
\n\t\t
\n\t\t
\n\t\t\t
Emery-Dreifuss muscular dystrophy 5, AD
\n\t\t\t
EDMD5
\n\t\t\t
612999
\n\t\t\t
14q23.2
\n\t\t\t
\n\t\t\t\tSYNE2\n\t\t\t
\n\t\t
\n\t\t
\n\t\t\t
Emery-Dreifuss muscular dystrophy 6, X-linked
\n\t\t\t
EDMD6
\n\t\t\t
300696
\n\t\t\t
Xq26.3
\n\t\t\t
\n\t\t\t\tFHL1\n\t\t\t
\n\t\t
\n\t\t
\n\t\t\t
Heart-hand syndrome, Slovenian type
\n\t\t\t
HHS-S
\n\t\t\t
610140
\n\t\t\t
1q22
\n\t\t\t
\n\t\t\t\tLMNA\n\t\t\t
\n\t\t
\n\t\t
\n\t\t\t
Malouf syndrome
\n\t\t\t
MLF
\n\t\t\t
212112
\n\t\t\t
1q22
\n\t\t\t
\n\t\t\t\tLMNA\n\t\t\t
\n\t\t
\n\t\t
\n\t\t\t
Muscular dystrophy, congenital
\n\t\t\t
MDC
\n\t\t\t
613205
\n\t\t\t
1q22
\n\t\t\t
\n\t\t\t\tLMNA\n\t\t\t
\n\t\t
\n\t\t
\n\t\t\t
Muscular dystrophy, limb-girdle, type 1B
\n\t\t\t
LGMD1B
\n\t\t\t
159001
\n\t\t\t
1q22
\n\t\t\t
\n\t\t\t\tLMNA\n\t\t\t
\n\t\t
\n\t\t
\n\t\t\t
\n\t\t\t\tLipodystrophy\n\t\t\t
\n\t\t
\n\t\t
\n\t\t\t
Acquired partial lipodystrophy
\n\t\t\t
APLD
\n\t\t\t
608709
\n\t\t\t
19p13.3
\n\t\t\t
\n\t\t\t\tLMNB2\n\t\t\t
\n\t\t
\n\t\t
\n\t\t\t
Lipodystrophy, familial partial, 2
\n\t\t\t
FPLD2
\n\t\t\t
151660
\n\t\t\t
1q22
\n\t\t\t
\n\t\t\t\tLMNA\n\t\t\t
\n\t\t
\n\t\t
\n\t\t\t
Mandibuloacral dysplasia with type A lipodystrophy
\n\t\t\t
MADA
\n\t\t\t
248370
\n\t\t\t
1q22
\n\t\t\t
\n\t\t\t\tLMNA\n\t\t\t
\n\t\t
\n\t\t
\n\t\t\t
Mandibuloacral dysplasia with type B lipodystrophy
A summary of primary and secondary laminopathies, grouped into five categories. LMNA, Lamin A/C; EMD, Emerin; SYNE1, Nesprin-1; SYNE2, Nesprin-2; FHL1, four and a half LIM domains; LMNB1, lamin B1; LMNB2, lamin B2; ZMPSTE24, zinc metallopeptidase (STE24 homolog); RECQL2, Werner syndrome, RecQ helicase-like; LBR, lamin B receptor; LEMD3, LEM domain-containing protein 3.
Figure 2.
Lower limb imaging of skeletal muscles from patients with laminopathies. Leg muscles from an unaffected control individual (A), a 44 years old female with LGMD1B, LMNA c.673C>T, p.R225X (B), and a 50 years old male with EDMD2, LMNA c.799T>C, p.Y267H (C). While the LGMD1B muscle shows a mild involvement of the medial head of gastrocnemius and moderate involvement of soleus (B) there is a moderate to severe involvement of the same muscles in the EDMD2 patient (C). Photo courtesy of Dr. Nicola Carboni and Dr. Marco Mura, University of Cagliari, Sardinia, Italy.
EDMD is characterised by an onset in the teenage years of a slow, progressive wasting of skeletal muscle tissue in the shoulder girdle and distal leg muscles. This atrophy leads to muscle weakness around the humerus and fibula (a pattern described as scapulo-humero-peroneal), early contractures of the pes cavus (resulting in high arched feet), proximal muscles of the lower leg and upper arm, and the elbow and Achilles tendons. Muscle cell damage is indicated by elevated serum creatine kinase levels. Muscle pathology shows variations in muscle fibre sizes and type-1 fibre atrophy. Cardiac muscle is also affected, with problems arising in early adulthood. Atrial rhythm disturbances, atrioventricular conduction defects, arrhythmias and dilated cardiomyopathy with atrial ventricular block lead to severe ventricular dysrhythmias and death [38,48].
2.1.2. Limb-girdle muscular dystrophy, type 1B
Limb-girdle muscular dystrophy, type 1B (LGMD1B) is a slowly progressive variant caused by an autosomal dominant mutation of the LMNA gene, and is characterised by a limb-girdle pattern of muscular atrophy [49,50].
Patients display a classic limb-girdle pattern of muscle atrophy, with a proximal lower limb muscular weakness starting by age 20. By the 30s and 40s upper limb muscles also gradual weakened [49]. As in EDMD, serum creatine kinase levels were normal or elevated. The late occurrence or absence of spinal, elbow and Achilles contractures distinguishes LGMD1B from EDMD. Cardiac conduction abnormalities with dilated cardiomyopathy also occur. One neonatally lethal case of LGMD1B was found to be caused by a homozygous LMNA Y259X mutation [51].
2.1.3. Dilated cardiomyopathy with conduction defect 1
Dilated cardiomyopathy with conduction defect 1 (CMD1A) is a highly heterogeneous disease, both genetically and phenotypically, with 16 genes currently found to be causatively mutated in cases of CMD1A [52]. Five heterozygotic missense mutations in the LMNA gene were identified in 5 of 11 families with autosomal dominant CMD [53].
Dilated cardiomyopathy is a serious cardiac condition, in which the heart becomes weakened and enlarged, with downstream effects on the lungs, liver and other organs. Conduction problems and dilated cardiomyopathy arise, leading to frequent heart failure and sudden death events. Affected family members have little or no associated skeletal myopathy.
2.1.4. Malouf syndrome
Malouf syndrome (MLF) is an extremely rare disorder with only a handful of cases described in the literature. The disease has been found to be caused by one of two mutations in exon 1 of the LMNA gene. These mutations, A57P and L59R (Figure 4), have been designated as causing AWS or atypical HGPS, however genital anomalies and missing progeroid features suggest instead a distinct laminopathy [54,55].
In males primary testicular failure, and in females premature ovarian failure, is a characteristic feature of the disease. Mild to moderate dilated cardiomyopathy also occurs. Micrognathia and sloping shoulders can give an atypical progeroid phenotype, however in patients suffering from MLF there is no severe growth failure, alopecia, or atherosclerosis [54].
2.1.5. Heart-hand syndrome, Slovenian type
The heterogeneous family of genetic diseases characterised by both congenital cardiac disease with limb deformities are known as Heart–hand syndromes (HHS). The Heart-hand syndrome, Slovenian type (HHS-S) disorder has been shown to be caused by a mutation (IVS9-12T-G) in intron 9 of the LMNA gene. It is an exceedingly rare disorder affecting several generations of a single family in Slovenia [56].
The characteristic changes to the hands and feet include short distal, and proximal phalanges, as well as webbing or fusion of the fingers or toes. Dilated cardiomyopathy, with an adult-onset progressive conduction disorder is also present, with sudden death due to ventricular tachyarrhythmia [56,57].
2.2. Lipodystrophies
Within this section, selected lipodystrophies were detailed, while Table 2 shows a complete listing of known lipodystrophy laminopathies, at the time of writing.
2.2.1. Familial partial lipodystrophy type 2
Familial partial lipodystrophy type 2 (FPLD2; Dunnigan variety of familial partial lipodystrophy) is an autosomal dominant lipodystophy, caused by a heterozygotic mutation in the LMNA gene [58-60]. Mutations are clustered in exons 8 and 11, in the globular C-terminal domain region of type-A lamins, the most common of which is a substitution of arginine at position 482 with a neutral amino acid [61].
FPLD2 shows the characteristic lypodystrophy reduction or loss of subcutaneous adipose tissue in certain regions, starting in childhood, puberty or early adulthood. Patients gradually lose fat from the upper and lower limbs, buttocks and trunk. However intramuscular and bone-marrow fat are preserved. Adipose tissue may increase around the face, neck, back and intra-abdominally [62]. Insulin resistance can occur with consequent complications of diabetes, dyslipidaemia, hypertension and hepatic steatosis. Clinical features may also include abnormalities of the menstrual cycle, hirsutism, and acanthosis nigricans.
2.2.2. Mandibuloacral dysplasia, type A and B
Mandibuloacral dysplasia (MAD) is an autosomal recessive disease, with strongly heterogeneous clinical features. It is categorised into type A (MADA), which is caused by mutations in the LMNA gene and type B (MADB), which is caused by mutations in the ZMPSTE24 gene [63-65].
Patients with MADA exhibit an acral loss of adipose tissue and a normal or increased fatty layer in the face, neck and trunk, whereas MADB is marked by a severe progressive glomerulopathy, and generalised lipodystrophy affecting the extremeties, but also the face. Growth retardation, osteolysis of the digits, pigmentary changes, mandibular hypoplasia and skeletal anomalies occur in both variants. Patients may also display some symptoms of progeria, and metabolic disorders such as insulin-resistant diabetes [63,66].
Adult-onset autosomal dominant leukodystrophy (ADLD) is an adult-onset neuropathy, caused by a heterozygous tandem genomic duplication resulting in a duplication of the lamin B1 gene, and a corresponding over-expression of lamin B1 [67,68].
ADLD is slowly progressive, with symptoms becoming apparent in the 40s and 50s, and are markedly similar to progressive multiple sclerosis. These symptoms include symmetric demyelination of the brain and spinal cord, autonomic abnormalities, as well as pyramidal and cerebellar dysfunction. Pathological examination reveals that ADLD differs from progressive multiple sclerosis with a lack of astrogliosis and a preservation of oligodendroglia in the presence of subtotal demyelination [67].
2.3.2. Charcot-Marie-Tooth disorder
Charcot-Marie-Tooth disorder (CMT) disorder was described simultaneously by Charcot, Marie and Tooth in 1886. Today the disease is considered a spectrum of phenotypically and genetically heterogeneous inherited neuropathies, with over 40 genes known to be associated with the disorder (www.molgen.ua.ac.be/CMTMutations). The autosomal recessive variant, CMT2B1 (AR-CMT2A or CMT4C1) (OMIM: 605588), is known to be caused by a mutation in LMNA [69,70]. All CMT disorders affect approximately 1 in 2,500 people, making them the most common group of inherited neuropathies [71,72]. Individuals with normal or slightly reduced sensory nerve conduction velocities (greater than 38 m/s) are categorised as type 2 (CMT2), and are diagnosed as axonal neuropathies [73]. The disease-causing mutation for CMT2B1 was identified as a homozygous LMNA c.829C>T mutation in exon 5 of the LMNA gene, causing an R298C amino acid substitution [69,70].
Sufferers of CMT2B1 display an early onset muscle wasting in the distal lower limbs (peroneal muscular atrophy syndrome), high arched feet (pes cavus), with a curled, claw-like appearance of the toes, as well as walking difficulties stemming from reduced tendon reflexes [74,75].
2.4. Segmental progeroid diseases
2.4.1. Hutchinson-Gilford progeria syndrome
Hutchinson-Gilford progeria syndrome (HGPS) is an extremely rare, fatal genetic disorder that displays a marked phenotype of premature senility (see chapter on Hutchinson-Gilford progeria syndrome). At least 90% of all HGPS cases are caused by a de novo mutation, where a single base nucleotide in exon 11 of the LMNA gene is substituted (c.1824C>T, p.G608G). This mutation results in an increased activation of a cryptic splice site in exon 11, which in turn increases the production and subsequent accumulation of a truncated, partially processed prelamin A protein that remains farnesylated, called progerin [76].
Individuals with HGPS are born normally but they present failure to thrive and sclerodermatous skin with loss of subcutaneous fat usually before one year of age. The early symptoms of HGPS also include short stature, and low body weight, which is followed by the occurrence of a tight skin over the abdomen and thighs beginning at the age one or two. Alopecia, scleroderma and the loss of subcutaneous fat also occur at early stages of the disease, succeeded by thin epidermis, fibrosis in the dermis and a loss of skin appendages. Patients often show micrognathia, prominent eyes and veins along with a small beaked nose. Atherosclerosis and calcification of the thoracic aorta is recurrent and death occurs in the early teenage years, most commonly due to cardiovascular complications [76-80].
2.4.2. Restrictive dermopathy
Restrictive dermopathy (RD) is a rare lethal autosomal recessive disease most often caused by loss of function mutations of the ZMPSTE24 gene, and one case has been described with a dominant mutation in intron 11 of the LMNA gene (Figure 4). Similar to HGPS, progerin accumulation occurs, however at a greater level, and this accumulation has been proposed to correspond to the severity of the clinical symptoms [81].
Intrauterine growth retardation is an early sign of RD, along with decreased foetal movement. Thin, translucent, tight skin, as well as joint contractures, respiratory insufficiency, a small pinched nose, micrognathia and mouth in a characteristic fixed ‘o’ shape are the signs of the disease at birth. Usually respiratory failure due to the tight skin leads to a neonatal death within a few weeks of birth [81,82].
2.4.3. Atypical Werner syndrome
First described in 1904 by Otto Werner, Werner syndrome (WS) is caused by mutations in the WRN gene, encoding a nuclear helicase [83]. However approximately 20% of patients diagnosed with WS do not carry mutations in the WRN gene, and are classed as suffering from atypical Werner syndrome (AWS). A minority of these have been found to carry heterozygous mutations in the LMNA gene, typically at the N-terminal region [84].
WRN is known as ‘progeria of the adult’ and symptoms, such as pubertal growth failure, begin to emerge in the early teenage years. Then in the late teenage years or early 20s, skin atrophy and ulcers, cataracts, type 2 diabetes mellitus, osteoporosis, atherosclerosis, hair greying and alopecia follow. Lipoatrophy and a mild axonal sensorimotor polyneuropathy can also occur. There is also an increased risk of malignancies, reduced fertility and gonadal atrophy. Severe coronary, and peripheral artery disease is also present, and the most common causes of death are myocardial infarction and cancer by a median age of 54 [85,86].
Hydrops-Ectopic calcification-moth-eaten (HEM) skeletal dysplasia is an extremely rare, autosomal recessive lethal chondrodystrophy, which was first described by Greenberg in 1988, in an examination of two sibling foetuses. A 7-bp, homozygous 1599–1605 TCTTCTArCTAGAAG substitution in exon 13 of the lamin B receptor gene (LBR), gave rise to a premature stop codon, resulting in a truncated protein and loss of LBR activity [87,88].
In utero radiological examination revealed ectopic calcifications, a ‘moth eaten’ appearance of the shortened tubular bones. Extramedullary erythropoiesis was also found in both foetuses [89].
2.5.2. Pelger-Huet anomaly
Pelger-Huet anomaly (PHA) is a benign, autosomal dominant blood disorder, with characteristic misshapen, hypolobulated nuclei and abnormally course chromatin in blood granulocytes, caused by a mutation in the LBR gene [89,90]. As PHA was found in relatives to two HEM cases, it is thought that these disorders may be related [91].
Heterozygous patients are clinically normal, while homozygosity has been associated with skeletal dysplasia and early lethality in animal models, although at least one case of non-lethal homozygotic PHA has been found in humans [92].
2.5.3. Reynolds syndrome
Reynolds syndrome (RP) is caused by a heterozygous mutation in the LBR gene, and was first described in 1971 by Reynolds et al. [93].
RP displays a highly heterogeneous set of clinical features similar to the elements of CREST syndrome (CREST is an acronym that stands for calcinosis, Raynaud\'s phenomenon, esophageal dysmotility, sclerodactyly, and telangiectasia). These symptoms include scleroderma, liver disease, telangiectasia, eosophageal varicies and Raynaud’s phenomenon [94].
Osteopoikilosis/Buschke-Ollendorff syndrome (BOS) is a highly penetrant, benign, rare, autosomal dominant bone disorder. It is caused by a mutation in the LEMD3 gene, which encodes the MAN1 protein, an integral protein of the inner nuclear membrane. BOS gives rise to osteopoikilosis with subcutaneous nevi or nodules [95], and is known as osteopoikilosis if no skin phenotype is present [96]. It displays an extremely variable set of clinical features even within the same family [97].
The osteopoikilosis is revealed by radiographs as numerous and widespread grain- to pea-sized areas of increased bone density, most often in the cancellous bone regions of the epiphyses and metaphyses, although they are found in almost all bones in the body, with the exception of the cranium where they are rarely found. The skin phenotype is manifested as firm lesions, which histologically are revealed to be either elastic-type (juvenile elastoma) or collagen-type (dermatofibrosis lenticularis disseminata) nevi. Joint stiffness may also be present [98].
2.5.5. Melorheostosis with osteopoikilosis
Melorheostosis with osteopoikilosis (MEL) has been thought to be caused by a mutation in the LEMD3 gene [96]. It is sometimes a features of BOS, however not universally, and evidence for LEMD3 mutations causing isolated sporadic melorheostosis has not yet been found [97].
MEL is characterised by the flowing hyperostosis of the tubular bone cortices, and sometimes accompanied by abnormalities in surrounding soft-tissue, such as muscle atrophy, joint-contractures, epidermal lesions or hemangiomas [96].
3. Linking genotype and phenotype of laminopathies
A marked change in heterochromatin is one of the most apparent features noted when examining cells affected by laminopathies, from loci of diminished or clumped heterochromatin to total loss of peripheral heterochromatin [99-103]. This alteration of normal heterochromatin, coupled with the known interactions between lamins and gene regulatory proteins, defines a major constituent for the molecular mechanism behind laminopathies [104]. Lamins have been shown to interact with proteins of the inner nuclear membrane (emerin, myne-1, nesprin, LAP1 and LAP2, LBR and MAN1), and chromatin-associated proteins (H2a, H2B, H3-H4, Ha95, HP1 and BAF) [105-109]. These associations allow for gene silencing by means of heterochromatin reorganisation, which could be a causative factor for phenotypic changes [107]. Recruiting genes selectively to the inner nuclear membrane has also been shown to result in their transcriptional repression [10]. The tissue specific gene regulatory role of lamins is thought to underlie the tissue-specific symptoms observed in laminopathies [34,110]. Tissue specific regulation of lamin A expression may also be an explanatory factor for tissue-specific symptoms. Low-level of prelamin A expression in the brain has been shown to be due to a brain-specific microRNA, miRNA-9 [111], and miR-9 overexpression has been shown to alleviate nuclear blebbing in non-neural cells [112].
A mouse model with the LMNA H222P mutation for EDMD, displaying muscular dystrophy and cardiomyopathy, was investigated in order to see how gene regulation and metabolic pathways are affected. This investigation revealed that the extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) branches of the Mitogen-Activated Protein Kinase (MAPK) pathway were activated before any histological changes were visible in the animals. This result was then in vitro confirmed by expressing the mutant lamin A in vitro [113]. This MAPK signalling change is known to be associated with cardiomyopathy [114-116]. Similar results have been demonstrated in an EMD-knockout mouse model for X-linked EDMD, in which MAPK pathway was activated [117].
The possibility of complex interactions between these different causative mechanisms, the complex multirole functionality of lamins, along with widely varying environmental and genetic co-factors affecting this spectrum of processes, would afford a possible explanation for the heterogeneity of disease effects amongst the sufferers of laminopathies [48,118,119]. This variance of disease is one of the most fascinating aspects of laminopathies, the disparity between how a very large family of mutations affecting many genes give rise to diseases with such interrelated clinical features, and on the other hand how even amongst members of a single family carrying the same mutation, disease manifestations are diverse and variable. In AD-EDMD, heterozygous mutations in the LMNA gene can give rise to diverse effects, varying from typical EDMD to no disease phenotype, while members of the same family displaying the same mutation can be disease free, or suffer from contractures and muscular atrophy [120].
The diversity of disease phenotypes in consanguineous patients with identical mutations, such as disease onset, severity and progress, indicates that laminopathies are strongly influenced by disease modifiers such as genetic or environmental factors. For example, female sufferers of FPLD2 exhibit a more pronounced phenotype than male [121], family members with BOS can have both or just one of the bone and skin manifestations of that disease. Different missense mutations at the same locus can also give rise to different laminopathies. For example, in the LMNA gene, R527H and R527C result in MAD [122,123], while R527P causes EMDM (Figure 4) [46]. The same missense mutation at the same locus can also give rise to different laminopathies. For example, S573L in exon 11 of the LMNA in one family gave rise to CDM1A, and in another FPLD2. Of five patients with the same E358K mutation in the LMNA gene, three were diagnosed with autosomal dominant EDMD, one with early-onset LGMD1B, and the last patient with congenital muscular dystrophy (Figure 4] [124]. Although the R644C mutation in exon 11 of LMNA is associated with CDM1A, three cases with this mutation, and one with an R644H mutation were found to have very high variance in their disease phenotypes, with features ranging from reduced foetal movement and a severe congenital muscular dystrophy-like phenotype, to mild skeletal muscle aberrations and severe and fatal hypertrophic cardiomyopathy [125, 126]. Even amongst members of the same family with the same single nucleotide deletion at position 959, in exon 6 of LMNA, one was classified as having DCM, one with EDMD and two with LGMD (Figure 4) [118]. This variation in phenotypes is a recurrent theme in the history of laminopathies, with multiple examples in the literature, which reinforces the importance of disease modifiers.
Figure 3.
Nuclei showing characteristic blebbing and herniation as a result of a mutation in the LMNA gene. (A) is from sample AG06298 (unaffected HGPS parent) and (B) is from sample AG06917 (HGPS), and has the c.1824C>T, G608G mutation in the LMNA gene. Approximately 50% of the AG06917 cells display blebs. Both are primary fibroblasts hybridised with an antibody for lamin A/C (green) and mitochondria (blue). Photo courtesy of Dr. Peter Berglund.
The LMNA missense mutations causing FPLD have been shown to result in nuclei with abnormal shapes, herniated NE and increased fragility, and other laminopathies (including HGPS, Figure 3) have also been found to cause severe changes in nuclear morphology [76,127]. A-type lamin knockout cells display misshapen nuclei with herniations of the NE, slight clustering of NPCs, with mislocalised emerin and B-type lamins. Whereas cells expressing progerin display nuclear blebbing, thickening and honeycombing of the lamina, intranuclear lamina foci, loss of heterochromatin and NPC clustering [2,113,117,128-132]. In PHA however, normally lobulated mature neutrophils exhibit hypolobulation and fail to correctly function [90,133].
An altered nuclear integrity, leading to a weakness in cell structure and a susceptibility to mechanical stress as a constituent of the causative mechanism for laminopathies is supported by the specificity of some laminopathies, such as HGPS or EDMD, to tissues affected by high levels of mechanical stress (the skin, muscles and aortic arch), as well as the similarity of muscular dystrophies caused by mutations in genes responsible for karyoskeleton, cytoskeleton and myotubule proteins to laminopathic muscular dystrophies. The unique expression pattern of lamins in muscle cells might also illuminate a causative system for laminopathies. As no lamin B1 is expressed in muscle cells at all, when LMNA protein products are expressed at reduced levels, or functionally impaired, lamin B2 alone must fulfil the lamina requirements of the cell, undergirding the inner nuclear membrane, localising and supporting key proteins of the inner nuclear membrane and organising and regulating the heterochromatin [134].
Various hypotheses have been put forward to account for the muscle cell specificity of EDMD [135]. Muscle cells contain very low or undetectable amounts of lamin B1, whereas in most other cell types lamin B1 is a major lamin, leaving muscle cells more sensitive to loss of function of either emerin or lamin A/C [42,136]. Emerin may also interact with transcription factors or directly with DNA to cause specific gene regulation in muscle cells [137]. Finally, muscle cells also undergo mechanical stress, and emerin, as part of a nucleo-cytoskeletal system may have a protective role against mechanical stress [138].
Lamin A mutations have also been shown to cause premature exhaustion of somatic stem cell populations, as well as stem cell dysfunction. As adult somatic stem cell population is depleted, tissues undergoing a high rate of turnover, such as the skin, would be affected first [139,140].
Figure 4.
Distribution of laminopathy-causing mutations causing mutations in the LMNA gene. Exons 1-9 and a section of exon 10 encode Lamin C, Lamin A is a result of alternative splicing, adding exon 11 and 12, but removing the lamin C specific part of exon 10 (lamin C specific amino acids marked in green). The conserved α-helical segments of the central rod domain marked with coil 1a, coil 1b, and coil 2. Numbers refer to residues in the primary sequence. Lipodystrophy causing mutations are clustered at exon 8, which codes for an Ig-like domain. The majority (80%) of lipodystrophy cases are caused by a mutation at p.482. Similarly most (>90%) HGPS patients carry the de novo c.1824C>T, G608G mutation, and most (85%) MAD patients carry a homozygous mutation at p.527 [76,141]. The size of introns are not to scale. CDM1A, dilated cardiomyopathy, type 1A; EDMD, Emery–Dreifuss muscular dystrophy; MLF, Malouf Syndrome; MDC, Muscular dystrophy, congenital; LGMD1B, limb girdle muscular dystrophy, type 1B; FPLD, Dunnigan familial partial lipodystrophy; MAD, mandibuloacral dysplasia; CMT2B1, Charcot–Marie–Tooth disorder, type 2B1; AWS, atypical Werner syndrome; HGPS, Hutchinson–Gilford progeria syndrome;
A consistent relationship between mutation location on the LMNA gene and its subsequent effect is difficult to pin down, as shown in figure 4, mutations causing muscular dystrophies are spread all along the gene. However the majority of mutations causing lipodystrophies are located at codon R482, which is conserved across human, mouse, rat and chicken lamin A/C genes [7]. Additionally, the vast majority of segmental progeriod cases are caused by mutations at G608, which affect splicing [34]. The position of the mutation on the LMNA gene relative to the NLS seems to play a significant role in the type of laminopathy induced. When laminopathies were segregated on the basis of which organs they showed clinical pathology in, it was found that there was a strong correlation between the position of the mutation relative to the NLS, and the group the resultant laminopathy was sorted into. For example laminopathies with mutations upstream (N-terminally) of the NLS were more likely to display cardiomyopathy and muscle atrophy, while laminopathies with mutations downstream of the NLS (C-Terminally) were more likely to have progeriod symptoms [32]. The tissue-specificity of the mutations may then be correlated with whether the mutation affects the conserved structurally important rod-domain that lies upstream of the NLS, or if it affects the region downstream of the NLS which has been shown to associate with chromatin and/or transcription factors (Figure 4) [142].
It was suspected that a duplication of the LMNB1 gene was the cause behind ADLD as LMNB1 was the only gene in the duplicated region expressed in the brain, as well as detection of increased levels of lamin B1 in the brains of affected individuals. The role of LMNB1 was confirmed by over-expressing lamin B1 in Drosophila melanogaster, and in HEK293 cells, which showed a strong phenotype, and nuclear folding and blebbing respectively [67,68].
Finally, a link between levels of progerin produced in laminopathies that exhibit an accumulation of the mutant lamin A/C precursor, and both the severity and age of onset of the phenotype has been shown. RD is considered to be similar but more severe than HGPS, with a correspondingly higher rate of prelamin A accumulation [143,144]. Two cases of a Werner syndrome-like form of progeria displayed a progeria-like aspect with middle age onset coronary artery disease, with a level of progerin that was one quarter of that seen in HGPS cells [85]. Further proof of the toxicity of accumulated progerin is shown by the decrease of progerin levels in cell cultures by treatment with rapamycin, with a resultant rescue of the phenotype [145]. As allele dependant differences in expression of the LMNA gene have been observed, with one allele accounting for 70% and the other accounting for 30% of the expressed lamin A and C transcripts, one explanation for phenotype variation might depend on which allele the disease-causing mutation is located [146].
These details paint a complex picture of a heterogeneous family of mutations resulting in varying and overlapping phenotypes, with a diversity in severity and age of onset resulting from tissue specific gene regulation, site of mutation and various genetic and possibly environmental co-factors.
4. Mouse models
Mouse models have yielded invaluable knowledge about the functions of the LMNA gene and about the molecular effects of mutations that cause laminopathies. Possibilities for treatment have also been explored with mouse models for these diseases. Various methods have been used to produce strains of mice with similar phenotype to those shown in human laminopathies. Most of the available relevant models have been summarized in the table below (Table 2).
Mice that were thought to completely lack A-type lamin expression were created in order to study a model with no expressed lamin A/C. These Lmna-null mice are phenotypically normal at birth, but develop a condition similar to EDMD. By two to three weeks of age they display a growth retardation and arrest. Skeletal abnormalities including kyphosis occur, and a loss of white adipose tissue was noted. Cardiac myopathies also develop, and death occurred within eight weeks. An analysis of mouse embryonic fibroblasts (MEFs) showed misshapen, herniated nuclei. Mice heterozygous for Lmna were phenotypically normal [101]. The phenotype for Lmna knockout mice showed neuropathic features, decreased axon density paired with increased axon diameter and non-myelinated axons, features that are markedly similar to human axonopathies [70,101]. The only known case of an LMNA-null human, with homozygous nonsense mutations in LMNA, resulted in a perinatal lethality, exhibiting small size, retrognathia, severe limb and phalangeal contractures, fractures in the femur and arm, muscular dystrophy. Death was due to respiratory failure [51]. Apart from these differences in disease severity, changes in the proliferation of LMNA-null fibroblasts were also markedly dissimilar for human as compared to mouse. Patient fibroblasts showed a reduced proliferation [160], while MEFs showed an increased proliferative potential compared to wild-type MEFs [161]. Recently these mice have been found to express a C-terminally truncated Lmna gene product, missing residues 461–657 of wild-type lamin A, which are normally encoded by exons 8–11. This expression, both on a transcriptional and protein level, perhaps explains the difference in fibroblast proliferative potential between human LMNA-null fibroblasts and MEFs from this mouse model, as well as raising questions about the many studies that have been performed on these mice [162].
Mice with the Zmpste24 gene knocked out were created independently by two groups [151,163]. While loss of the ZMPSTE24 gene due to homozygous or compound heterozygous mutations in humans results in the neonatally lethal disease, RD, these mouse models did not display an equivalent phenotype. The Zmpste24-/- mice lack the ability to convert farnesylated prelamin A to mature lamin A, and so accumulate prelamin A at the nuclear rim, resulting in aberrant nuclear morphology. Normal at birth, they develop a HGPS-like condition, showing growth retardation, alopecia, kyphosis, weight loss and incisor defects. Spontaneous bone fractures also occur as the animals age and death occurs prematurely, at 20-30 weeks [150,151]. That the accumulation of prelamin A was the direct cause of the disease state was demonstrated when Zmpste24-/- mice with only one allele for the Lmna gene were compared to Zmpste24-/- mice with two copies of Lmna. The Zmpste24-/-Lmna +/- mice had significantly reduced levels of prelamin A compared to Zmpste24-/-Lmna +/+ mice. All disease phenotype was missing, and the ratio of misshapen nuclei to normal was also reduced [103].
\n\t\t
\n\t\t
\n\t\t
\n\t\t
\n\t\t
\n\t\t\t
Mouse model
\n\t\t\t
Description
\n\t\t\t
Pathology
\n\t\t\t
Reference
\n\t\t
\n\t\t
\n\t\t\t
\n\t\t\t\tLmna\n\t\t\t\t−/−\n\t\t\t
\n\t\t\t
These Lmna null mice were designed to produce no lamin A or C. Recently however they have been found to produce a truncated lamin A protein.
\n\t\t\t
Postnatal lethality, with cardiomyopathy and muscular dystrophy
Growth retardation, developmental heart defects, skeletal muscle hypotrophy, decreased subcutaneous adipose tissue. Death occurs at 2 to 3 weeks post partum, without dilated cardiomyopathy or an obvious progeroid phenotype.
These mice are null for the endoprotease responsible for the final cleavage step in prelamin A maturation, leading to an accumulation of farnesylated pre-lamin A.
\n\t\t\t
Mice have rib fractures, osteoporosis, muscle weakness and die at 6–7 months.
These mice carry an Lmna-knock in allele that produces progerin. Mice accumulate farnesyl–prelamin A.
\n\t\t\t
Heterozygous mice, Lmna\n\t\t\t\tHG/- , express large amounts of progerin and develop many disease phenotypes of progeria. MEFs display nuclear blebbing.
The wild-type mouse lmna gene is replaced with a copy containing the c.1827C>T;p.G609G mutation. This is the equivalent of the HGPS c.1824C>T;p.G608G mutation in the human LMNA gene.
\n
Growth retardation, weight loss, cardiovascular problems and shortened lifespan.
Selected mouse models relevant for studying laminopathies.
A mouse model for EDMD was created by knocking out the Emd gene. These animals had no abnormal clinical features outside of a slightly retarded muscle regeneration, and altered motor coordination when tested on a rotarod [158,159]. The human AD-EDMD mutations in the LMNA gene, H222P (with a histidine substituting for a proline at residue 222) and N195K (with a lysine substituting for asparagine at residue 195), have also been used to create mouse models for AD-EDMD. Again, mice heterozygous for the mutations are indistinguishable from wild-type animals. Mice with two copies of the mutation however, showed a muscular dystrophy and cardiomyopathy phenotype [152,153].
Knock-in mouse models such as the LmnaG609G mouse model closely mimic the human disease HGPS. A copy of the wild-type mouse lmna gene was replaced with a copy containing the c.1827C>T;p.G609G mutation, the equivalent of the HGPS c.1824C>T;p.G608G mutation in the human LMNA gene. This gave a phenotype of growth retardation, weight loss, cardiovascular problems and curtailed lifespan, correlating neatly with the clinical features found in the human disease. However, the disease symptoms were most marked and similar in the homozygous state, whereas in humans an autosomal dominant state with only a single mutated allele confers the disease state [157].
A mouse model where only lamin-C is produced (LmnaLCO), without producing any prelamin A or mature lamin A. These LmnaLCO/LCO animals were entirely healthy, with only a minimal alteration to normal nuclear shape [132]. More recently a mouse model where only mature lamin A is expressed was made. These LmnaLAO/LAO mice synthesis mature lamin A without any prelamin A synthesis or processing steps. They display no disease phenotype, but do have an increased level of nuclear blebbing compared to wild-type, demonstrating that bypassing prelamin A processing and directly synthesising mature lamin A has little effect on the transportation of lamin A to the nuclear envelope [149].
In order to study early post-natal development effects caused by loss of lamin A/C, an LmnaGT-/- model was created. This model simultaneously inactivates and reports the expression of Lmna. Loss of lamin A/C resulted in growth retardation, developmental defects of the heart, skeletal muscle hypotrophy, loss of subcutaneous adipose tissue and impaired ex vivo adipogenic differentiation. Premature death occurred at two to three week post partum [148].
A mouse model was created using a heart-selective promoter (α-myosin heavy chain promoter) to control the expression of human normal lamin A, and lamin A containing the EDMD causing mutation M371K. Mice expressing the wild-type human lamin A were born at slightly less than expected rates, and had a normal lifespan. However, mice expressing mutant M371K lamin A exhibited a much higher risk of prenatal death, and were born at only a fraction (0.07) of the expected frequency. Those animals that were born died within 2-7 weeks, and displayed pulmonary and cardia edema. Cardiac cells from these mice showed abnormal, convoluted nuclear envelopes with clumped chromatin and intranuclear foci of lamins [156].
Mouse models of laminopathies are limited by the gross physiological differences between rodent (mouse models being the most relevant models used to investigate laminopathies) and human. However, despite the limitations of mouse models, the advantages are legion; being able to study very rare diseases at any stage of disease, with limitless sampling, temporal and physically controlled expression of mutant protein, and with the possibilities for testing different type of treatment.
5. Treatment
Current treatments for laminopathies are largely symptomatic, controlling the secondary effects of the disease. Corrective surgery is used to treat the EDMD contractures, coronary artery bypass surgery for HGPS, pacemaker installation or heart transplantation for DCMI or LGMD1B patients [164]. FPLD2 patients with diabetes mellitus and hypertension are treated with antidiabetic drugs, angiotensin converting enzyme inhibitors, calcium channel blockers and beta blockers [52,165,166]. The administration of a recombinant methionyl human leptin has been tried with some success in patients suffering from FPLD, giving rise to improved fasting glucose concentrations, insulin sensitivity, and triglyceride levels [167,168]. The impairment of pre-adipocyte differentiation, an impairment which is brought about by the negative effects of prelamin A accumulation on the rate of DNA-bound SREBP1, may also be treated with troglitazone, a PPAR-gamma ligand which promotes the adipogenic program [169].
Curative treatment for laminopathies that are autosomal-recessive involving loss-of-function of a protein, such as EDMD-AR, would require the expression of a healthy wild-type allele in the affected tissue. However, autosomal dominant laminopathies require a more complex treatment, in which the production, modification and/or the effect of the mutant protein also need to be eliminated. For example, in a phase II clinical trial with HGPS patients, lonafarnib, a farnesyl transferase inhibitor (FTI) is being given as treatment (see chapter on Hutchinson-Gilford progeria syndrome) [170]. FTI is normally used as an anti-tumour treatment, but it also reduces the amount of progerin produced by inhibiting the farnesylation of prelamin A. Previous experiments with FTIs in cell cultures showed marked improvements, with a reduction of misshapen nuclei [171]. With mouse models for HGPS an improvement in disease phenotype was noted, although no total reversal was apparent [172-176]. This may be due to the fact that although FTI treatment inhibits the farnesylation of prelamin-A by farnesyl transferase, a secondary modification pathway, a geranylgeranylation by geranylgeranyltransferase, allows prelamin A to be processed into progerin despite the FTI treatment [177]. However, a combination of statins (a potent HMG-CoA reductase inhibitor, used to inhibit the production of cholesterol in the liver) and bisphosphonates (a class of drugs used to treat osteoporosis), was used to inhibit the synthesis of farnesyl pyrophosphate, a co-substrate of farnesyltransferase and a precursor of a substrate for geranylgeranyltransferase I. This combination inhibits prenylation, and when used to treat laminopathies, resulted in an increased longevity, reduced oxidative stress, cellular senescence and improved phenotype in mice [61,154,172,178,179]. A triple drug trial was initiated in 2009 to examine the efficacy of treatment involving an FTI, a statin and a bisphosphonate, however the results of this trial have not yet been made public.
Long-term treatment with FTIs is not without risks. All CaaX box/motif proteins would have their farnesylation processing inhibited, which would mean an inhibition of lamin-B maturation. Non-farnesylated lamins might also accumulate in the cell, with unexpected effects. In a mice model where non-farnesylated prelamin-A was solely expressed, with the CaaX motif/box mutated to SAAX, a cardiomyopathy was observed to occur [180]. In HIV treatment, acquired lipodystrophy is a possible side-effect of the use of HIV protease inhibitors, which cause pre-lamin A accumulation [181]. This pre-lamin accumulation was also observed in fibroblasts from FPLD2 patients, further hinting at the toxicity of pre-lamin A accumulation [61].
Rapamycin, an immunosuppressant antibiotic drug, has also been examined as a possible treatment in laminopathies. Rapamycin treatment in HGPS cell cultures resulted in reduced nuclear blebbing and decreased rates of senescence, as well as a marked reduction of progerin and prelamin A levels, a restoration of wildtype LAP2α, BAF and trimethylated H3K9 organisation, and a rescue of the normal chromatin phenotype. These effects come about by means of autophagic degradation of prelamin A, triggered by inactivation of the inhibitory mammalian target of rapamycin (mTOR) dependent pathway [145,182]. In an Lmna−/− mouse model treatment with rapamycin was shown to improve cardiac and skeletal muscle function, as well as improving the survival rate [183]. In the LmnaH222P/H222P mouse model, rapamycin treatment was shown to improve cardiac function [184]. This mouse model has also been treated with other inhibitors of MAPK/ERK kinase (MEK) (the mitogen-activated protein kinase (MAPK kinase) that activates extracellular signal-regulated protein kinase (ERK)), in order to see if administration would alleviate or prevent the cardiomyopathy. The MEK-inhibitor treated animals were indistinguishable from wild-type animals, while untreated control animals displayed reduced ejection fraction, indicating a dilated cardiomyopathy. Interestingly, abnormal elongation of heart cell nuclei was noted in untreated control animals, but was not observed in the treatment group [113,185]. As with FTIs, the long-term treatment of patients with rapamycin would entail the acceptance of know side-effects, such as lung toxicity, insulin resistance, cataracts and testicular degeneration [186-189].
Pre-lamin A antisense oligonucleotides were used to reduce pre-lamin A levels, with a resultant decrease in misshapen nuclei. The most common HGPS point mutation causes an increased usage of a cryptic splice site in exon 11, CAG#GTGGGC, which is also used at near-undetectable levels in wild-type cells. Antisense morpholino oligonucleotides directed to this site resulted in an improvement of HGPS fibroblast disease phenotype [190]. RNA interference has also been used to successfully improve proliferation and nuclear morphology, as well as reducing senescence in fibroblasts expressing mutant lamin A [191]. In another experiment exon 11 splice donor site antisense oligonucleotides were also used to promote the alternative splice pathway, leading to an increased in progerin production in fibroblast cells, and short hairpin RNA (shRNA) were then used to diminish this production in fibroblasts, leading to an improvement of phenotype [192]. Morpholinos have also been used to target the cryptic splicing event in mouse. The use of antisense morpholinos to the exon 10 lamin A splice donor site and the c.1827C>T;p.G609G mutation of the LMNA transcript was shown to reduce progerin levels, partially restore a wild-type phenotype and extend lifespan of a mouse model for HGPS [157].
In light of the recent Glybera Gene therapy [193], future gene therapies for the treatment of the cardiomyopathy prevalent in muscular dystrophies may also be an area of interest [194-196].
6. Conclusion
During the last decade the number of diseases found to be caused by mutations in lamin or lamin associated genes has increased significantly. These phenotypically diverse diseases have been categorised both phenotypically and genetically, and today research is focused on both deciphering the pathogenic mechanisms behind their pathophysiological processes, as well as understanding how such diverse pathologies can arise from this related family of mutations. During that time the appreciated role for lamins has changed from being regarded merely as a structural scaffold for the nucleus, to a key element in DNA replication and transcription, chromatin organisation, cell replication and differentiation. Future research is sure to continue at an ever-increasing pace, especially as the development and integration of next generation sequencing technologies and technologies that allows for global analysis of the genome and epigenome into both research and clinical settings. For researchers this level of genomic interrogation brings about unprecedented access to new information about our genome, which will be valuable for the creation of maps of genetic and possibly epigenetic variation that influence disease.
The laminopathies described in this review are without a doubt, exceedingly rare. However by researching these rare conditions, it is hoped that we can shed light on their all too common clinical symptoms, such as cardiac disease, metabolic disorders such as insulin resistance, and even ageing itself.
Acknowledgments
Our work is supported by a VINNMER fellow grant from VINNOVA, and an Innovator grant from The Progeria Research Foundation. We thank the patients, and Dr. Nicola Carboni and Dr Marco Mura for contributing photos of patients. Primary fibroblast cultures were obtained from the Aging Repository of the Coriell Cell Repository.
\n',keywords:null,chapterPDFUrl:"https://cdn.intechopen.com/pdfs/41310.pdf",chapterXML:"https://mts.intechopen.com/source/xml/41310.xml",downloadPdfUrl:"/chapter/pdf-download/41310",previewPdfUrl:"/chapter/pdf-preview/41310",totalDownloads:2558,totalViews:445,totalCrossrefCites:2,totalDimensionsCites:2,hasAltmetrics:0,dateSubmitted:"April 26th 2012",dateReviewed:"September 25th 2012",datePrePublished:null,datePublished:"January 9th 2013",dateFinished:null,readingETA:"0",abstract:null,reviewType:"peer-reviewed",bibtexUrl:"/chapter/bibtex/41310",risUrl:"/chapter/ris/41310",book:{slug:"genetic-disorders"},signatures:"Tomás McKenna, Jean-Ha Baek and Maria Eriksson",authors:[{id:"45285",title:"Mr.",name:"Tomás",middleName:null,surname:"McKenna",fullName:"Tomás McKenna",slug:"tomas-mckenna",email:"Tomas.Mckenna@ki.se",position:null,institution:null},{id:"156739",title:"Dr.",name:"Maria",middleName:null,surname:"Eriksson",fullName:"Maria Eriksson",slug:"maria-eriksson",email:"Maria.Eriksson.2@ki.se",position:null,institution:null},{id:"156913",title:"Dr.",name:"Jean-Ha",middleName:null,surname:"Baek",fullName:"Jean-Ha Baek",slug:"jean-ha-baek",email:"jean-ha.baek@ki.se",position:null,institution:null}],sections:[{id:"sec_1",title:"1. Introduction ",level:"1"},{id:"sec_1_2",title:"1.1. The nuclear envelope",level:"2"},{id:"sec_2_2",title:"1.2. The lamins",level:"2"},{id:"sec_4",title:"2. Laminopathies",level:"1"},{id:"sec_4_2",title:"2.1. Muscular dystrophies",level:"2"},{id:"sec_4_3",title:"Table 1.",level:"3"},{id:"sec_5_3",title:"2.1.2. Limb-girdle muscular dystrophy, type 1B",level:"3"},{id:"sec_6_3",title:"2.1.3. Dilated cardiomyopathy with conduction defect 1",level:"3"},{id:"sec_7_3",title:"2.1.4. Malouf syndrome",level:"3"},{id:"sec_8_3",title:"2.1.5. Heart-hand syndrome, Slovenian type ",level:"3"},{id:"sec_10_2",title:"2.2. Lipodystrophies",level:"2"},{id:"sec_10_3",title:"2.2.1. Familial partial lipodystrophy type 2 ",level:"3"},{id:"sec_11_3",title:"2.2.2. Mandibuloacral dysplasia, type A and B",level:"3"},{id:"sec_13_2",title:"2.3. Neuropathies",level:"2"},{id:"sec_13_3",title:"2.3.1. Adult-onset autosomal dominant leukodystrophy",level:"3"},{id:"sec_14_3",title:"2.3.2. Charcot-Marie-Tooth disorder",level:"3"},{id:"sec_16_2",title:"2.4. Segmental progeroid diseases",level:"2"},{id:"sec_16_3",title:"2.4.1. Hutchinson-Gilford progeria syndrome",level:"3"},{id:"sec_17_3",title:"2.4.2. Restrictive dermopathy",level:"3"},{id:"sec_18_3",title:"2.4.3. Atypical Werner syndrome",level:"3"},{id:"sec_20_2",title:"2.5. Overlapping syndromes",level:"2"},{id:"sec_20_3",title:"2.5.1. Hydrops-Ectopic calcification-moth-eaten skeletal dysplasia",level:"3"},{id:"sec_21_3",title:"2.5.2. Pelger-Huet anomaly",level:"3"},{id:"sec_22_3",title:"2.5.3. Reynolds syndrome",level:"3"},{id:"sec_23_3",title:"2.5.4. Osteopoikilosis/Buschke-Ollendorff syndrome",level:"3"},{id:"sec_24_3",title:"2.5.5. Melorheostosis with osteopoikilosis",level:"3"},{id:"sec_27",title:"3. Linking genotype and phenotype of laminopathies",level:"1"},{id:"sec_28",title:"4. Mouse models",level:"1"},{id:"sec_29",title:"5. Treatment",level:"1"},{id:"sec_30",title:"6. Conclusion",level:"1"},{id:"sec_31",title:"Acknowledgments",level:"1"}],chapterReferences:[{id:"B1",body:'Cronshaw JM, Krutchinsky AN, Zhang W, Chait BT, Matunis MJ. Proteomic analysis of the mammalian nuclear pore complex. Journal of Cell Biology. 2002Sep.2;158(5):915–27. '},{id:"B2",body:'Shimi T, Butin-Israeli V, Goldman RD. The functions of the nuclear envelope in mediating the molecular crosstalk between the nucleus and the cytoplasm. Current Opinion in Cell Biology. 2012Feb.;24(1):71–8. '},{id:"B3",body:'Fried H, Kutay U. Nucleocytoplasmic transport: taking an inventory. Cell. Mol. Life Sci. 2003Aug.;60(8):1659–88. '},{id:"B4",body:'Zastrow MS, Vlcek S, Wilson KL. Proteins that bind A-type lamins: integrating isolated clues. '},{id:"B5",body:'Lin F. MAN1, an integral protein of the inner nuclear membrane, binds Smad2 and Smad3 and antagonizes transforming growth factor- signaling. Human Molecular Genetics. 2004Dec.8;14(3):437–45. '},{id:"B6",body:'Fisher D, Chaudhary N. cDNA sequencing of nuclear lamins A and C reveals primary and secondary structural homology to intermediate filament proteins. Proceedings of the …. 1986Jan.1. '},{id:"B7",body:'Stuurman N, Heins S, Aebi U. Nuclear Lamins: Their Structure, Assembly, and Interactions* 1. Journal of structural biology. 1998Aug.18;:1–25. '},{id:"B8",body:'Dechat T, Pfleghaar K, Sengupta K, Shimi T, Shumaker DK, Solimando L, et al. Nuclear lamins: major factors in the structural organization and function of the nucleus and chromatin. Genes & development. 2008Apr.1;22(7):832–53. '},{id:"B9",body:'Moir R, Spann T. The structure and function of nuclear lamins: implications for disease. Cellular and Molecular Life Sciences. 2001Jan.1. '},{id:"B10",body:'Reddy KL, Zullo JM, Bertolino E, Singh H. Transcriptional repression mediated by repositioning of genes to the nuclear lamina. Nature. 2008Mar.13;452(7184):243–7. '},{id:"B11",body:'Gruenbaum Y, Margalit A, Goldman RD, Shumaker DK, Wilson KL. The nuclear lamina comes of age. Nat Rev Mol Cell Biol. 2005Jan.;6(1):21–31. '},{id:"B12",body:'Rout MP. The Nuclear Pore Complex as a Transport Machine. Journal of Biological Chemistry. 2001Apr.5;276(20):16593–6. '},{id:"B13",body:'Lin F, Worman HJ. Structural organization of the human gene encoding nuclear lamin A and nuclear lamin C. J Biol Chem. 1993Aug.5;268(22):16321–6. '},{id:"B14",body:'Barrowman J, Hamblet C, George CM, Michaelis S. Analysis of prelamin A biogenesis reveals the nucleus to be a CaaX processing compartment. Mol. Biol. Cell. 2008Dec.;19(12):5398–408. '},{id:"B15",body:'Röber RA, Weber K, Osborn M. Differential timing of nuclear lamin A/C expression in the various organs of the mouse embryo and the young animal: a developmental study. Development. 1989Feb.;105(2):365–78. '},{id:"B16",body:'Zorenc AHG. An Alternative Splicing Product of the Lamin A/C Gene Lacks Exon 10. Journal of Biological Chemistry. 1996Apr.19;271(16):9249–53. '},{id:"B17",body:'Jahn D, Schramm S, Benavente R, Alsheimer M. Dynamic properties of meiosis-specific lamin C2 and its impact on nuclear envelope integrity. Nucleus. 2010May;1(3):273–83. '},{id:"B18",body:'Alsheimer M, Benavente R. Change of karyoskeleton during mammalian spermatogenesis: expression pattern of nuclear lamin C2 and its regulation. Experimental Cell Research. 1996Nov.1;228(2):181–8. '},{id:"B19",body:'Stick R, Hausen P. Changes in the nuclear lamina composition during early development of Xenopus laevis. Cell. 1985May;41(1):191–200. '},{id:"B20",body:'Lehner CF, Stick R, Eppenberger HM, Nigg EA. Differential expression of nuclear lamin proteins during chicken development. Journal of Cell Biology. 1987Jul.;105(1):577–87. '},{id:"B21",body:'Furukawa K, Inagaki H, Hotta Y. Identification and cloning of an mRNA coding for a germ cell-specific A-type lamin in mice. Experimental Cell Research. 1994Jun.;212(2):426–30. '},{id:"B22",body:'Lin F, Worman HJ. Structural organization of the human gene (LMNB1) encoding nuclear lamin B1. Genomics. 1995May20;27(2):230–6. '},{id:"B23",body:'Biamonti G, Giacca M, Perini G, Contreas G, Zentilin L, Weighardt F, et al. The gene for a novel human lamin maps at a highly transcribed locus of chromosome 19 which replicates at the onset of S-phase. Mol. Cell. Biol. 1992Aug.;12(8):3499–506. '},{id:"B24",body:'Furukawa K, Hotta Y. cDNA cloning of a germ cell specific lamin B3 from mouse spermatocytes and analysis of its function by ectopic expression in somatic cells. The EMBO journal. 1993Jan.;12(1):97–106. '},{id:"B25",body:'Pollard KM, Chan EK, Grant BJ, Sullivan KF, Tan EM, Glass CA. In vitro posttranslational modification of lamin B cloned from a human T-cell line. Mol. Cell. Biol. 1990May;10(5):2164–75. '},{id:"B26",body:'Kitten GT, Nigg EA. The CaaX motif is required for isoprenylation, carboxyl methylation, and nuclear membrane association of lamin B2. Journal of Cell Biology. 1991Apr.;113(1):13–23. '},{id:"B27",body:'Lutz RJ, Trujillo MA, Denham KS, Wenger L, Sinensky M. Nucleoplasmic localization of prelamin A: implications for prenylation-dependent lamin A assembly into the nuclear lamina. Proceedings of the National Academy of Sciences of the United States of America. 1992Apr.1;89(7):3000–4. '},{id:"B28",body:'Holtz D, Tanaka RA, Hartwig J, McKeon F. The CaaX motif of lamin A functions in conjunction with the nuclear localization signal to target assembly to the nuclear envelope. Cell. 1989Dec.22;59(6):969–77. '},{id:"B29",body:'Vergnes L, Péterfy M, Bergo MO, Young SG, Reue K. Lamin B1 is required for mouse development and nuclear integrity. Proceedings of the National Academy of Sciences of the United States of America. 2004Jul.13;101(28):10428–33. '},{id:"B30",body:'Hennekes H, Nigg EA. The role of isoprenylation in membrane attachment of nuclear lamins. A single point mutation prevents proteolytic cleavage of the lamin A precursor and confers membrane binding properties. 1994. '},{id:"B31",body:'Worman HJ, Fong LG, Muchir A, Young SG. Laminopathies and the long strange trip from basic cell biology to therapy. J. Clin. Invest. 2009Jul.;119(7):1825–36. '},{id:"B32",body:'Hegele R. LMNA mutation position predicts organ system involvement in laminopathies. Clinical Genetics. 2005Apr.5;68(1):31–4. '},{id:"B33",body:'Landires I, Pascale JM, Motta J. The position of the mutation within the LMNA gene determines the type and extent of tissue involvement in laminopathies. Clinical Genetics. 2007Apr.25;71(6):592–3. '},{id:"B34",body:'Broers JLV, Ramaekers FCS, Bonne G, Yaou RB, Hutchison CJ. Nuclear lamins: laminopathies and their role in premature ageing. Physiological Reviews [Internet]. 2006Jul.;86(3):967–1008. Available from: http://physrev.physiology.org/cgi/content/abstract/86/3/967'},{id:"B35",body:'Zaremba-Czogalla M, Dubińska-Magiera M, Rzepecki R. Laminopathies: the molecular background of the disease and the prospects for its treatment. Cell. Mol. Biol. Lett. 2011Mar.;16(1):114–48. '},{id:"B36",body:'Hegele RA, Cao H, Liu DM, Costain GA, Charlton-Menys V, Rodger NW, et al. Sequencing of the reannotated LMNB2 gene reveals novel mutations in patients with acquired partial lipodystrophy. Am. J. Hum. Genet. 2006Aug.;79(2):383–9. '},{id:"B37",body:'Emery AE, Dreifuss FE. Unusual type of benign x-linked muscular dystrophy. J. Neurol. Neurosurg. Psychiatr. 1966Aug.;29(4):338–42. '},{id:"B38",body:'Muchir A, Worman HJ. Emery-Dreifuss muscular dystrophy. Curr Neurol Neurosci Rep. 2007Jan.;7(1):78–83. '},{id:"B39",body:'Helbling-Leclerc A, Bonne G, Schwartz K. Emery-Dreifuss muscular dystrophy. Eur J Hum Genet. 2002Mar.;10(3):157–61. '},{id:"B40",body:'Manilal S, Nguyen TM, Sewry CA, Morris GE. The Emery-Dreifuss muscular dystrophy protein, emerin, is a nuclear membrane protein. Human Molecular Genetics. 1996Jun.;5(6):801–8. '},{id:"B41",body:'Nagano A, Koga R, Ogawa M, Kurano Y, Kawada J, Okada R, et al. Emerin deficiency at the nuclear membrane in patients with Emery-Dreifuss muscular dystrophy. Nat Genet. 1996Mar.;12(3):254–9. '},{id:"B42",body:'Manilal S. Distribution of emerin and lamins in the heart and implications for Emery-Dreifuss muscular dystrophy. Human Molecular Genetics. 1999Feb.1;8(2):353–9. '},{id:"B43",body:'Meinke P, Nguyen TD, Wehnert MS. The LINC complex and human disease. Biochem. Soc. Trans. 2011Dec.;39(6):1693–7. '},{id:"B44",body:'Scharner J, Brown CA, Bower M, Iannaccone ST, Khatri IA, Escolar D, et al. Novel LMNA mutations in patients with Emery-Dreifuss muscular dystrophy and functional characterization of four LMNA mutations. Hum. Mutat. 2011Feb.;32(2):152–67. '},{id:"B45",body:'Lassuthová P, Baránková L, Kraus J, Maríková T, Seeman P. Emery-Dreifuss muscular dystrophy: a novel mutation in the LMNA gene. Pediatr. Neurol. 2009Aug.;41(2):127–30. '},{id:"B46",body:'Bonne G, Di Barletta MR, Varnous S, Bécane HM, Hammouda EH, Merlini L, et al. Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat Genet. 1999Mar.;21(3):285–8. '},{id:"B47",body:'Felice KJ, Schwartz RC, Brown CA, Leicher CR, Grunnet ML. Autosomal dominant Emery-Dreifuss dystrophy due to mutations in rod domain of the lamin A/C gene. Neurology. 2000Jul.25;55(2):275–80. '},{id:"B48",body:'Canki-Klain N, Récan D, Milicić D, Llense S, Leturcq F, Deburgrave N, et al. Clinical variability and molecular diagnosis in a four-generation family with X-linked Emery-Dreifuss muscular dystrophy. Croat. Med. J. 2000Dec.;41(4):389–95. '},{id:"B49",body:'Muchir A, Bonne G, van der Kooi AJ, van Meegen M, Baas F, Bolhuis PA, et al. Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B). Human Molecular Genetics. 2000May22;9(9):1453–9. '},{id:"B50",body:'Yuan W-L, Huang C-Y, Wang J-F, Xie S-L, Nie R-Q, Liu Y-M, et al. R25G mutation in exon 1 of LMNA gene is associated with dilated cardiomyopathy and limb-girdle muscular dystrophy 1B. Chin. Med. J. 2009Dec.5;122(23):2840–5. '},{id:"B51",body:'van Engelen BGM, Muchir A, Hutchison CJ, van der Kooi AJ, Bonne G, Lammens M. The lethal phenotype of a homozygous nonsense mutation in the lamin A/C gene. Neurology. 2005Jan.24;64(2):374–6. '},{id:"B52",body:'Song K, Dubé MP, Lim J, Hwang I, Lee I, Kim J-J. Lamin A/C mutations associated with familial and sporadic cases of dilated cardiomyopathy in Koreans. Exp. Mol. Med. 2007Feb.28;39(1):114–20. '},{id:"B53",body:'Fatkin D, MacRae C, Sasaki T, Wolff MR, Porcu M, Frenneaux M, et al. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. New England journal of medicine. 1999Dec.2;341(23):1715–24. '},{id:"B54",body:'McPherson E, Turner L, Zador I, Reynolds K, Macgregor D, Giampietro PF. Ovarian failure and dilated cardiomyopathy due to a novel lamin mutation. Am. J. Med. Genet. 2009Feb.15;149A(4):567–72. '},{id:"B55",body:'Garg A, Subramanyam L, Agarwal AK, Simha V, Levine B, D\'Apice MR, et al. Atypical Progeroid Syndrome due to Heterozygous Missense LMNA Mutations. Journal of Clinical Endocrinology & Metabolism. 2009Dec.3;94(12):4971–83. '},{id:"B56",body:'Renou L, Stora S, Yaou RB, Volk M, Sinkovec M, Demay L, et al. Heart-hand syndrome of Slovenian type: a new kind of laminopathy. Journal of Medical Genetics. 2008Jun.25;45(10):666–71. '},{id:"B57",body:'Sinkovec M, Petrovič D, Volk M, Peterlin B. Familial progressive sinoatrial and atrioventricular conduction disease of adult onset with sudden death, dilated cardiomyopathy, and brachydactyly. A new type of heart-hand syndrome? Clinical Genetics. 2005Jun.17;68(2):155–60. '},{id:"B58",body:'Morel CF. A LMNA Splicing Mutation in Two Sisters with Severe Dunnigan-Type Familial Partial Lipodystrophy Type 2. Journal of Clinical Endocrinology & Metabolism. 2006Apr.18;91(7):2689–95. '},{id:"B59",body:'Shackleton S, Lloyd DJ, Jackson SN, Evans R, Niermeijer MF, Singh BM, et al. LMNA, encoding lamin A/C, is mutated in partial lipodystrophy. Nat Genet. 2000Feb.;24(2):153–6. '},{id:"B60",body:'Saha B, Lessel D, Hisama FM, Leistritz DF, Friedrich K, Martin GM, et al. A Novel LMNA Mutation Causes Altered Nuclear Morphology and Symptoms of Familial Partial Lipodystrophy (Dunnigan Variety) with Progeroid Features. Mol Syndromol. 2010Sep.;1(3):127–32. '},{id:"B61",body:'Caron M, Auclair M, Donadille B, Béréziat V, Guerci B, Laville M, et al. Human lipodystrophies linked to mutations in A-type lamins and to HIV protease inhibitor therapy are both associated with prelamin A accumulation, oxidative stress and premature cellular senescence. Cell Death Differ. Nature Publishing Group; 2007Jul.6;14(10):1759–67. '},{id:"B62",body:'GARG A, Wilson R, Barnes R, Arioglu E, Zaidi Z, Gurakan F, et al. A gene for congenital generalized lipodystrophy maps to human chromosome 9q34. Journal of Clinical Endocrinology & Metabolism. 1999Sep.;84(9):3390–4. '},{id:"B63",body:'Garavelli L, D\'Apice MR, Rivieri F, Bertoli M, Wischmeijer A, Gelmini C, et al. Mandibuloacral dysplasia type A in childhood. Am. J. Med. Genet. 2009Oct.;149A(10):2258–64. '},{id:"B64",body:'Agarwal AK, Fryns J-P, Auchus RJ, Garg A. Zinc metalloproteinase, ZMPSTE24, is mutated in mandibuloacral dysplasia. Human Molecular Genetics. 2003Aug.15;12(16):1995–2001. '},{id:"B65",body:'Garg A, Cogulu O, Ozkinay F, Onay H, Agarwal AK. A novel homozygous Ala529Val LMNA mutation in Turkish patients with mandibuloacral dysplasia. Journal of Clinical Endocrinology & Metabolism. 2005Sep.;90(9):5259–64. '},{id:"B66",body:'Zirn B, Kress W, Grimm T, Berthold LD, Neubauer B, Kuchelmeister K, et al. Association of homozygous LMNA mutation R471C with new phenotype: mandibuloacral dysplasia, progeria, and rigid spine muscular dystrophy. Am. J. Med. Genet. 2008Apr.15;146A(8):1049–54. '},{id:"B67",body:'Padiath QS, Saigoh K, Schiffmann R, Asahara H, Yamada T, Koeppen A, et al. Lamin B1 duplications cause autosomal dominant leukodystrophy. Nat Genet. 2006Oct.;38(10):1114–23. '},{id:"B68",body:'Schuster J, Sundblom J, Thuresson A-C, Hassin-Baer S, Klopstock T, Dichgans M, et al. Genomic duplications mediate overexpression of lamin B1 in adult-onset autosomal dominant leukodystrophy (ADLD) with autonomic symptoms. Neurogenetics. 2011Feb.;12(1):65–72. '},{id:"B69",body:'Bouhouche A, Benomar A, Birouk N, Mularoni A, Meggouh F, Tassin J, et al. A locus for an axonal form of autosomal recessive Charcot-Marie-Tooth disease maps to chromosome 1q21. 2-q21. 3. Am. J. Hum. Genet. Elsevier; 1999;65(3):722–7. '},{id:"B70",body:'de Sandre-Giovannoli A, Chaouch M, Kozlov S, Vallat J-M, Tazir M, Kassouri N, et al. Homozygous defects in LMNA, encoding lamin A/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse. Am. J. Hum. Genet. 2002Mar.;70(3):726–36. '},{id:"B71",body:'Skre H. Genetic and clinical aspects of Charcot‐Marie‐Tooth\'s disease. Clinical Genetics. Wiley Online Library; 1974;6(2):98–118. '},{id:"B72",body:'Krajewski KM, Lewis RA, Fuerst DR, Turansky C, Hinderer SR, Garbern J, et al. Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A. Brain. 2000Jul.;123 ( Pt 7):1516–27. '},{id:"B73",body:'Garcia CA. A clinical review of Charcot-Marie-Tooth. Ann. N. Y. Acad. Sci. 1999Sep.14;883:69–76. '},{id:"B74",body:'De Jonghe P, Timmerman V, Van Broeckhoven C. 2nd Workshop of the European CMT Consortium: 53rd ENMC International Workshop on Classification and Diagnostic Guidelines for Charcot-Marie-Tooth Type 2 (CMT2–HMSN II) and Distal Hereditary Motor Neuropathy (Distal HMN–Spinal CMT) 26–28 September 1997, Naarden, The Netherlands. Neuromuscular Disorders. Elsevier; 1998;8(6):426–31. '},{id:"B75",body:'Gemignani F, Marbini A. Charcot-Marie-Tooth disease (CMT): distinctive phenotypic and genotypic features in CMT type 2. J. Neurol. Sci. 2001Feb.15;184(1):1–9. '},{id:"B76",body:'Eriksson M, Brown WT, Gordon LB, Glynn MW, Singer J, Scott L, et al. Recurrent de novo point mutations in lamin A cause Hutchinson–Gilford progeria syndrome. Nature. Nature Publishing Group; 2003Apr.25;423(6937):293–8. '},{id:"B77",body:'Salamat M, Dhar PK, Neagu DL, Lyon JB. Aortic calcification in a patient with hutchinson-gilford progeria syndrome. Pediatr Cardiol. 2010Aug.;31(6):925–6. '},{id:"B78",body:'Rodríguez JI, Pérez-Alonso P, Funes R, Pérez-Rodríguez J. Lethal neonatal Hutchinson-Gilford progeria syndrome. Am. J. Med. Genet. 1999Jan.29;82(3):242–8. '},{id:"B79",body:'Gillar PJ, Kaye CI, McCourt JW. Progressive Early Dermatologic Changes in Hutchinson-Gilford Progeria Syndrome. Pediatr Dermatol. 1991Sep.;8(3):199–206. '},{id:"B80",body:'Merideth MA, Gordon LB, Clauss S, Sachdev V, Smith ACM, Perry MB, et al. Phenotype and course of Hutchinson–Gilford progeria syndrome. New England journal of medicine. Mass Medical Soc; 2008;358(6):592–604. '},{id:"B81",body:'Smigiel R, Jakubiak A, Esteves-Vieira V, Szela K, Halon A, Jurek T, et al. Novel frameshifting mutations of the ZMPSTE24 gene in two siblings affected with restrictive dermopathy and review of the mutations described in the literature. Am. J. Med. Genet. 2010Feb.;152A(2):447–52. '},{id:"B82",body:'Mok Q, Curley R, Tolmie J, Marsden R. Restrictive dermopathy: a report of three cases. Journal of Medical Genetics. 1990Jan.1. '},{id:"B83",body:'Yu CE, Oshima J, Fu YH, Wijsman EM, Hisama F, Alisch R, et al. Positional cloning of the Werner\'s syndrome gene. Science. 1996Apr.12;272(5259):258–62. '},{id:"B84",body:'Chen L, Lee L, Kudlow BA, Santos Dos HG, Sletvold O, Shafeghati Y, et al. LMNA mutations in atypical Werner\'s syndrome. The Lancet. Elsevier; 2003;362(9382):440–5. '},{id:"B85",body:'Hisama FM, Lessel D, Leistritz D, Friedrich K, McBride KL, Pastore MT, et al. Coronary artery disease in a Werner syndrome-like form of progeria characterized by low levels of progerin, a splice variant of lamin A. Am. J. Med. Genet. 2011Dec.;155A(12):3002–6. '},{id:"B86",body:'Hisama FM, Kubisch C, Martin GM, Oshima J. Clinical utility gene card for: Werner syndrome. Eur J Hum Genet. Nature Publishing Group; 2012Jan.18;20(5):1–3. '},{id:"B87",body:'Wassif CA, Brownson KE, Sterner AL, Forlino A, Zerfas PM, Wilson WK, et al. HEM dysplasia and ichthyosis are likely laminopathies and not due to 3beta-hydroxysterol Delta14-reductase deficiency. Human Molecular Genetics. 2007May15;16(10):1176–87. '},{id:"B88",body:'Waterham HR, Koster J, Mooyer P, Noort G, Kelley RI, Wilcox WR, et al. Autosomal Recessive HEM/Greenberg Skeletal Dysplasia Is Caused by 3β-Hydroxysterol Δ 14-Reductase Deficiency Due to Mutations in the Lamin B Receptor Gene. Am. J. Hum. Genet. Elsevier; 2003;72(4):1013–7. '},{id:"B89",body:'Konstantinidou A, Karadimas C, Waterham HR, Superti-Furga A, Kaminopetros P, Grigoriadou M, et al. Pathologic, radiographic and molecular findings in three fetuses diagnosed with HEM/Greenberg skeletal dysplasia. Prenat. Diagn. 2008;28(4):309–12. '},{id:"B90",body:'Hoffmann K, Dreger CK, Olins AL, Olins DE, Shultz LD, Lucke B, et al. Mutations in the gene encoding the lamin B receptor produce an altered nuclear morphology in granulocytes (Pelger-Huët anomaly). Nat Genet. 2002Aug.;31(4):410–4. '},{id:"B91",body:'Waterham HR, Koster J, Mooyer P, Noort Gv GV, Kelley RI, Wilcox WR, et al. Autosomal Recessive HEM/Greenberg Skeletal Dysplasia Is Caused by 3β-Hydroxysterol Δ 14-Reductase Deficiency Due to Mutations in the Lamin B Receptor Gene. Am. J. Hum. Genet. 2003Apr.;72(4):1013–7. '},{id:"B92",body:'Oosterwijk JC. Congenital abnormalities reported in Pelger-Huet homozygosity as compared to Greenberg/HEM dysplasia: highly variable expression of allelic phenotypes. Journal of Medical Genetics. BMJ Group; 2003Dec.1;40(12):937–41. '},{id:"B93",body:'Reynolds TB, Denison EK, Frankl HD, Lieberman FL, Peters RL. Primary biliary cirrhosis with scleroderma, Raynaud\'s phenomenon and telangiectasia. New syndrome. Am. J. Med. 1971Mar.;50(3):302–12. '},{id:"B94",body:'Gaudy-Marqueste C, Roll P, Esteves-Vieira V, Weiller PJ, Grob JJ, Cau P, et al. LBR mutation and nuclear envelope defects in a patient affected with Reynolds syndrome. Journal of Medical Genetics. 2010Jun.3;47(6):361–70. '},{id:"B95",body:'Berlin R, Hedensiö B, Lilja B, Linder L. Osteopoikilosis—‐a Clinical and Genetic Study. Acta Medica Scandinavica. Wiley Online Library; 1967;181(3):305–14. '},{id:"B96",body:'Hellemans J, Preobrazhenska O, Willaert A, Debeer P, Verdonk PCM, Costa T, et al. Loss-of-function mutations in LEMD3 result in osteopoikilosis, Buschke-Ollendorff syndrome and melorheostosis. Nat Genet. 2004Oct.17;36(11):1213–8. '},{id:"B97",body:'Zhang Y, Castori M, Ferranti G, Paradisi M, Wordsworth BP. Novel and recurrent germline LEMD3mutations causing Buschke-Ollendorff syndrome and osteopoikilosis but not isolated melorheostosis. Clinical Genetics. 2009Jun.;75(6):556–61. '},{id:"B98",body:'Schena D, Germi L, Zamperetti MR, Colato C, Girolomoni G. Buschke-Ollendorff syndrome. Int. J. Dermatol. 2008Nov.;47(11):1159–61. '},{id:"B99",body:'Liu B, Wang J, Chan KM, Tjia WM, Deng W, Guan X, et al. Genomic instability in laminopathy-based premature aging. Nat Med. 2005Jul.;11(7):780–5. '},{id:"B100",body:'Scaffidi P, Misteli T. Reversal of the cellular phenotype in the premature aging disease Hutchinson-Gilford progeria syndrome. Nat Med. 2005Apr.;11(4):440–5. '},{id:"B101",body:'Sullivan T, Escalante-Alcalde D, Bhatt H, Anver M, Bhat N, Nagashima K, et al. Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy. Journal of Cell Biology. 1999Nov.29;147(5):913–20. '},{id:"B102",body:'Goldman A, Erdos M, Eriksson M, Collins FS. Accumulation of mutant lamin A causes progressive changes in nuclear architecture in Hutchinson–Gilford progeria syndrome. Proceedings of the National Academy of Sciences. 2004Jan.1. '},{id:"B103",body:'Fong LG, Ng JK, Meta M, Coté N, Yang SH, Stewart CL, et al. Heterozygosity for Lmna deficiency eliminates the progeria-like phenotypes in Zmpste24-deficient mice. Proceedings of the …. 2004. '},{id:"B104",body:'Arancio W. A Bioinformatics Analysis of Lamin-A Regulatory Network: A Perspective on Epigenetic Involvement in Hutchinson–Gilford Progeria Syndrome. Rejuvenation Research. 2012Apr.;15(2):123–7. '},{id:"B105",body:'Padmakumar VC, Libotte T, Lu W, Zaim H, Abraham S, Noegel AA, et al. The inner nuclear membrane protein Sun1 mediates the anchorage of Nesprin-2 to the nuclear envelope. Journal of Cell Science. 2005Aug.1;118(Pt 15):3419–30. '},{id:"B106",body:'Mislow JMK, Kim MS, Davis DB, McNally EM. Myne-1, a spectrin repeat transmembrane protein of the myocyte inner nuclear membrane, interacts with lamin A/C. Journal of Cell Science. 2002Jan.1;115(Pt 1):61–70. '},{id:"B107",body:'Maraldi NM, Lattanzi G. Linkage of lamins to fidelity of gene transcription. Crit. Rev. Eukaryot. Gene Expr. 2005;15(4):277–94. '},{id:"B108",body:'Lattanzi G, Cenni V, Marmiroli S, Capanni C, Mattioli E, Merlini L, et al. Association of emerin with nuclear and cytoplasmic actin is regulated in differentiating myoblasts. Biochem Biophys Res Commun. 2003Apr.11;303(3):764–70. '},{id:"B109",body:'Lattanzi G, Columbaro M, Mattioli E, Cenni V, Camozzi D, Wehnert M, et al. Pre-Lamin A processing is linked to heterochromatin organization. J. Cell. Biochem. 2007Dec.1;102(5):1149–59. '},{id:"B110",body:'Vlcek S, Foisner R. Lamins and lamin-associated proteins in aging and disease. Current Opinion in Cell Biology. 2007Jun.;19(3):298–304. '},{id:"B111",body:'Jung HJ, Sun T, Pleasure S, Young S, al E. Regulation of prelamin A but not lamin C by miR-9, a brain-specific microRNA. Proceedings of the …. 2012. '},{id:"B112",body:'Nissan X, Blondel S, Navarro C, Maury Y, Denis C, Girard M, et al. Unique Preservation of Neural Cells in Hutchinson- Gilford Progeria Syndrome Is Due to the Expression of the Neural-Specific miR-9 MicroRNA. Cell Reports. 2012Jul.;2(1):1–9. '},{id:"B113",body:'Muchir A, Pavlidis P, Decostre V, Herron AJ, Arimura T, Bonne G, et al. Activation of MAPK pathways links LMNA mutations to cardiomyopathy in Emery-Dreifuss muscular dystrophy. J. Clin. Invest. 2007May;117(5):1282–93. '},{id:"B114",body:'Haq S, Choukroun G, Lim H, Tymitz KM, del Monte F, Gwathmey J, et al. Differential activation of signal transduction pathways in human hearts with hypertrophy versus advanced heart failure. Circulation. 2001Feb.6;103(5):670–7. '},{id:"B115",body:'Cook S. Activation of c-Jun N-Terminal Kinases and p38-Mitogen-activated Protein Kinases in Human Heart Failure Secondary to Ischaemic Heart Disease. Journal of Molecular and Cellular Cardiology. 1999Aug.;31(8):1429–34. '},{id:"B116",body:'Nicol RL, Frey N, Pearson G, Cobb M, Richardson J, Olson EN. Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy. The EMBO journal. 2001Jun.1;20(11):2757–67. '},{id:"B117",body:'Muchir A, Pavlidis P, Bonne G, Hayashi YK, Worman HJ. Activation of MAPK in hearts of EMD null mice: similarities between mouse models of X-linked and autosomal dominant Emery Dreifuss muscular dystrophy. Human Molecular Genetics. 2007Aug.1;16(15):1884–95. '},{id:"B118",body:'Brodsky GL, Muntoni F, Miocic S, Sinagra G, Sewry C, Mestroni L. Lamin A/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement. Circulation. 2000Feb.8;101(5):473–6. '},{id:"B119",body:'Vytopil M, Ricci E, Russo Dello A, Hanisch F, Neudecker S, Zierz S, et al. Frequent low penetrance mutations in the Lamin A/C gene, causing Emery Dreifuss muscular dystrophy. Neuromuscular Disorders. 2002Dec.;12(10):958–63. '},{id:"B120",body:'Marina Raffaele di Barletta ERGGPTMMLMARTVKHOLMCTVBIH-PSBRRKSGBDT. Different Mutations in the LMNA Gene Cause Autosomal Dominant and Autosomal Recessive Emery-Dreifuss Muscular Dystrophy. Am. J. Hum. Genet. Elsevier; 2000Apr.1;66(4):1407. '},{id:"B121",body:'Genschel J, Schmidt HHJ. Mutations in the LMNA gene encoding lamin A/C. Hum. Mutat. Wiley Online Library; 2000;16(6):451–9. '},{id:"B122",body:'Novelli G, Muchir A, Sangiuolo F, Helbling-Leclerc A, D\'Apice MR, Massart C, et al. Mandibuloacral dysplasia is caused by a mutation in LMNA-encoding lamin A/C. Am. J. Hum. Genet. 2002Aug.;71(2):426–31. '},{id:"B123",body:'Shen JJ, Brown CA, Lupski JR, Potocki L. Mandibuloacral dysplasia caused by homozygosity for the R527H mutation in lamin A/C. Journal of Medical Genetics. 2003Nov.;40(11):854–7. '},{id:"B124",body:'Mercuri E, Poppe M, Quinlivan R, Messina S, Kinali M, Demay L, et al. Extreme variability of phenotype in patients with an identical missense mutation in the lamin A/C gene: from congenital onset with severe phenotype to milder classic Emery-Dreifuss variant. Arch. Neurol. 2004May;61(5):690–4. '},{id:"B125",body:'Mercuri E, Brown SC, Nihoyannopoulos P, Poulton J, Kinali M, Richard P, et al. Extreme variability of skeletal and cardiac muscle involvement in patients with mutations in exon 11 of the lamin A/C gene. Muscle Nerve. 2005;31(5):602–9. '},{id:"B126",body:'Genschel J, Bochow B, Kuepferling S, Ewert R, Hetzer R, Lochs H, et al. A R644C mutation within lamin A extends the mutations causing dilated cardiomyopathy. Hum. Mutat. 2001Feb.;17(2):154. '},{id:"B127",body:'Vigouroux C, Auclair M, Dubosclard E, Pouchelet M, Capeau J, Courvalin J-C, et al. Nuclear envelope disorganization in fibroblasts from lipodystrophic patients with heterozygous R482Q/W mutations in the lamin A/C gene. Journal of Cell …. 2001. '},{id:"B128",body:'Gonzalez JM, Navarro-Puche A, Casar B, Crespo P, Andres V. Fast regulation of AP-1 activity through interaction of lamin A/C, ERK1/2, and c-Fos at the nuclear envelope. The Journal of Cell Biology. 2008Nov.10;183(4):653–66. '},{id:"B129",body:'de Sandre-Giovannoli A, Bernard R, Cau P, Navarro C, Amiel J, Boccaccio I, et al. Lamin a truncation in Hutchinson-Gilford progeria. Science. 2003Jun.27;300(5628):2055. '},{id:"B130",body:'Muchir A, Wu W, Worman HJ. Reduced expression of A-type lamins and emerin activates extracellular signal-regulated kinase in cultured cells. Biochim. Biophys. Acta. 2009Jan.;1792(1):75–81. '},{id:"B131",body:'Emerson LJ, Holt MR, Wheeler MA, Wehnert M, Parsons M, Ellis JA. Defects in cell spreading and ERK1/2 activation in fibroblasts with lamin A/C mutations. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease. Elsevier; 2009;1792(8):810–21. '},{id:"B132",body:'Fong LG. Prelamin A and lamin A appear to be dispensable in the nuclear lamina. J. Clin. Invest. 2006Mar.1;116(3):743–52. '},{id:"B133",body:'Olins AL, Olins DE. Cytoskeletal influences on nuclear shape in granulocytic HL-60 cells. BMC Cell Biol. 2004Aug.19;5:30. '},{id:"B134",body:'Dahl KN, Booth-Gauthier EA, Ladoux B. In the middle of it all: mutual mechanical regulation between the nucleus and the cytoskeleton. Journal of biomechanics. Elsevier; 2010;43(1):2–8. '},{id:"B135",body:'Morris GE. Heart to heart: from nuclearproteins to Emery-Dreifuss muscular dystrophy. Human Molecular Genetics. 1999Sep.1;8(10):1847–51. '},{id:"B136",body:'Broers J, Machiels B, Kuijpers H, Smedts F, van den Kieboom R, Raymond Y, et al. A-and B-type lamins are differentially expressed in normal human tissues. Histochemistry and cell biology. 1997;107(6):505–17. '},{id:"B137",body:'Ostlund C, Ellenberg J, Hallberg E, Lippincott-Schwartz J, Worman HJ. Intracellular trafficking of emerin, the Emery-Dreifuss muscular dystrophy protein. Journal of Cell Science. 1999Jun.;112 ( Pt 11):1709–19. '},{id:"B138",body:'Maniotis AJ, Chen CS, Ingber DE. Demonstration of mechanical connections between integrins, cytoskeletal filaments, and nucleoplasm that stabilize nuclear structure. Proceedings of the National Academy of Sciences of the United States of America. 1997Feb.4;94(3):849–54. '},{id:"B139",body:'Rosengardten Y, McKenna T, Grochová D, Eriksson M. Stem cell depletion in Hutchinson-Gilford progeria syndrome. Aging Cell. 2011Sep.8. '},{id:"B140",body:'Meshorer E, Gruenbaum Y. Gone with the Wnt/Notch: stem cells in laminopathies, progeria, and aging. The Journal of Cell Biology. 2008Apr.7;181(1):9–13. '},{id:"B141",body:'Bertrand AT, Chikhaoui K, Yaou RB, Bonne G. Clinical and genetic heterogeneity in laminopathies. Biochem. Soc. Trans. 2011Nov.21;39(6):1687–92. '},{id:"B142",body:'Herrmann H, Aebi U. Intermediate filaments: molecular structure, assembly mechanism, and integration into functionally distinct intracellular Scaffolds. Annu. Rev. Biochem. 2004;73:749–89. '},{id:"B143",body:'Reunert J, Wentzell R, Walter M, Jakubiczka S, Zenker M, Brune T, et al. Neonatal progeria: increased ratio of progerin to lamin A leads to progeria of the newborn. Eur J Hum Genet. 2012Mar.14. '},{id:"B144",body:'Moulson C, Fong L, Gardner J. Increased progerin expression associated with unusual LMNA mutations causes severe progeroid syndromes. Hum. Mutat. 2007Jan.1. '},{id:"B145",body:'Cenni V, Capanni C, Columbaro M, Ortolani M, D\'Apice MR, Novelli G, et al. Autophagic degradation of farnesylated prelamin A as a therapeutic approach to lamin-linked progeria. Eur J Histochem. 2011;55(4):e36. '},{id:"B146",body:'Rodriguez S, Eriksson M. Low and high expressing alleles of the LMNA gene: implications for laminopathy disease development. PLoS ONE. 2011;6(9):e25472. '},{id:"B147",body:'Jahn D, Schramm S, Schnölzer M, Heilmann CJ, de Koster CG, Schütz W, et al. A truncated lamin A in the Lmna (-/-) mouse line: Implications for the understanding of laminopathies. Nucleus. 2012Sep.1;3(5). '},{id:"B148",body:'Kubben N, Voncken JW, Konings G, van Weeghel M, van den Hoogenhof MMG, Gijbels M, et al. Post-natal myogenic and adipogenic developmental: Defects and metabolic impairment upon loss of A-type lamins. Nucleus. Landes Bioscience; 2011May1;2(3):195–207. '},{id:"B149",body:'Coffinier C, Jung HJ, Li Z, Nobumori C, Yun UJ, Farber EA, et al. Direct Synthesis of Lamin A, Bypassing Prelamin A Processing, Causes Misshapen Nuclei in Fibroblasts but No Detectable Pathology in Mice. Journal of Biological Chemistry. 2010Jun.25;285(27):20818–26. '},{id:"B150",body:'Bergo M, Gavino B, Ross J. Zmpste24 deficiency in mice causes spontaneous bone fractures, muscle weakness, and a prelamin A processing defect. Proceedings of the National Academy of Sciences. 2002Jan.1. '},{id:"B151",body:'Pendás AM, Zhou Z, Cadiñanos J, Freije JMP, Wang J, Hultenby K, et al. Defective prelamin A processing and muscular and adipocyte alterations in Zmpste24 metalloproteinase-deficient mice. Nat Genet. 2002May;31(1):94–9. '},{id:"B152",body:'Mounkes LC, Kozlov SV, Rottman JN, Stewart CL. Expression of an LMNA-N195K variant of A-type lamins results in cardiac conduction defects and death in mice. Human Molecular Genetics. 2005Aug.1;14(15):2167–80. '},{id:"B153",body:'Arimura T, Helbling-Leclerc A, Massart C, Varnous S, Niel F, Lacène E, et al. Mouse model carrying H222P-Lmna mutation develops muscular dystrophy and dilated cardiomyopathy similar to human striated muscle laminopathies. Human Molecular Genetics. 2005Jan.1;14(1):155–69. '},{id:"B154",body:'Yang SH, Bergo MO, Toth JI, Qiao X, Hu Y, Sandoval S, et al. Blocking protein farnesyltransferase improves nuclear blebbing in mouse fibroblasts with a targeted Hutchinson-Gilford progeria syndrome mutation. Proceedings of the National Academy of Sciences. 2005Jul.19;102(29):10291–6. '},{id:"B155",body:'Mounkes LC, Kozlov S, Hernandez L, Sullivan T, Stewart CL. A progeroid syndrome in mice is caused by defects in A-type lamins. Nature. 2003May15;423(6937):298–301. '},{id:"B156",body:'Wang Y, Herron AJ, Worman HJ. Pathology and nuclear abnormalities in hearts of transgenic mice expressing M371K lamin A encoded by an LMNA mutation causing Emery-Dreifuss muscular dystrophy. Human Molecular Genetics. 2006Aug.15;15(16):2479–89. '},{id:"B157",body:'Osorio FG, Navarro CL, Cadinanos J, Lopez-Mejia IC, Quiros PM, Bartoli C, et al. Splicing-Directed Therapy in a New Mouse Model of Human Accelerated Aging. Science Translational Medicine. 2011Oct.26;3(106):106ra107–7. '},{id:"B158",body:'Melcon G, Kozlov S, Cutler DA, Sullivan T, Hernandez L, Zhao P, et al. Loss of emerin at the nuclear envelope disrupts the Rb1/E2F and MyoD pathways during muscle regeneration. Human Molecular …. 2006. '},{id:"B159",body:'Ozawa R, Hayashi YK, Ogawa M, Kurokawa R, Matsumoto H, Noguchi S, et al. Emerin-lacking mice show minimal motor and cardiac dysfunctions with nuclear-associated vacuoles. Am. J. Pathol. 2006Mar.;168(3):907–17. '},{id:"B160",body:'Muchir A, van Engelen BG, Lammens M, Mislow JM, McNally E, Schwartz K, et al. Nuclear envelope alterations in fibroblasts from LGMD1B patients carrying nonsense Y259X heterozygous or homozygous mutation in lamin A/C gene. Experimental Cell Research. 2003Dec.10;291(2):352–62. '},{id:"B161",body:'Van Berlo JH, Voncken JW, Kubben N, Broers JLV, Duisters R, van Leeuwen REW, et al. A-type lamins are essential for TGF-beta1 induced PP2A to dephosphorylate transcription factors. Human Molecular Genetics. 2005Oct.1;14(19):2839–49. '},{id:"B162",body:'Jahn D, Schramm S, Schnölzer M, Heilmann CJ, de Koster CG, Schütz W, et al. A truncated lamin A in the Lmna−/− mouse line: Implications for the understanding of laminopathies. Nucleus. 2012Sep.1;3(5). '},{id:"B163",body:'Leung GK, Schmidt WK, Bergo MO, Gavino B, Wong DH, Tam A, et al. Biochemical studies of Zmpste24-deficient mice. J Biol Chem. 2001Aug.3;276(31):29051–8. '},{id:"B164",body:'Ambrosi P, Mouly-Bandini A, Attarian S, Habib G. Heart transplantation in 7 patients from a single family with limb-girdle muscular dystrophy caused by lamin A/C mutation. International Journal of Cardiology. 2009Nov.;137(3):e75–6. '},{id:"B165",body:'Dyck JD, David TE, Burke B, Webb GD, Henderson MA, Fowler RS. Management of coronary artery disease in Hutchinson-Gilford syndrome. The Journal of Pediatrics. 1987Sep.;111(3):407–10. '},{id:"B166",body:'Savage DB, Tan GD, Acerini CL, Jebb SA, Agostini M, Gurnell M, et al. Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-gamma. Diabetes. 2003Apr.;52(4):910–7. '},{id:"B167",body:'Javor ED, Cochran EK, Musso C, Young JR, Depaoli AM, Gorden P. Long-term efficacy of leptin replacement in patients with generalized lipodystrophy. Diabetes. 2005Jul.;54(7):1994–2002. '},{id:"B168",body:'Park JY, Javor ED, Cochran EK, Depaoli AM, Gorden P. Long-term efficacy of leptin replacement in patients with Dunnigan-type familial partial lipodystrophy. Metab. Clin. Exp. 2007Apr.;56(4):508–16. '},{id:"B169",body:'Maraldi NM, Capanni C, Lattanzi G, Camozzi D, Facchini A, Manzoli FA. SREBP1 interaction with prelamin A forms: A pathogenic mechanism for lipodystrophic laminopathies. Advances in Enzyme Regulation. Advances in enzyme …; 2008Jan.;48(1):209–23. '},{id:"B170",body:'Kieran MW, Gordon L, Kleinman M. New approaches to progeria. Pediatrics. 2007Oct.;120(4):834–41. '},{id:"B171",body:'Capell B, Erdos M, Madigan J, Fiordalisi J. Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson- …. Proceedings of the National Academy of Sciences. 2005Jan.1. '},{id:"B172",body:'Mallampalli MP, Huyer G, Bendale P, Gelb MH, Michaelis S. Inhibiting farnesylation reverses the nuclear morphology defect in a HeLa cell model for Hutchinson-Gilford progeria syndrome. Proceedings of the National Academy of Sciences of the United States of America. 2005Oct.4;102(40):14416–21. '},{id:"B173",body:'Toth J, Yang S, Qiao X, Beigneux A, Gelb M. Blocking protein farnesyltransferase improves nuclear shape in fibroblasts from humans with …. Proceedings of the National Academy of Sciences. 2005Jan.1. '},{id:"B174",body:'Capell BC, Olive M, Erdos MR, Cao K, Faddah DA, Tavarez UL, et al. A farnesyltransferase inhibitor prevents both the onset and late progression of cardiovascular disease in a progeria mouse model. Proceedings of the National Academy of Sciences. 2008Oct.14;105(41):15902–7. '},{id:"B175",body:'Yang S. Treatment with a farnesyltransferase inhibitor improves survival in mice with a Hutchinson–Gilford progeria syndrome mutation. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 2008Jan.1;1781(1-2):36–9. '},{id:"B176",body:'Fong L, Frost D, Meta M, Qiao X, Yang S. A Protein Farnesyltransferase Inhibitor Ameliorates Disease in a Mouse Model of Progeria. Science. 2006Jan.1. '},{id:"B177",body:'Shao H Yang DAAHPSSGYLGF. Progerin elicits disease phenotypes of progeria in mice whether or not it is farnesylated. The Journal of Clinical Investigation. American Society for Clinical Investigation; 2008Oct.1;118(10):3291. '},{id:"B178",body:'Varela I, Pereira S, Ugalde AP, Navarro CL, Suárez MF, Cau P, et al. Combined treatment with statins and aminobisphosphonates extends longevity in a mouse model of human premature aging. Nat Med. 2008Jun.29;14(7):767–72. '},{id:"B179",body:'Glynn M, Glover T. Incomplete processing of mutant lamin A in Hutchinson-Gilford progeria leads to nuclear …. Human Molecular Genetics. 2005Jan.1. '},{id:"B180",body:'Davies BSJ, Barnes RH, Tu Y, Ren S, Andres DA, Spielmann HP, et al. An accumulation of non-farnesylated prelamin A causes cardiomyopathy but not progeria. Human Molecular Genetics. 2010Jun.10;19(13):2682–94. '},{id:"B181",body:'Coffinier C, Hudon SE, Farber EA, Chang SY, Hrycyna CA, Young SG, et al. HIV protease inhibitors block the zinc metalloproteinase ZMPSTE24 and lead to an accumulation of prelamin A in cells. Proceedings of the National Academy of Sciences of the United States of America. 2007Aug.14;104(33):13432–7. '},{id:"B182",body:'Cao K, Graziotto JJ, Blair CD, Mazzulli JR, Erdos MR, Krainc D, et al. Rapamycin reverses cellular phenotypes and enhances mutant protein clearance in Hutchinson-Gilford progeria syndrome cells. Science Translational Medicine. 2011Jun.29;3(89):89ra58. '},{id:"B183",body:'Ramos FJ, Chen SC, Garelick MG, Dai D-F, Liao C-Y, Schreiber KH, et al. Rapamycin Reverses Elevated mTORC1 Signaling in Lamin A/C-Deficient Mice, Rescues Cardiac and Skeletal Muscle Function, and Extends Survival. Science Translational Medicine. 2012Jul.25;4(144):144ra103. '},{id:"B184",body:'Choi JC, Muchir A, Wu W, Iwata S. Temsirolimus activates autophagy and ameliorates cardiomyopathy caused by lamin A/C gene mutation. Science. 2012. '},{id:"B185",body:'Wu W, Muchir A, Shan J, Bonne G, Worman HJ. Mitogen-Activated Protein Kinase Inhibitors Improve Heart Function and Prevent Fibrosis in Cardiomyopathy Caused by Mutation in Lamin A/C GeneClinical Perspective. Circulation. Am Heart Assoc; 2011;123(1):53–61. '},{id:"B186",body:'Chhajed PN, Dickenmann M, Bubendorf L, Mayr M, Steiger J, Tamm M. Patterns of pulmonary complications associated with sirolimus. Respiration. 2006;73(3):367–74. '},{id:"B187",body:'Filippone EJ, Carson JM, Beckford RA, Jaffe BC, Newman E, Awsare BK, et al. Sirolimus-induced pneumonitis complicated by pentamidine-induced phospholipidosis in a renal transplant recipient: a case report. Transplant. Proc. 2011Sep.;43(7):2792–7. '},{id:"B188",body:'Pham P-TT, Pham P-CT, Danovitch GM, Ross DJ, Gritsch HA, Kendrick EA, et al. Sirolimus-Associated Pulmonary Toxicity. Transplantation. 2004Apr.27;77(8):1215. '},{id:"B189",body:'Lamming DW, Ye L, Katajisto P, Goncalves MD, Saitoh M, Stevens DM, et al. Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity. Science. 2012Mar.30;335(6076):1638–43. '},{id:"B190",body:'Scaffidi P. Lamin A-Dependent Nuclear Defects in Human Aging. Science. 2006. '},{id:"B191",body:'Huang S, Chen L, Libina N, Janes J, Martin GM, Campisi J, et al. Correction of cellular phenotypes of Hutchinson-Gilford Progeria cells by RNA interference. Hum. Genet. 2005Dec.;118(3-4):444–50. '},{id:"B192",body:'Fong LG, Vickers TA, Farber EA, Choi C, Yun UJ, Hu Y, et al. Activating the synthesis of progerin, the mutant prelamin A in Hutchinson-Gilford progeria syndrome, with antisense oligonucleotides. Human Molecular Genetics. 2009Jun.10;18(13):2462–71. '},{id:"B193",body:'Flemming A. Regulatory watch: Pioneering gene therapy on brink of approval. Nat Rev Drug Discov. 2012Aug.31;11(9):664. '},{id:"B194",body:'Mazhari R, Hare JM. Mechanisms of action of mesenchymal stem cells in cardiac repair: potential influences on the cardiac stem cell niche. Nat Clin Pract Cardiovasc Med. 2007Feb.;4 Suppl 1:S21–6. '},{id:"B195",body:'Trollet C, Athanasopoulos T, Popplewell L, Malerba A, Dickson G. Gene therapy for muscular dystrophy: current progress and future prospects. Expert Opin. Biol. Ther. 2009Jul.;9(7):849–66. '},{id:"B196",body:'Merkulov S, Chen X, Chandler MP, Stelzer JE. In Vivo cMyBPC Gene Transfer Rescues Myofilament Contractile Dysfunction in cMyBPC Null Mice. Circ Heart Fail. 2012Aug.1. '}],footnotes:[],contributors:[{corresp:"yes",contributorFullName:"Tomás McKenna",address:"tomas.mckenna@ki.se",affiliation:'
Department of Biosciences and Nutrition, Center for Biosciences, Karolinska Institutet, Huddinge, Sweden
Department of Biosciences and Nutrition, Center for Biosciences, Karolinska Institutet, Huddinge, Sweden
'}],corrections:null},book:{id:"3308",title:"Genetic Disorders",subtitle:null,fullTitle:"Genetic Disorders",slug:"genetic-disorders",publishedDate:"January 9th 2013",bookSignature:"Maria Puiu",coverURL:"https://cdn.intechopen.com/books/images_new/3308.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"31786",title:"Prof.",name:"Maria",middleName:null,surname:"Puiu",slug:"maria-puiu",fullName:"Maria Puiu"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},chapters:[{id:"41308",title:"A Therapeutic Role for Hematopoietic Stem Cells in Osteogenesis Imperfecta",slug:"a-therapeutic-role-for-hematopoietic-stem-cells-in-osteogenesis-imperfecta",totalDownloads:2388,totalCrossrefCites:1,signatures:"Meenal Mehrotra and Amanda C. LaRue",authors:[{id:"155763",title:"Associate Prof.",name:"Amanda",middleName:null,surname:"LaRue",fullName:"Amanda LaRue",slug:"amanda-larue"}]},{id:"41310",title:"Laminopathies",slug:"laminopathies",totalDownloads:2558,totalCrossrefCites:2,signatures:"Tomás McKenna, Jean-Ha Baek and Maria Eriksson",authors:[{id:"45285",title:"Mr.",name:"Tomás",middleName:null,surname:"McKenna",fullName:"Tomás McKenna",slug:"tomas-mckenna"},{id:"156739",title:"Dr.",name:"Maria",middleName:null,surname:"Eriksson",fullName:"Maria Eriksson",slug:"maria-eriksson"},{id:"156913",title:"Dr.",name:"Jean-Ha",middleName:null,surname:"Baek",fullName:"Jean-Ha Baek",slug:"jean-ha-baek"}]},{id:"41856",title:"Hutchinson-Gilford Progeria Syndrome",slug:"hutchinson-gilford-progeria-syndrome",totalDownloads:4096,totalCrossrefCites:1,signatures:"Jean-Ha Baek, Tomás McKenna and Maria Eriksson",authors:[{id:"45285",title:"Mr.",name:"Tomás",middleName:null,surname:"McKenna",fullName:"Tomás McKenna",slug:"tomas-mckenna"},{id:"156739",title:"Dr.",name:"Maria",middleName:null,surname:"Eriksson",fullName:"Maria Eriksson",slug:"maria-eriksson"},{id:"156913",title:"Dr.",name:"Jean-Ha",middleName:null,surname:"Baek",fullName:"Jean-Ha Baek",slug:"jean-ha-baek"}]},{id:"41852",title:"Genetic Determinants of Heart Rate Variation and Cardiovascular Diseases",slug:"genetic-determinants-of-heart-rate-variation-and-cardiovascular-diseases",totalDownloads:2016,totalCrossrefCites:1,signatures:"Vyacheslav A. Korshunov, Igor A. Dyachenko and Arkady N. Murashev",authors:[{id:"156998",title:"Dr.",name:"Vyacheslav Slava",middleName:null,surname:"Korshunov",fullName:"Vyacheslav Slava Korshunov",slug:"vyacheslav-slava-korshunov"},{id:"158905",title:"Dr.",name:"Igor",middleName:null,surname:"Dyachenko",fullName:"Igor Dyachenko",slug:"igor-dyachenko"},{id:"158906",title:"Prof.",name:"Arkady",middleName:null,surname:"Murashev",fullName:"Arkady Murashev",slug:"arkady-murashev"}]},{id:"41316",title:"Structural Insights Into Disease Mutations of the Ryanodine Receptor",slug:"structural-insights-into-disease-mutations-of-the-ryanodine-receptor",totalDownloads:2894,totalCrossrefCites:0,signatures:"Zhiguang Yuchi, Lynn Kimlicka and Filip Van Petegem",authors:[{id:"157461",title:"Dr.",name:"Filip",middleName:null,surname:"Van Petegem",fullName:"Filip Van Petegem",slug:"filip-van-petegem"},{id:"157463",title:"Dr.",name:"Zhiguang",middleName:null,surname:"Yuchi",fullName:"Zhiguang Yuchi",slug:"zhiguang-yuchi"},{id:"158648",title:"BSc.",name:"Lynn",middleName:null,surname:"Kimlicka",fullName:"Lynn Kimlicka",slug:"lynn-kimlicka"}]},{id:"40481",title:"The Genetics of Mental Retardation",slug:"the-genetics-of-mental-retardation",totalDownloads:3223,totalCrossrefCites:1,signatures:"Maria Puiu, Simona Dumitriu, Adela Chiriță-Emandi, Raluca Grădinaru and Smaranda Arghirescu",authors:[{id:"31786",title:"Prof.",name:"Maria",middleName:null,surname:"Puiu",fullName:"Maria Puiu",slug:"maria-puiu"},{id:"158437",title:"Dr.",name:"Adela",middleName:null,surname:"Chiriță-Emandi",fullName:"Adela Chiriță-Emandi",slug:"adela-chirita-emandi"},{id:"159135",title:"Dr.",name:"Simona",middleName:null,surname:"Dumitriu",fullName:"Simona Dumitriu",slug:"simona-dumitriu"},{id:"159137",title:"Dr.",name:"Raluca",middleName:null,surname:"Grădinaru",fullName:"Raluca Grădinaru",slug:"raluca-gradinaru"},{id:"166056",title:"Dr.",name:"Smaranda",middleName:null,surname:"Arghirescu",fullName:"Smaranda Arghirescu",slug:"smaranda-arghirescu"}]},{id:"41317",title:"Molecular Bases of Ataxia Telangiectasia: One Kinase Multiple Functions",slug:"molecular-bases-of-ataxia-telangiectasia-one-kinase-multiple-functions",totalDownloads:2082,totalCrossrefCites:1,signatures:"Venturina Stagni, Simonetta Santini and Daniela Barila",authors:[{id:"157647",title:"Dr.",name:"Daniela",middleName:null,surname:"Barilà",fullName:"Daniela Barilà",slug:"daniela-barila"}]},{id:"41647",title:"Epilepsy and Genetics",slug:"epilepsy-and-genetics",totalDownloads:1824,totalCrossrefCites:0,signatures:"Roya Vakili and Babak Kateby Kashy",authors:[{id:"157763",title:"Dr.",name:"Roya",middleName:null,surname:"Vakili",fullName:"Roya Vakili",slug:"roya-vakili"},{id:"158950",title:"Dr.",name:"Babak",middleName:null,surname:"Kateby Kashy",fullName:"Babak Kateby Kashy",slug:"babak-kateby-kashy"}]},{id:"41327",title:"Rett Syndrome: A Model of Genetic Neurodevelopmental Disorders",slug:"rett-syndrome-a-model-of-genetic-neurodevelopmental-disorders",totalDownloads:2265,totalCrossrefCites:0,signatures:"Christopher A. Chapleau, Jane Lane, Lucas Pozzo-Miller and Alan K. Percy",authors:[{id:"157812",title:"Prof.",name:"Alan",middleName:null,surname:"Percy",fullName:"Alan Percy",slug:"alan-percy"}]},{id:"41370",title:"Genetic Diseases Associated with Protein Glycosylation Disorders in Mammals",slug:"genetic-diseases-associated-with-protein-glycosylation-disorders-in-mammals",totalDownloads:3736,totalCrossrefCites:2,signatures:"Yoshiaki Nakayama, Naosuke Nakamura, Daisuke Tsuji, Koji Itoh and Akira Kurosaka",authors:[{id:"65159",title:"Dr.",name:"Yoshiaki",middleName:null,surname:"Nakayama",fullName:"Yoshiaki Nakayama",slug:"yoshiaki-nakayama"}]},{id:"39509",title:"Genetics and Obesity",slug:"genetics-and-obesity",totalDownloads:3805,totalCrossrefCites:0,signatures:"Maria Puiu, Adela Chirita Emandi and Smaranda Arghirescu",authors:[{id:"31786",title:"Prof.",name:"Maria",middleName:null,surname:"Puiu",fullName:"Maria Puiu",slug:"maria-puiu"},{id:"158437",title:"Dr.",name:"Adela",middleName:null,surname:"Chiriță-Emandi",fullName:"Adela Chiriță-Emandi",slug:"adela-chirita-emandi"},{id:"166056",title:"Dr.",name:"Smaranda",middleName:null,surname:"Arghirescu",fullName:"Smaranda Arghirescu",slug:"smaranda-arghirescu"}]},{id:"41372",title:"Role of the Genetic Factors in the Development of Myopia",slug:"role-of-the-genetic-factors-in-the-development-of-myopia",totalDownloads:2490,totalCrossrefCites:0,signatures:"Malgorzata Mrugacz",authors:[{id:"49288",title:"Prof.",name:"Malgorzata",middleName:null,surname:"Mrugacz",fullName:"Malgorzata Mrugacz",slug:"malgorzata-mrugacz"}]},{id:"41627",title:"Bone Marrow Microenvironment defects in Fanconi AnemiaBone Marrow Microenvironment Defects in Fanconi Anemia",slug:"bone-marrow-microenvironment-defects-in-fanconi-anemiabone-marrow-microenvironment-defects-in-fancon",totalDownloads:1602,totalCrossrefCites:0,signatures:"Wen Xing, Mingjiang Xu and Feng-Chun Yang",authors:[{id:"155829",title:"Associate Prof.",name:"Fengchun",middleName:null,surname:"Yang",fullName:"Fengchun Yang",slug:"fengchun-yang"},{id:"166402",title:"Dr.",name:"Wen",middleName:null,surname:"Xing",fullName:"Wen Xing",slug:"wen-xing"}]},{id:"41373",title:"Cystic Fibrosis: Does CFTR Malfunction Alter pH Regulation?",slug:"cystic-fibrosis-does-cftr-malfunction-alter-ph-regulation-",totalDownloads:2046,totalCrossrefCites:0,signatures:"Douglas B. Luckie and Mauri E. Krouse",authors:[{id:"156091",title:"Dr.",name:"Douglas",middleName:"Barton",surname:"Luckie",fullName:"Douglas Luckie",slug:"douglas-luckie"},{id:"158333",title:"Dr.",name:"Mauri",middleName:null,surname:"Krouse",fullName:"Mauri Krouse",slug:"mauri-krouse"}]}]},relatedBooks:[{type:"book",id:"1280",title:"Selected Topics in DNA Repair",subtitle:null,isOpenForSubmission:!1,hash:"bffa19c9b25bf5aaf029cc9e528916f4",slug:"selected-topics-in-dna-repair",bookSignature:"Clark C. Chen",coverURL:"https://cdn.intechopen.com/books/images_new/1280.jpg",editedByType:"Edited by",editors:[{id:"62462",title:"Prof.",name:"Clark",surname:"Chen",slug:"clark-chen",fullName:"Clark Chen"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"},chapters:[{id:"22707",title:"The DNA-Damage Response to Ionizing Radiation in Human Lymphocytes",slug:"the-dna-damage-response-to-ionizing-radiation-in-human-lymphocytes",signatures:"Maddalena Mognato, Mauro Grifalconi, Sabrina Canova, Cristina Girardi and Lucia Celotti",authors:[{id:"41691",title:"Dr.",name:"Maddalena",middleName:null,surname:"Mognato",fullName:"Maddalena Mognato",slug:"maddalena-mognato"},{id:"42660",title:"Prof.",name:"Lucia",middleName:null,surname:"Celotti",fullName:"Lucia Celotti",slug:"lucia-celotti"},{id:"99511",title:"Dr.",name:"Mauro",middleName:null,surname:"Grifalconi",fullName:"Mauro Grifalconi",slug:"mauro-grifalconi"},{id:"99513",title:"Dr.",name:"Cristina",middleName:null,surname:"Girardi",fullName:"Cristina Girardi",slug:"cristina-girardi"},{id:"99516",title:"Dr.",name:"Sabrina",middleName:null,surname:"Canova",fullName:"Sabrina Canova",slug:"sabrina-canova"}]},{id:"22708",title:"Interactions by Carcinogenic Metal Compounds with DNA Repair Processes",slug:"interactions-by-carcinogenic-metal-compounds-with-dna-repair-processes",signatures:"Simona Catalani and Pietro Apostoli",authors:[{id:"52026",title:"Prof.",name:"Pietro",middleName:null,surname:"Apostoli",fullName:"Pietro Apostoli",slug:"pietro-apostoli"},{id:"52033",title:"Dr.",name:"Simona",middleName:null,surname:"Catalani",fullName:"Simona Catalani",slug:"simona-catalani"}]},{id:"22709",title:"Effect of Oxidative Stress on DNA Repairing Genes",slug:"effect-of-oxidative-stress-on-dna-repairing-genes",signatures:"Bedia Cakmakoglu, Zeynep Birsu Cincin and Makbule Aydin",authors:[{id:"41618",title:"Prof.",name:"Bedia",middleName:null,surname:"Cakmakoglu",fullName:"Bedia Cakmakoglu",slug:"bedia-cakmakoglu"},{id:"57423",title:"MSc",name:"Zeynep Birsu",middleName:null,surname:"Cincin",fullName:"Zeynep Birsu Cincin",slug:"zeynep-birsu-cincin"},{id:"111568",title:"Prof.",name:"Makbule",middleName:null,surname:"Aydin",fullName:"Makbule Aydin",slug:"makbule-aydin"}]},{id:"22710",title:"UV Damaged DNA Repair & Tolerance in Plants",slug:"uv-damaged-dna-repair-tolerance-in-plants",signatures:"Ashwin L. Ganpudi and Dana F. Schroeder",authors:[{id:"46453",title:"Dr.",name:"Dana",middleName:null,surname:"Schroeder",fullName:"Dana Schroeder",slug:"dana-schroeder"},{id:"57994",title:"Mr",name:"Ashwin",middleName:null,surname:"Ganpudi",fullName:"Ashwin Ganpudi",slug:"ashwin-ganpudi"}]},{id:"22711",title:"DNA Helix Destabilization by Alkylating Agents: From Covalent Bonding to DNA Repair",slug:"dna-helix-destabilization-by-alkylating-agents-from-covalent-bonding-to-dna-repair",signatures:"Gaëlle Lenglet, Sabine Depauw, Denise Mendy-Belaiche and Marie-Hélène David-Cordonnier",authors:[{id:"43845",title:"Dr.",name:"Marie-Hélène",middleName:null,surname:"David-Cordonnier",fullName:"Marie-Hélène David-Cordonnier",slug:"marie-helene-david-cordonnier"},{id:"57034",title:"Dr.",name:"Gaëlle",middleName:null,surname:"Lenglet",fullName:"Gaëlle Lenglet",slug:"gaelle-lenglet"},{id:"57035",title:"Ms.",name:"Sabine",middleName:null,surname:"Depauw",fullName:"Sabine Depauw",slug:"sabine-depauw"},{id:"57036",title:"Dr.",name:"Denise",middleName:null,surname:"Mendy-Belaiche",fullName:"Denise Mendy-Belaiche",slug:"denise-mendy-belaiche"}]},{id:"22712",title:"DNA Damage Caused by Polycyclic Aromatic Hydrocarbons: Mechanisms and Markers",slug:"dna-damage-caused-by-polycyclic-aromatic-hydrocarbons-mechanisms-and-markers",signatures:"Balam Muñoz and Arnulfo Albores",authors:[{id:"48058",title:"Dr.",name:"Arnulfo",middleName:null,surname:"Albores",fullName:"Arnulfo Albores",slug:"arnulfo-albores"},{id:"52340",title:"Dr.",name:"Balam",middleName:null,surname:"Muñoz",fullName:"Balam Muñoz",slug:"balam-munoz"}]},{id:"22713",title:"DNA Repair: Lessons from the Evolution of Ionizing- Radiation-Resistant Prokaryotes – Fact and Theory",slug:"dna-repair-lessons-from-the-evolution-of-ionizing-radiation-resistant-prokaryotes-fact-and-theory",signatures:"Haïtham Sghaier",authors:[{id:"47210",title:"Dr.",name:"Haitham",middleName:null,surname:"Sghaier",fullName:"Haitham Sghaier",slug:"haitham-sghaier"}]},{id:"22714",title:"Involvement of Non-Homologous End-Joining in Radiation-Induced Genomic Instability",slug:"involvement-of-non-homologous-end-joining-in-radiation-induced-genomic-instability",signatures:"Keiji Suzuki, Motohiro Yamauchi, Masatoshi Suzuki, Yasuyoshi Oka and Shunichi Yamashita",authors:[{id:"48708",title:"Prof.",name:"Keiji",middleName:null,surname:"Suzuki",fullName:"Keiji Suzuki",slug:"keiji-suzuki"},{id:"48714",title:"Dr.",name:"Motohiro",middleName:null,surname:"Yamauchi",fullName:"Motohiro Yamauchi",slug:"motohiro-yamauchi"},{id:"48715",title:"Dr.",name:"Masatoshi",middleName:null,surname:"Suzuki",fullName:"Masatoshi Suzuki",slug:"masatoshi-suzuki"},{id:"48716",title:"Dr.",name:"Yasuyoshi",middleName:null,surname:"Oka",fullName:"Yasuyoshi Oka",slug:"yasuyoshi-oka"},{id:"110807",title:"Prof.",name:"Shunichi",middleName:null,surname:"Yamashita",fullName:"Shunichi Yamashita",slug:"shunichi-yamashita"}]},{id:"22715",title:"Role of RPA Proteins in Radiation Repair and Recovery",slug:"role-of-rpa-proteins-in-radiation-repair-and-recovery",signatures:"Patrick E. Gygli, J. Scott Lockhart and Linda C. DeVeaux",authors:[{id:"42827",title:"Dr.",name:"Linda",middleName:null,surname:"DeVeaux",fullName:"Linda DeVeaux",slug:"linda-deveaux"},{id:"57407",title:"Mr.",name:"Patrick",middleName:null,surname:"Gygli",fullName:"Patrick Gygli",slug:"patrick-gygli"},{id:"58052",title:"Mr",name:"James",middleName:null,surname:"Lockhart",fullName:"James Lockhart",slug:"james-lockhart"}]},{id:"22716",title:"Recognition and Repair Pathways of Damaged DNA in Higher Plants",slug:"recognition-and-repair-pathways-of-damaged-dna-in-higher-plants",signatures:"Sascha Biedermann, Sutton Mooney and Hanjo Hellmann",authors:[{id:"42896",title:"Prof.",name:"Hanjo",middleName:null,surname:"Hellmann",fullName:"Hanjo Hellmann",slug:"hanjo-hellmann"},{id:"56085",title:"Dr.",name:"Sutton",middleName:null,surname:"Mooney",fullName:"Sutton Mooney",slug:"sutton-mooney"},{id:"92881",title:"Mr",name:"Sascha",middleName:null,surname:"Biedermann",fullName:"Sascha Biedermann",slug:"sascha-biedermann"}]},{id:"22717",title:"DNA Damage Protection and Induction of Repair by Dietary Phytochemicals and Cancer Prevention: What Do We Know?",slug:"dna-damage-protection-and-induction-of-repair-by-dietary-phytochemicals-and-cancer-prevention-what-d",signatures:"Alice A. Ramos, Cristóvão F. Lima and Cristina Pereira-Wilson",authors:[{id:"46395",title:"Prof.",name:"Cristina",middleName:null,surname:"Pereira-Wilson",fullName:"Cristina Pereira-Wilson",slug:"cristina-pereira-wilson"},{id:"58005",title:"MSc",name:"Alice",middleName:null,surname:"Ramos",fullName:"Alice Ramos",slug:"alice-ramos"},{id:"58006",title:"Mr.",name:"Cristóvăo",middleName:null,surname:"Lima",fullName:"Cristóvăo Lima",slug:"cristovao-lima"},{id:"101964",title:"Dr.",name:"Cristovao",middleName:null,surname:"Lima",fullName:"Cristovao Lima",slug:"cristovao-lima"}]},{id:"22718",title:"The Nuclear Compartmentation of Glutathione: Effect on Cell Cycle Progression",slug:"the-nuclear-compartmentation-of-glutathione-effect-on-cell-cycle-progression",signatures:"Jelena Markovic, Nancy Mora, Amparo Gimeno, Consuelo Burguete, José Luis García-Gimenez and Federico V. Pallardó",authors:[{id:"48308",title:"Prof.",name:"Federico",middleName:null,surname:"Pallardó",fullName:"Federico Pallardó",slug:"federico-pallardo"},{id:"57501",title:"Prof.",name:"Jelena",middleName:null,surname:"Markovic",fullName:"Jelena Markovic",slug:"jelena-markovic"},{id:"57502",title:"Dr.",name:"Amparo",middleName:null,surname:"Gimeno",fullName:"Amparo Gimeno",slug:"amparo-gimeno"},{id:"57503",title:"Dr.",name:"Jose Luis",middleName:null,surname:"Garcia-Giménez",fullName:"Jose Luis Garcia-Giménez",slug:"jose-luis-garcia-gimenez"},{id:"65088",title:"Dr.",name:"María",middleName:"Consuelo",surname:"Burguete",fullName:"María Burguete",slug:"maria-burguete"}]},{id:"22719",title:"Role for PKCδ on Apoptosis in the DNA Damage Response",slug:"role-for-pkc-on-apoptosis-in-the-dna-damage-response",signatures:"Kiyotsugu Yoshida",authors:[{id:"57025",title:"Dr.",name:"Kiyotsugu",middleName:null,surname:"Yoshida",fullName:"Kiyotsugu Yoshida",slug:"kiyotsugu-yoshida"}]},{id:"22720",title:"New Players in Recognition of Intact and Cleaved AP Sites: Implication in DNA Repair in Mammalian Cells",slug:"new-players-in-recognition-of-intact-and-cleaved-ap-sites-implication-in-dna-repair-in-mammalian-cel",signatures:"Svetlana Khodyreva and Olga Lavrik",authors:[{id:"58303",title:"Prof.",name:"Olga",middleName:null,surname:"Lavrik",fullName:"Olga Lavrik",slug:"olga-lavrik"},{id:"58304",title:"Dr.",name:"Svetlana",middleName:null,surname:"Khodyreva",fullName:"Svetlana Khodyreva",slug:"svetlana-khodyreva"}]},{id:"22721",title:"SiDNA and Other Tools for the Indirect Induction of DNA Damage Responses",slug:"sidna-and-other-tools-for-the-indirect-induction-of-dna-damage-responses",signatures:"Maria Quanz, Amélie Croset and Marie Dutreix",authors:[{id:"46480",title:"Dr.",name:"Marie",middleName:null,surname:"Dutreix",fullName:"Marie Dutreix",slug:"marie-dutreix"},{id:"57915",title:"Dr.",name:"Maria",middleName:null,surname:"Quanz",fullName:"Maria Quanz",slug:"maria-quanz"},{id:"57919",title:"MSc",name:"Amélie",middleName:null,surname:"Croset",fullName:"Amélie Croset",slug:"amelie-croset"}]},{id:"22722",title:"DNA Repair in Pathogenic Eukaryotic Cells: Insights from Comparative Genomics of Parasitic Protozoan",slug:"dna-repair-in-pathogenic-eukaryotic-cells-insights-from-comparative-genomics-of-parasitic-protozoan",signatures:"Laurence A. Marchat, Mavil López-Casamichana, Esther Orozco and César López-Camarillo",authors:[{id:"35092",title:"Dr.",name:"Esther",middleName:null,surname:"Orozco",fullName:"Esther Orozco",slug:"esther-orozco"},{id:"40928",title:"Dr.",name:"Cesar",middleName:null,surname:"Lopez-Camarillo",fullName:"Cesar Lopez-Camarillo",slug:"cesar-lopez-camarillo"},{id:"48366",title:"Dr.",name:"Laurence A.",middleName:null,surname:"Marchat",fullName:"Laurence A. Marchat",slug:"laurence-a.-marchat"},{id:"59012",title:"Dr.",name:"Mavil",middleName:null,surname:"Lopez Casamichana",fullName:"Mavil Lopez Casamichana",slug:"mavil-lopez-casamichana"}]},{id:"22723",title:"Mechanisms of Mutagenic DNA Nucleobase Damages and Their Chemical and Enzymatic Repairs Investigated by Quantum Chemical Methods",slug:"mechanisms-of-mutagenic-dna-nucleobase-damages-and-their-chemical-and-enzymatic-repairs-investigated",signatures:"Eric A. C. Bushnell, Jorge Llano, Leif A. Eriksson and James W. Gauld",authors:[{id:"46910",title:"Dr.",name:"James",middleName:"W.",surname:"Gauld",fullName:"James Gauld",slug:"james-gauld"},{id:"58413",title:"Dr.",name:"Jorge",middleName:null,surname:"Llano",fullName:"Jorge Llano",slug:"jorge-llano"},{id:"58414",title:"Dr.",name:"Leif",middleName:null,surname:"Eriksson",fullName:"Leif Eriksson",slug:"leif-eriksson"},{id:"72304",title:"Prof.",name:"Eric",middleName:"Andrew Charles",surname:"Bushnell",fullName:"Eric Bushnell",slug:"eric-bushnell"}]},{id:"22724",title:"DNA Radiosensitization: The Search for Repair Refractive Lesions Including Double Strand Breaks and Interstrand Crosslinks",slug:"dna-radiosensitization-the-search-for-repair-refractive-lesions-including-double-strand-breaks-and-i",signatures:"Tsvetan G. Gantchev, Marie-Eve Dextraze and Darel J. Hunting",authors:[{id:"54287",title:"Prof.",name:"Darel",middleName:null,surname:"Hunting",fullName:"Darel Hunting",slug:"darel-hunting"},{id:"58047",title:"Dr.",name:"Tsvetan",middleName:null,surname:"Gantchev",fullName:"Tsvetan Gantchev",slug:"tsvetan-gantchev"}]},{id:"22725",title:"The Influence of Individual Genome Sensitivity in DNA Damage Repair Assessment in Chronic Professional Exposure to Low Doses of Ionizing Radiation",slug:"the-influence-of-individual-genome-sensitivity-in-dna-damage-repair-assessment-in-chronic-profession",signatures:"Mirta Milić, Ružica Rozgaj, Vilena Kašuba, Ana Marija Jazbec, Patrizia Hrelia and Sabrina Angelini",authors:[{id:"40591",title:"Dr.",name:"Mirta",middleName:null,surname:"Milić",fullName:"Mirta Milić",slug:"mirta-milic"},{id:"57808",title:"Dr.",name:"Ružica",middleName:null,surname:"Rozgaj",fullName:"Ružica Rozgaj",slug:"ruzica-rozgaj"},{id:"57809",title:"Dr.",name:"Vilena",middleName:null,surname:"Kašuba",fullName:"Vilena Kašuba",slug:"vilena-kasuba"},{id:"57810",title:"Prof.",name:"Anamarija",middleName:null,surname:"Jazbec",fullName:"Anamarija Jazbec",slug:"anamarija-jazbec"},{id:"57811",title:"Dr.",name:"Sabrina",middleName:null,surname:"Angelini",fullName:"Sabrina Angelini",slug:"sabrina-angelini"},{id:"57812",title:"Prof.",name:"Patrizia",middleName:null,surname:"Hrelia",fullName:"Patrizia Hrelia",slug:"patrizia-hrelia"}]},{id:"22726",title:"Application of Host Cell Reactivation in Evaluating the Effects of Anticancer Drugs and Environmental Toxicants on Cellular DNA Repair Activity in Head and Neck Cancer",slug:"application-of-host-cell-reactivation-in-evaluating-the-effects-of-anticancer-drugs-and-environmenta",signatures:"Yi-Shan Tsai, Jau-Ling Huang and Chang-Shen Lin",authors:[{id:"57600",title:"Dr.",name:"Chang Shen",middleName:null,surname:"Lin",fullName:"Chang Shen Lin",slug:"chang-shen-lin"},{id:"57606",title:"Dr.",name:"Yi-Shan",middleName:null,surname:"Tsai",fullName:"Yi-Shan Tsai",slug:"yi-shan-tsai"},{id:"57607",title:"Dr.",name:"Jau-Ling",middleName:null,surname:"Huang",fullName:"Jau-Ling Huang",slug:"jau-ling-huang"}]},{id:"22727",title:"Role of Radioprotectors in the Inhibition of DNA Damage and Modulation of DNA Repair After Exposure to Gamma-Radiation",slug:"role-of-radioprotectors-in-the-inhibition-of-dna-damage-and-modulation-of-dna-repair-after-exposure-",signatures:"Dharmendra Kumar Maurya and Thomas Paul Asir Devasagayam",authors:[{id:"56167",title:"Dr.",name:"Thomas Paul Asir",middleName:null,surname:"Devasagayam",fullName:"Thomas Paul Asir Devasagayam",slug:"thomas-paul-asir-devasagayam"},{id:"56170",title:"Dr.",name:"Dharmedra K",middleName:null,surname:"Maurya",fullName:"Dharmedra K Maurya",slug:"dharmedra-k-maurya"}]},{id:"22728",title:"DNA-Binding Radioprotectors",slug:"dna-binding-radioprotectors",signatures:"Pavel Lobachevsky, Alesia Ivashkevich, Olga A. Martin and Roger F. Martin",authors:[{id:"50843",title:"Dr.",name:"Olga",middleName:"A.",surname:"Martin",fullName:"Olga Martin",slug:"olga-martin"},{id:"58135",title:"Dr",name:"Pavel",middleName:"N.",surname:"Lobachevsky",fullName:"Pavel Lobachevsky",slug:"pavel-lobachevsky"},{id:"58136",title:"Dr.",name:"Alesia",middleName:null,surname:"Ivashkevich",fullName:"Alesia Ivashkevich",slug:"alesia-ivashkevich"},{id:"58137",title:"Dr.",name:"Roger F.",middleName:null,surname:"Martin",fullName:"Roger F. Martin",slug:"roger-f.-martin"}]},{id:"22729",title:"DNA Damage Response and Repair: Insights into Strategies for Radiation Sensitization",slug:"dna-damage-response-and-repair-insights-into-strategies-for-radiation-sensitization",signatures:"Joshua D. Lawson, Kristopher T. Kahle, Kimberly Ng, Bob Carter, Santosh Kesari and Clark C. Chen",authors:[{id:"62462",title:"Prof.",name:"Clark",middleName:null,surname:"Chen",fullName:"Clark Chen",slug:"clark-chen"},{id:"85623",title:"Prof.",name:"Kimberly",middleName:null,surname:"Ng",fullName:"Kimberly Ng",slug:"kimberly-ng"},{id:"86785",title:"Dr.",name:"Joshua",middleName:null,surname:"Lawson",fullName:"Joshua Lawson",slug:"joshua-lawson"},{id:"86788",title:"Dr.",name:"Santosh",middleName:null,surname:"Kesari",fullName:"Santosh Kesari",slug:"santosh-kesari"},{id:"86789",title:"Dr.",name:"Bob",middleName:null,surname:"Carter",fullName:"Bob Carter",slug:"bob-carter"},{id:"86790",title:"Dr.",name:"Kirstopher",middleName:null,surname:"Kahle",fullName:"Kirstopher Kahle",slug:"kirstopher-kahle"}]},{id:"22730",title:"The Botanical Extract Feverfew PFE Reduces DNA Damage and Induces DNA Repair Processes",slug:"the-botanical-extract-feverfew-pfe-reduces-dna-damage-and-induces-dna-repair-processes",signatures:"Michael D. Southall, Simarna Kaur and Khalid Mahmood",authors:[{id:"42297",title:"Dr.",name:"Michael",middleName:null,surname:"Southall",fullName:"Michael Southall",slug:"michael-southall"},{id:"54272",title:"Dr.",name:"Simarna",middleName:null,surname:"Kaur",fullName:"Simarna Kaur",slug:"simarna-kaur"},{id:"54559",title:"Dr.",name:"Khalid",middleName:null,surname:"Mahmood",fullName:"Khalid Mahmood",slug:"khalid-mahmood"}]},{id:"22731",title:"Food Factors and Oxidative DNA Damage / DNA Repair Systems",slug:"food-factors-and-oxidative-dna-damage-dna-repair-systems",signatures:"Takeshi Hirano and Kazuyoshi Tamae",authors:[{id:"41165",title:"Prof.",name:"Takeshi",middleName:null,surname:"Hirano",fullName:"Takeshi Hirano",slug:"takeshi-hirano"},{id:"41284",title:"Dr.",name:"Kazuyoshi",middleName:null,surname:"Tamae",fullName:"Kazuyoshi Tamae",slug:"kazuyoshi-tamae"}]},{id:"22732",title:"Enhancing DNA Repair by Combining only Dietary Supplement Ingredients that do not Metabolically Compete in Order to Achieve Synergism",slug:"enhancing-dna-repair-by-combining-only-dietary-supplement-ingredients-that-do-not-metabolically-comp",signatures:"Ronald W. Pero",authors:[{id:"56402",title:"Prof.",name:"Ronald",middleName:null,surname:"Pero",fullName:"Ronald Pero",slug:"ronald-pero"}]}]}]},onlineFirst:{chapter:{type:"chapter",id:"74269",title:"Soil Management and Conservation: An Approach to Mitigate and Ameliorate Soil Contamination",doi:"10.5772/intechopen.94526",slug:"soil-management-and-conservation-an-approach-to-mitigate-and-ameliorate-soil-contamination",body:'
1. Introduction
One of the central component of terrestrial ecosystem is soil. Loss in ecosystem is a representation of the degradation of soil. The soil plays a key role in the health of ecosystem, however, over-exploitation of these ecosystem by humans causes considerable degradation and migration of contaminants. The use of land for agriculture occupies 36.5% of the earth’s land mass [1]. Though this human activities may be justified to provide greater benefit in other services termed development, but consistent degradation of this ecosystem and exposure of it to various contaminants is not in the best interest of the society and it is detrimental to the environment that sustains all life forms.
Soil conservation are various practices of farming operations and management strategies which are conducted with the purpose of controlling soil erosion by avoiding or minimizing soil particle detachment and movement of water or/and air. It also helps in preventing the loss of the top-most layer of the soil and fertility which could also be caused by soil contamination. Understanding the processes and factors that govern soil erosion is very important to implementing its control practice and will help to manage soil erosion thus leading to soil conservation. The mechanics involve fluid (wind/water) detachment or entrainment which is being accompanied by the transportation of soil particles and its subsequent deposition as soil sediments. Conservation approaches and management strategies that ensures these include crop rotation, cover cropping, planting windbreaks and conservation tillage, which have been harnessed for millennia. Soil conservation practices are said to be farming operations and soil management strategies carried out with the aim of achieving a goal which is to control soil erosion by preventing or reducing soil particle detachment and transport in air or water [2]. Soil conservation started with the aim to protect an ecology from agricultural production by making use of largely unproven technology that failed to adapt with the natural requirements of the land. The evolving land degradation trend could only be understood by determining if the causes were as a result of natural occurrences or by unwise use [3].
In Europe, Common Agricultural Policy (CAP) is put in place in a bid to target the application of best management practices such as winter cover crops, reduced tillage, plant residues and grass margins in order to address conservation [4]. This traditional approaches which enhanced the productivity, environmental benefits and profits are based on procedures of no-tillage, and the broader concepts of agricultural conservation and land management sustainability. These concepts are one and not divided, but part of a continuous land management practices which range from detailed soil management practices such as zero-tillage, to the enhnaced concepts, principles and objectives of agricultural conservation and land management for sustainability.
2. Soil conservation methods
2.1 Cover cropping and mulching
This method is effective in reducing migration of top soil by leaving a cover over the soil in a bid to reduce soil displacement which is associated with the impacts from raindrops on the soil particles. Cover crops and mulching also reduces the amount of runoff and its velocity over the soil. Mulching, which is the application of organic materials over exposed soil to confer a form of covering to it over a period before decomposing. Straw can be used as mulch but hay is proven to be the best and it is important to ensure that it is harvested before the weeds mature. These crops are necessary to control erosion especially when the main crops planted do not give sufficient residue for more conventional residue management-based erosion control [5]. Where precipitation is adequate, cover crops like peas can help protect against wind erosion and also add nitrogen to the soil. The nitrogen released from the roots of these legumes are energy source for microbial metabolic activities hence such live mulch or cover crop give rise to an active microbial community in the rhizosphere soil.
2.2 Crop rotation
Crop rotation is an indigenous and practical way for managing agro-ecosystem biodiversity by enhancing soil health, minimizing pests and disease outbreaks [6]. This method enables farmers to improve the structure of the soil, increase the soil organic matter and rooting depth. This happens when secondary crops are grown in order to enhance soil health. As a result of the extensive shattering of soil aggregrates during seedbed preparation and harvesting, root crops are particularly destructive to the soil structure. Therefore, it is advised that root crops should be grown once in every three years. Corn can be grown in the following year with two years of silage followed in succession by three or more years of forage. Leguminous crops (such as pea and chickpea) during crop rotation helps in modifying soil functional microbial communities. In the rotation, cover cropping or mulching, and zero tillage should be incorporated too. Crop rotations can provide better opportunities for the growth of some soil functional microorganisms. This brings about rich biodiversity within the soil ecosystem as both the shallow feeding crops and deep rooted crops activates varying species of microorganismsper time thus creating a build up of microbes exhibiting varying characteristics to colonize the soil. Thus, different crops can produce various residues and root exudates to boost soil microbial diversity and activity, and increase soil microbial biomass as well as enhance C and N cycling [7, 8].
2.3 Conservation tillage
This method is aimed atpreserving soil aggregates, organic matter and crop residues [9, 10]. Conservation tillage include changes in making use of less destructive tillage implements (for instance, instead of using mouldboard plow, use chisel plow), minimum tillage (that is, one turn instead of two), leaving crop residue on the soil surface to prevent erosion. Plowing and tilling land for the preparation of the seed bed are basis of the traditional agricultural practices. However, these practices have been proven to be highly destructive to the soil with 24% of global agricultural land degraded as a result of this [11]. New approach which is centered on conserving and improving soil is gradually replacing soil tillage. The soil is typically inverted to a depth of less than 20 cm using mouldboard plow during conventional tillage system, however, in conservation tillage system, the soil is not disturbed or disturbed to a lesser degree [12]. This conservation method has shown to improve soil structure, reduce soil erosion, improve drainage and water holding capacity of the soil, increase soil organic matter and also increase microbial and earthworm activity [13].
2.4 Ridges, terraces and contours
The ridges are made across wind and they consist of tall listed seed beds that are being formed over the entire field or as trap strips which is in a position perpendicular to the direction of the prevailing wind. The formation of an earthen embankment along a common elevation contour gives an elevated terrace structure that can directly reduce wind erosion by potential reduction in wind speed and interception of soil particles. Indirect wind erosion control benefits of terraces and the related contour tillage and cropping practices expand overall crop grain and residue productivity by controlling runoff for increased water storage in the soil [14]. The underlying layer of soil becomes relatively less disturbed by the action of erosion hence making room for an increased microbial population within the micro-climate.
2.5 Strip cropping/planting windbreaks
This is another method of conserving the soil and for controlling wind erosion. A windbreak serves as a barrier with the purpose of deflecting the flow of air and reducing leeward wind speed [15]. However, the availability of irrigation makes this conservation method useful in a difficult environment. The crops may be cultured in strips perpendicular to the prevailing wind where field orientation is not restricted as a means to reduce the near surface wind speed [16]. This practice is broadly accommodating of various width of crop strips depending on the crop tolerance to eroding soil or potential to trap soil grains. The interplay between erosivity and erodibility potential of soil determines the gradient of detachment experienced within varying soil types. This confers significance on the efficacy of windbreaks/strip crops to band soil particles together thereby curtailing dislodgement.
2.6 Residue management
This is the most preferred method for controlling wind erosion for most crops and climates [17]. It is made up of several tillage practices that maintain residue from a previously harvested crop as a surface cover to prevent soil erosion. Residue management also maintains mulches which may be standing or flat to intercept soil grains by trapping their movement [18]. Leaving the residue of the previous crop on the surface of the soil is beneficial in that it improves soil water storage regardless of the runoff controlling contours, it helps to increase rain infiltration and reduce evaporation from the soil. The micro-climate here is well adapted for microbial activities as there exists a steady retrieval of energy from the decomposing biomass of residues thereby giving rise to mineralization of organic compounds and disintegration of complex molecules.
3. Effects of agriculture on environmental health
Soil health is the innate potential of a soil to function within ecosystem boundaries (either natural or managed), sustain plant productivity, maintain water and air quality, support human well-being, and provide habitats for biodiversity [19, 20, 21]. Agricultural intensification is placing huge pressure on the soil’s potential to maintain its functions which is progressively leading to large-scale ecosystem degradation and loss of productivity in the long term [22, 23, 24]. Over a few decades, significant efforts have been made to enhance agricultural productivity through increased fertilization and pesticide application, improved irrigation, soil management regimes and crops, and massive land conversions [25]. However, there is a growing concern that the use of natural ecosystems for agricultural purposes has incurred substantial environmental costs, including desertification, increased emissions of greenhouse gasses, decreased organic matter in soils, loss of biodiversity, and alterations to biogeochemical and hydrological cycles [26, 27].
The quality of the soil, conversely, is an extrinsic feature of soils and changes with the desired usage of that soil by humans. This may be related to agricultural production and its capacity to support wildlife, watershed production, or recreation outputs provision. Some of the environmental challenges that are related to agriculture are expressed as pollutants, climate change, soil degradation, and deforestation [28].
3.1 Climate change
Climate is described as general or average weather conditions of a certain region, including temperature, rainfall and wind, over a long period. Climate change has direct and indirect effect in speeding up or slowing down terrestrial microbial community composition and their functional activities. Climatic change alters the relative population of microorganisms and their functions within soil communities since soil community members differ in their physiology, temperature sensitivity, and growth rates [29, 30, 31, 32, 33, 34]. The direct effects of climatic change on microbial population, composition and function have been reviewed extensively [35, 36, 37, 38, 39]. Temperature and water are essential environmental factors for microbial growth. Increased temperature alters microbial community structures and processes such as respiration, fermentation and methanogenesis are also accelerated. This directly affects enzyme activity and microbial physiological property. Both agriculture and climate change are interrelated processes, of which they both take place on a global scale. Climate change impacts microbial community structure and activities both directly, through alteration of the soil chemical and physical environment, and indirectly through changes in land use. Environmental changes such as global warming are directly altering microbial soil respiration rates because soil microorganisms, and the processes they mediate, are temperature sensitive. The role of the prevailing changing climate, visibly expressed with elevated temperature, in microbial metabolism has been accorded considerable attention of recent [40, 41, 42, 43]. This stresses the effects of climatic changes on soil microorganisms which are essential components in the ecosystem since they play a key role in maintaining soil health through ecological intensification.
3.2 Deforestation
Deforestation is a major driver of climate change and cause of the loss of habitat for millions of species. The soil is the basis for agriculture, natural plant communities and natural climate regulation, with 75% organic carbon stored in terrestrial habitat [44, 45, 46]. Vegetation has extensive contribution in sustaining ecosystem services of both surface and subsurface soil. Deforestation exacerbates climate change in that trees are completely or selectively removed to create farmland. Land use changes have several undesirable consequences, with significant effect on radical losses in soil fertility, soil carbon and nitrogen stocks have been recorded in the first 20–25 years after deforestation [47, 48].
3.3 Pollutants
Synthetic pesticides are the most common and widely use method of controlling pests in agriculture. A large number of agricultural chemicals (such as fertilizer, pesticides, etc.) are used and some become pollutants through their use, misuse or ignorance hence leaching through the soil to pollute the groundwater. Soil erosion has been instrumental in the horizontal and vertical movement of these pollutants (earlier bonded with soil particles but displaced) from agricultural fields to other places, especially water bodies (both surface and underground). Consequently, pollutants from agricultural fields do have large effect on the quality of water. Poorly managed animal feeding operations, overgrazing, heavy use of fertilizers, plowing, and improper, heavy use, or wrongly timed use of pesticides, causes pollution. These pollutants find their ways through the soil profile and across the gradient of slope hence affecting rivers, groundwater, wetlands, lakes, and estuaries [28] through continued deposition over a long period. In the same vein, untreated industrial pollutants discharged from the industries and factories have prevalent toxic concentration. Oftentimes, these wastes are discharged into the water body and affect aquatic cultures as well as flora and fauna life cycles. Usage of unsuitable contaminated water and the discharge of untreated industrial wastewater into water bodies form a main source of water pollution. Soil pollution occurs due to untreated disposal of industrial wastes (laden with high toxic contaminants) into soil. Wastes from industries have varying amount of toxic chemicals such that when deposited in soil, they cause the soil layer strength in the top soil to deteriorate, thus reducing fertility and microbial activity of the soil. In addition, the hazardous effect of these pollutants leads to ecological imbalances within the soil ecosystem.
3.4 Soil degradation
Soil degradation is the decrease in the quality of soil that can be as a result of many factors, most especially from agriculture. Soils hold the majority of the world’s biodiversity, and healthy soils are essential for food production and adequate water supply [49]. Soil degradation shows expression in salting, waterlogging, compaction, pesticide contamination, decline in soil structure, loss of fertility, increase in soil acidity, alkalinity, salinity, and prevalence of erosion. Soil erosion is the wearing away of topsoil by water, wind, or farming activities [50]. At the same time, agriculture has been shown to contribute significantly to degradation, mainly through the continued dependence and improper use of inorganic fertilizers, synthetic pesticides, etc., which culminates in production and release of greenhouse gases such as carbon dioxide, methane, and nitrous oxide. Moreover, agriculture that practices conventional practices such as tillage, fertilization, and pesticide application also release ammonia, nitrate, phosphorus, and many other gases that pollute the air, water, and soil quality, as well as biodiversity. Agriculture also changes the land cover of the Earth, which can change its ability to absorb or reflect heat and light, hence contributing to radiative forcing. Soil degradation also has a large impact on biological degradation, which influence the microbial community of the soil negatively and alters nutrient cycling, pest and disease control, and chemical transformation properties of the soil.
4. Effects of microbial activities on soil contaminants
By 2050, it is projected that the world population will increase to 8.9 billion people and this will lead to higher demand for agricultural produce [51]. In the future, the high demand of food and shortage of new agricultural land development will require increasing crop yields making use of sustainable means. Improvement of soil conservation increases soil organic matter and reduces erosion in other to have a sustainable agricultural land management and improved soil health [52]. Assessment of soil is based on the quality of soil variables that guarantee crop production sustainability in agricultural lands [19, 53]. Soil biota components such as microbial community, activity, abundance, stability and diversity which are improved by soil conservation have been discussed in several studies to be important indicators of soil quality [19, 54]. The rhizosphere of the plant is the narrow zone of the soil that is closed to the root system and sustains the production of crops with agrochemical inputs level that is balance or minimized [55]. Rhizoremediation of organic pollutants [8] and organic compounds creates nutrient-rich environment that influence microbial communities and the degradation of organic contaminants [56]. Soil biota plays a great role in residues of plant mineralization to form plants nutrients which can be easily absorbed by the plants for their growth and development [57]. Also, soil biota increases the rate of decomposition by excreting different enzymes that support plants’s nutrients kinetics in the soil [58]. Microorganisms in the soil especially bacteria and fungi, transforms N between organic and inorganic forms which improves plant minerals uptake [59]. Microbial communities support the fundamental processes that provide productivity and stability of agroecosystems [60].
Soil conservation activities such as cover crops and minimum tillage as earlier mentioned can favorably improve soil health by increasing the number of soil organisms that break down organic matter, and in the process, release nutrients for the plant uptake. This soil organism breaks organic soil contaminants and several factors can interfere with the soil–microbe–plant complex hence influencing its functionality. Soil type [61], organic carbon level [60], temperature and moisture [62], oxygen level [63], electrical conductivity, calcium level and pH [64] are all factors that can change the composition and functionality of soil microbial communities. Of the soil macrofauna, earthworms are a major component and are very important in the soil fertility dynamics as their burrowing activities helps in improving the soil aeration and infiltration of water into the soil. The population of earthworm is influenced by soil conservation. [65, 66] discussed how minimum tillage which is part of soil conservation affects the population of earthworm. The increase of earthworms could encourage biological-remediation of contaminated soil known as vermiremediation [67]; soils contaminated with metallic contaminants [68] and organic pollutants and some chlorinated compounds inclusive [69]. The earthworms makes holes through the soil, mix the soil, affects its structure, and alters its nutritional profile and fungal and bacterial communities [70].
Fungi are chemoorganotrophic organism that are present everywhere and plays fundamental roles in geological and ecological processes [71, 72]. They can transform a large varieties of organic substrates, in addition with natural polymers not only lignin, cellulose, starch and chitin, but also other anthropogenic products such as explosives, pesticides and other xenobiotics [73, 74]. Mycoremediation, that is, the use of fungi to remove soil contaminant, has emerged as one of the most promising and cost-effective soil remediation techniques [75, 76, 77, 78, 79]. Bacterial genera, namely, Gordonia, Brevibacterium, Aeromicrobium, Dietzia, Burkholderia, and Mycobacterium, Fungal genera, namely, Amorphoteca, Neosartorya, Talaromyces, and Graphium as well as terrestrial fungi, namely, Aspergillus, Cephalosporium, and Penicillium and yeast genera, namely, Candida, Yarrowia, and Pichia which were isolated from soil that has been contaminated by petroleum proved to be organisms that has the potential for degrading hydrocarbon while yeast species, namely, Candida lipolytica, Rhodotorula mucilaginosa, Geotrichum spp., and Trichosporon mucoides isolated from water that has been contaminated were discovered to degrade petroleum compounds [80, 81, 82]. When soil microorganism is improved by soil conservation, mycoremediation will be facilitated in order to remove soil contaminant. For instance, fungi is a potential approach for specific site Arsenic bioremediation [78, 79]. This adaptation of fungi towards soil that has been contaminated could be the high surface area to volume ratio and their various detoxification of metal mechanisms [83].
The physical and chemical properties of the soil significantly influence the soil fungal community structure and this is determined by agricultural practices [84, 85]. Increase in fungal biomass and bacterial is termed as changes in soil microbial communities and it has been observed in zero tillage than in conventional tillage practices [86]. Various land management practices has been examined to increase fungal biomass in the soil. Total fungal hyphal biomass and fungal propagules were discovered to be more in soil collected from organically managed agricultural systems [87, 88, 89]. The density of fungi in soil were found to be affected by crop rotation, animal grazing and soil tillage [90, 91, 92, 93, 94, 95, 96, 97, 98].
5. Conclusion
The type of land management practices in agroecosystems as an impacts on the structure of microbial community and function through a variety of different mechanisms. Land-use changes also impact on soil microbial community structure through alterations in carbon availability and quality, pH and nutrient availability. Since the ratio of fungal population to bacterial population are commonly measured as indicators of microbial community structure, and the relative proportions of fungi are increased by no-till practices, crop rotations, and use of cover crops, thus biological mechanisms are regulating carbon and nitrogen exchanges between the land, water and atmosphere. This reveals the importance of soil management and conservation approach in enhancing microbial activity for soil ecological intensification as well as buffering the soil to neutralize contaminants. Albeit, microbial ecology to assess terrestrial carbon cycle plays a crucial role in maintaining balance within the ecosystem.
Conflict of interest
There is no conflict of interest.
\n',keywords:"degradation, land-use, ecology, biodiversity, soil conservation",chapterPDFUrl:"https://cdn.intechopen.com/pdfs/74269.pdf",chapterXML:"https://mts.intechopen.com/source/xml/74269.xml",downloadPdfUrl:"/chapter/pdf-download/74269",previewPdfUrl:"/chapter/pdf-preview/74269",totalDownloads:66,totalViews:0,totalCrossrefCites:0,dateSubmitted:"July 12th 2020",dateReviewed:"October 16th 2020",datePrePublished:"December 1st 2020",datePublished:null,dateFinished:"December 1st 2020",readingETA:"0",abstract:"The chapter mainstreamed Soil Management and Conservation approach as a potent remedy for Soil Contamination. Largely, microbial activities play significant role in maintaining balance within the ecosystem however changes in Land-use has a direct influence on soil biota, including the floral and fauna components. The introduction of contaminants, from varying sources such as agrochemicals, petrochemicals, landfills, sludge, effluents, etc., into the soil builds up the amount of heavy metals present in the deposits hence degrading the soil and polluting groundwater. Integrating soil management options to enhance biodiversity and strengthen microbial activities improve the soil ecology thus creating a buffer for neutralizing potential contaminants.",reviewType:"peer-reviewed",bibtexUrl:"/chapter/bibtex/74269",risUrl:"/chapter/ris/74269",signatures:"Oluwatosin Ayobami Ogunsola, Odunayo David Adeniyi and Victoria Abimbola Adedokun",book:{id:"9843",title:"Soil Contamination",subtitle:null,fullTitle:"Soil Contamination",slug:null,publishedDate:null,bookSignature:"Dr. Marcelo L. Larramendy and Dr. Sonia Soloneski",coverURL:"https://cdn.intechopen.com/books/images_new/9843.jpg",licenceType:"CC BY 3.0",editedByType:null,editors:[{id:"14764",title:"Dr.",name:"Marcelo L.",middleName:null,surname:"Larramendy",slug:"marcelo-l.-larramendy",fullName:"Marcelo L. Larramendy"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:null,sections:[{id:"sec_1",title:"1. Introduction",level:"1"},{id:"sec_2",title:"2. Soil conservation methods",level:"1"},{id:"sec_2_2",title:"2.1 Cover cropping and mulching",level:"2"},{id:"sec_3_2",title:"2.2 Crop rotation",level:"2"},{id:"sec_4_2",title:"2.3 Conservation tillage",level:"2"},{id:"sec_5_2",title:"2.4 Ridges, terraces and contours",level:"2"},{id:"sec_6_2",title:"2.5 Strip cropping/planting windbreaks",level:"2"},{id:"sec_7_2",title:"2.6 Residue management",level:"2"},{id:"sec_9",title:"3. Effects of agriculture on environmental health",level:"1"},{id:"sec_9_2",title:"3.1 Climate change",level:"2"},{id:"sec_10_2",title:"3.2 Deforestation",level:"2"},{id:"sec_11_2",title:"3.3 Pollutants",level:"2"},{id:"sec_12_2",title:"3.4 Soil degradation",level:"2"},{id:"sec_14",title:"4. Effects of microbial activities on soil contaminants",level:"1"},{id:"sec_15",title:"5. Conclusion",level:"1"},{id:"sec_19",title:"Conflict of interest",level:"1"}],chapterReferences:[{id:"B1",body:'FAOSTAT. (2008). Fact sheet. FAO, Rome, Italy.'},{id:"B2",body:'Dabney, S.M., Shields, F.D., Binger, R.L., Kuhnle, R.A., Rigby, J.R. 2012. Watershed management for erosion and sedimentation control case study. Godwin Creek, Panola County, MS. In: Lal R., Stewart, B.A. (Eds.) Advances in Soil Science: Soil Water and Agronomic Productivity. Boca Raton, FL: Taylor and Francis. Pp; 539-568.'},{id:"B3",body:'Tanner, T. (Ed.), (2012). Aldo Leopold: The Man and His Legacy. Ankeny, IA Soil and Water Conservation society.'},{id:"B4",body:'Panagos, Panos; Borrelli, Pasquale; Meusburger, Katrin; Alewell, Christine; Lugato, Emanuele; Montanarella, Luca. (2015). Estimating the soil erosion cover-management factor at the European scale. Land Use Policy, 48, 38-50. doi:doi:10.1016/j.landusepol.2015.05.021'},{id:"B5",body:'Keeling, W., Segarra, E., Abernathy, J.R 1989. Evaluation of conservation tillage cropping systems for cotton on the Texas High Plains. Journal of Production Agriculture. 2; 269-273.'},{id:"B6",body:'Barbieri, P., S. Pellerin, V. Seufert, T. Nesme (2019). Changes in crop rotations would impact food production in an organically farmed worldNat. Sustain., 2, pp. 378-385.'},{id:"B7",body:'Gurr,G.M., Z. Lu, X. Zheng, H. Xu, P. Zhu, G. Chen, X. Yao, J. Cheng, Z. Zhu, J.L. Catindig, S. Villareal, H. VanChien, L.Q. Cuong, C. Channoo, N. Chengwattana, L.P. Lan, L.H. Hai, J. Chaiwong, H.I. Nicol, D.J. Perovic, S.D. Wratten, K.L. Heong (2016). Multi-country evidence that crop diversification promotes ecological intensification of agriculture Nature Plants, 2.'},{id:"B8",body:'Liu, S.H., G.M. Z.-Y.-H. (2017). Bioremediation mechanisms of combined pollution of PAHs and heavy metals by bacteria and fungi: a mini review. Bioresources Technology, 224, 25-33.'},{id:"B9",body:'Lal, R., D. R. (2007). Evolution of the plow over 10,000 years and the rationale for no-till farming. Soil Tillage Resources, 93, 1-12.'},{id:"B10",body:'Skaalsveen, K., J. I. (2019). The effect of no-till farming on the soil functions of water purification and retention in north-western Europe: a literature review. Soil Tillage Resources, 189, 98-109.'},{id:"B11",body:'Bai, Z.G., D.L. Olson, Schaepman, M.E. (2008). Report 2008/01. Global assessment of land degradation and improvement., ISRIC-World Soil Information Report, Wageningen.'},{id:"B12",body:'Morris, N., Miller, P., Orson, J., & Froud-Williams, R. (2010). The adoption of non-inversion tillage systems in the United Kingdom and the agronomic impact on soil, crops and the environment—a review. Soil Tillage Resources, 1-15.'},{id:"B13",body:'Abdollahi, L., & Munkholm, L. (2014). Tillage system and cover crop effects on soil quality: I. Chemical, mechanical, and biological properties. Soil Water Management Conservation, 9.'},{id:"B14",body:'Duncan, D., Burns, K. (2012). The Dust Bowl: An Illustrated History. San Francisco, FL: Chronicle Books LLC.'},{id:"B15",body:'Brandle, J.R., Hodges, L., Zhou, X.H. (2004). Windbreaks in North American agricultural systems. Agroforestry Systems 61, 65-78.'},{id:"B16",body:'Woodruff, N.P., Lyles, L., Siddoway, F.H, Fryrear, D.W., 1972. How to Control Wind Erosion Washington DC: Government Print Office US Department of Agriculture Bulletin. 354.'},{id:"B17",body:'Fryrear, D.W., Skidmore, E.L. 1985. Methods for controlling wind erosion. In: Follett, R.F., Stewart B.A (Eds.), Soil Erosion and Crop Productivity. Madison, Wl: American Society of Agronomy, Crop Science Society of America, Soil Science Society of America, pp. 443-457.'},{id:"B18",body:'Miner, G.L., Hansen, N.C., Inman, D., Sherrod, L.A., Peterson, G.A. 2013. Constraints of no-till dryland agroecosystems as bioenergy production systems. Agronomy Journal; 105, 364-376.'},{id:"B19",body:'Doran, J., & Zeiss, M. (2000). Soil health and sustainability: Managing the biotic component of soil quality. Applied Soil Ecology, 15, 3-11. doi: 10.1016/S0929-1393(00)00067-6'},{id:"B20",body:'Doran, J.W. (2002). Soil health and global sustainability: translating science into practice. Agric. Ecosyst. Environ. 88, 119-127. doi: 10.1016/S0167-8809(01)00246-8'},{id:"B21",body:'Gugino, B.K., Idowu, O.J., Schindelbeck, R.R., van Es, H.M., Wolfe, D.W., Moebius, B.N. (2009). Cornell Soil Health Assessment Training Manual, 2nd Edn. Geneva: Cornell University.'},{id:"B22",body:'Tilman, D., Fargione, J., Wolff, B., D’Antonio, C., Dobson, A., Howarth, R. (2001). Forecasting agriculturally driven global environmental change. Science 292, 281-284. doi: 10.1126/science.1057544'},{id:"B23",body:'Foley, J.A., DeFries, R., Asner, G.P., Barford, C., Bonan, G., Carpenter, S.R. (2005). Global consequences of land use. Science 309, 570-574. doi: 10.1126/science.1111772'},{id:"B24",body:'Vitousek, P.M., Naylor, R., Crews, T., David, M.B., Drinkwater, L.E., Holland, E. (2009). Nutrient imbalances in agricultural development. Science 324:1519. doi: 10.1126/science.1170261'},{id:"B25",body:'Tilman, D., Cassman, K.G., Matson, P.A., Naylor, R., and Polasky, S. (2002). Agricultural sustainability and intensive production practices. Nature 418, 671-677. doi: 10.1038/nature01014'},{id:"B26",body:'Balmford, A., Bennun, L., Brink, B.T., Cooper, D., Cote, I.M., Crane, P. (2005). The convention on biological diversity’s 2010 target. Science 307, 212-213. doi: 10.1126/science.1106281'},{id:"B27",body:'Trivedi, P., Delgado-Baquerizo, M., Anderson, I.C, and Singh, B.K. (2016). Response of Soil Properties and Microbial Communities to Agriculture: Implications for Primary Productivity and Soil Health Indicators. Front. Plant Sci. 7:990. doi: 10.3389/fpls.2016.00990'},{id:"B28",body:'van der Warf, Hayo; Petit, Jean (2002). “Evaluation of the environmental impact of agriculture at the farm level: a comparison and analysis of 12 indicator-based methods”. Agriculture, Ecosystems and Environment.93 (1-3): 131-145. doi:10.1016/S0167-8809(01)00354-1.'},{id:"B29",body:'Castro, H.F., A.T. Classen, E.E. Austin, R.J. Norby, and C.W. Schadt. (2010). Soil microbial community responses to multiple experimental climate change drivers. Applied and Environmental Microbiology76: 999-1007.'},{id:"B30",body:'Gray, S.B., A.T. Classen, P. Kardol, Z. Yermakov, and R.M. Miller. (2011). Multiple climate change factors interact to alter soil microbial community structure in an old-field ecosystem. Soil Science Society of America Journal75: 2217-2226.'},{id:"B31",body:'Lennon, J.T., Z.T. Aanderud, B.K. Lehmkuhl, and D.R. Schoolmaster, Jr. (2012). Mapping the niche space of soil microorganisms using taxonomy and traits. Ecology93: 1867-1879.'},{id:"B32",body:'Briones, M.J.I., N.P. McNamara, J. Poskitt, S.E. Crow, and N.J. Ostle. (2014). Interactive biotic and abiotic regulators of soil carbon cycling: evidence from controlled climate experiments on peatland and boreal soils. Global Change Biology20: 2971-2982.'},{id:"B33",body:'Delgado-Baquerizo, M., F.T. Maestre, C. Escolar, A. Gallardo, V. Ochoa, B. Gozalo, and A. Prado-Comesana. (2014). Direct and indirect impacts of climate change on microbial and biocrust communities alter the resistance of the N cycle in a semiarid grassland. Journal of Ecology102: 1592-1605.'},{id:"B34",body:'Whitaker, J., N. Ostle, A.T. Nottingham, A. Ccahuana, N. Salinas, R.D. Bardgett, P. Meir, and N. P. McNamara. (2014). Microbial community composition explains soil respiration responses to changing carbon inputs along an Andes-to-Amazon elevation gradient. Journal of Ecology102: 1058-1071.'},{id:"B35",body:'Blankinship, J.C., P.A. Niklaus, and B.A. Hungate. (2011). A meta-analysis of responses of soil biota to global change. Oecologia165: 553-565.'},{id:"B36",body:'Henry, H.A.L. (2012). Soil extracellular enzyme dynamics in a changing climate. Soil Biology and Biochemistry47: 53-59.'},{id:"B37",body:'Manzoni, S., J.P. Schimel, and A. Porporato. (2012). Responses of soil microbial communities to water stress: results from a meta-analysis. Ecology93: 930-938.'},{id:"B38",body:'A’Bear, A.D., T.H. Jones, and L. Boddy. (2014). Potential impacts of climate change on interactions among saprotrophic cord-forming fungal mycelia and grazing soil invertebrates. Fungal Ecology10: 34-43.'},{id:"B39",body:'Chen, S., J. Zou, Z. Hu, H. Chen, and Y. Lu. (2014). Global annual soil respiration in relation to climate, soil properties and vegetation characteristics: summary of available data. Agricultural and Forest Meteorology198: 335-346.'},{id:"B40",body:'Bradford, M.A. (2013). Thermal adaptation of decomposer communities in warming soils. Frontiers in Microbiology. doi: http://dx.doi.org/10.3389/fmicb.2013.00333'},{id:"B41",body:'Frey, S.D., J. Lee, J.M. Melillo, and J. Six. (2013). The temperature response of soil microbial efficiency and its feedback to climate. Nature Climate Change3: 395-398.'},{id:"B42",body:'Hagerty, S.B., K.J. van Groenigen, S.D. Allison, B.A. Hungate, E. Schwartz, G.W. Koch, R.K. Kolka, and P. Dijkstra. (2014). Accelerated microbial turnover but constant growth efficiency with warming in soil. Nature Climate Change4: 903-906.'},{id:"B43",body:'Karhu, K. (2014). Temperature sensitivity of soil respiration rates enhanced by microbial community response. Nature513: 81-84.'},{id:"B44",body:'Lal, R. (2004). Soil carbon sequestration impacts on global climate change and food security Science, 304, pp. 1623-1627.'},{id:"B45",body:'Lemenih, M. and Itanna, F. (2004). Soil carbon stocks and turnovers in various vegetation types and arable lands along an elevation gradient in southern Ethiopia Geoderma, 123, pp. 177-188'},{id:"B46",body:'Lemenih, M. (2004). Effects of Land use Changes on Soil Quality and Native Flora Degradation and Restoration in the Highlands of Ethiopia. Implication for Sustainable Land Management. Doctoral thesis Swedish University of Agricultural Sciences, Sweden.'},{id:"B47",body:'Tesfaye, M.A., F. Bravo, R. Ruiz-Peinado, V. Pando, A. Bravo-Oviedo (2016) Impact of changes in land use, species and elevation on soil organic carbon and total nitrogen in Ethiopian Central Highlands Geoderma, 261, pp. 70-79.'},{id:"B48",body:'Henok, K., S. Dondeyne, J. Poesen, A. Frankl, J. Nyssen (2017) Transition from Forest-based to Cereal-based Agricultural Systems: A Review of the Drivers of Land use Change and Degradation in Southwest Ethiopia Land Degradation and Development, 28, pp. 431-449.'},{id:"B49",body:'Hemphill, D. (1993). “Agricultural Plastics as Solid Waste: What are the Options for Disposal?”. Hort Technology. 3 (1): 70-73. Retrieved 23 April 2015.'},{id:"B50",body:'Kidd, G. (2000). “Pesticides and Plastic Mulch Threaten the Health of Maryland and Virginia East Shore Waters”(PDF). Pesticides and You. 19 (4): 22-23. Retrieved 23 April 2015.'},{id:"B51",body:'Lichtfouse, E., Navarrete, M., Debaeke, P., Souchere, V., Alberola, C., & Menassieu, J. (2009). Agronomy for sustainable. A review Agron. Seustain. Dev., 29, 1-6.'},{id:"B52",body:'Doran, J. (2002). Soil health and global sustainability: Translating science into practice. Agric. Ecosyst. Environ., 88, 119-127.'},{id:"B53",body:'Sahu, P., Singh, D., Prabha, R., Meena, K., & Abhilash, P. (2019). Connecting microbial capabilities with the soil and plant health: Options for agricultural sustainability. Ecol. Indic., 105, 601-612.'},{id:"B54",body:'Leskovar, D., Othman, Y., & Dong, X. (2016). Strip tillage improves soil biological activity, fruit yield and sugar content of triploid watermelon. Soil Tillage Res., 163, 266-273.'},{id:"B55",body:'Berendsen, R., Pieterse, C., & Bakker, P. (2012). The rhizosphere microbiome and plant health. Trends Plant Science, 17, 478-486.'},{id:"B56",body:'Kuiper, I., E. L. (2004). Rhizoremediation: a beneficial plant-microbe interaction. Mol. Plant Microbe Interact., 17, 6-15.'},{id:"B57",body:'Meena, R., Bohra, J., Singh, S., Meena, V., Verma, J., Verma, S., & Sihag, S. (2016). Towards the prime response of manure to enhance nutrient use efficiency and soil sustainability a current need: A book Review.. J. Clean. Prod., 1258-1260.'},{id:"B58",body:'Dotaniya, M., Meena, V., Basak, B., & Meena, R. (2016). Potassium uptake by crops as well as microorganisms. n Potassium Solubilizing Microorganisms for Sustainable Agriculture; Springer, 267-280.'},{id:"B59",body:'Van der Heijden, M., Bardgett, R., & van Straalen, N. (2008). The unseen majority: Soil microbes as drivers of plant diversity and productivity in terrestrial Ecosystems. Ecol. Lett., 11, 296-310.'},{id:"B60",body:'Singh, J. (2015). Plant–Microbe Interactions: A Viable Tool for Agricultural Sustainability Plant Microbes Symbiosis: Applied Facets. (N. E. Arora, Ed.) Springer, 384.'},{id:"B61",body:'Dai,M., C. Hamel, M.S.Arnaud, Y. He, C. Grant, N. Lupwayi, H. Janzen, S.S. Malhi, X. Yang, Z. Zhou (2012). Arbuscular mycorrhizal fungi assemblages in chernozem great groups revealed by massively parallel pyrosequencing Can. J. Microbiol., 58, pp. 81-92.'},{id:"B62",body:'Wu, X., T. Ge, W. Wang, H. Yuan, C.E. Wegner, Z. Zhu, A.S. Whiteley, J. Wu (2015). Cropping systems modulate the rate and magnitude of soil microbial autotrophic CO2 fixation in soil Front. Microbiol., 6.'},{id:"B63",body:'Yang, C., C. Hamel, M.P. Schellenberg, J.C. Perez, R.L. Berbara (2010). Diversity and functionality of arbuscular mycorrhizal fungi in three plant communities in semiarid Grasslands National Park, Canada Microb. Ecol., 59, pp. 724-733.'},{id:"B64",body:'Maarastawi, S.A., K. Frindte, M. Linnartz, C. Knief (2018). Crop rotation and straw application impact microbial communities in Italian and Philippine Soils and the rhizosphere of Zea mays Front. Microbiol., 9.'},{id:"B65",body:'Bainard,L.D., P.L. Chagnon, B.J. CadeMenun, E.G. Lamb, K. LaForge, M. Schellenberg, C. Hamel (2017). Plant communities and soil properties mediate agricultural land use impacts on arbuscular mycorrhizal fungi in the Mixed Prairie ecoregion of the North American Great Plains Agric. Ecosyst. Environ., 249, pp. 187-195.'},{id:"B66",body:'Rasmussen, K. (1999). Impact of ploughless soil tillage on yield and soil quality: A Scandinavian review. Soil and Tillage Research, 53, 3-14.'},{id:"B67",body:'Anderson, E. (1987). Corn root growth and distribution as influenced by tillage and nitrogen fertilization. Agronomy Journal, 79, 544-549.'},{id:"B68",body:'Sinha, R.K., G. B. (2008). Converting wasteland into wonderland by earthworms—a low-cost nature’s technology for soil remediation: a case study of vermiremediation of PAHs contaminated soil. Environmentalist, 28, 466-475.'},{id:"B69",body:'Suthar, S. (2008). Metal remediation from partially composted distillery sludge using composting earthworm Eisenia fetida. Journal of Environmenal Monitor, 10, 1099-1106.'},{id:"B70",body:'Shi Z., J. L. (2020). Vermiremediation of organically contaminated soils: concepts, current status, and future perspectives. Applied Soil Ecology, 147, 103,377.'},{id:"B71",body:'Rodriguez-Campos J., L. D.-B.-R. (2014). Potential of earthworms to accelerate removal of organic contaminants from soil: a review. Applied Soil Ecology, 79, 10-25.'},{id:"B72",body:'Gadd, G.M. (2010). Metals, minerals and microbes: geomicrobiology and bioremediation. Microbiology, 609-643. doi:https://doi.org/10.1016/j.mycres.2006.12.001'},{id:"B73",body:'Gadd, G.M., R. Y. (2012). Geomycology: metals, actinides and biominerals. Environmetal Microbiology Reports, 4(3), 270-296. doi:https://doi.org/10.1111/j.1758-2229.2011.00283.x'},{id:"B74",body:'Gadd, G.M. (2013). Geomycology: fungi as agents of biogeochemical change. PRAEGER REVIEW, 113B(2), 139-153. Retrieved from https://www.jstor.org/stable/42912447'},{id:"B75",body:'Harms H, S. D. (2011). Untapped potential: exploiting fungi in bioremediation of hazardous chemicals. Nature Reviews Microbiology, 9, 177-192.'},{id:"B76",body:'Caporale, G., A., Sommella, A., Lorito, M., Lombardi, N., M.G.G., S., Azam,. .. Ruocco, M. (2014). Trichoderma spp. alleviate phytotoxicity in lettuce plants (Lactucasativa L.) irrigated with arsenic-contaminated water. Journal of Plant Phsiology, 171(15), 1378-1384. doi:https://doi.org/10.1016/j.jplph.2014.05.011'},{id:"B77",body:'Govarthanan, M., R. Mythili, T. Selvankumar, S. Kamala-Kannan, & H. Han. (2018). Myco-phytoremediation of arsenic-and lead-contaminated soils by Helianthus annuus and wood rot fungi, Trichoderma sp. isolated from decayed wood. Ecotoxicology and Environmental Safety, 151(30), 279-284. doi:https://doi.org/10.1016/j.ecoenv.2018.01.020'},{id:"B78",body:'Srivastava, P. K., Vaish, A., Dwivedi, S., Chakrabarty, D., Singh, N., & Tripathi, R. D. (2011). Biological removal of arsenic pollution by soil fungi. Science of The Total Environment, 409(12), 2430-2442. doi:https://doi.org/10.1016/j.scitotenv.2011.03.002'},{id:"B79",body:'Singh, M., P. S. (2015). Soil fungi for mycoremediation of arsenic pollution in agricultural soils. Journal of Applied Microbiology, 119, 1278-1290. doi:doi:10.1111/jam.12948'},{id:"B80",body:'Singh, R.K., R. T. (2020). Fungi as potential candidates for bioremediation. Abatement of Environmental Pollutants, Elsevier, 177-191.'},{id:"B81",body:'Chaillan, F., A. Le Flèche, E. Bury, Y.-H. Phantavong, P. Grimont, A. Saliot, and J. Oudot (2004). “Identification and biodegradation potential of tropical aerobic hydrocarbon-degrading microorganisms,” Research in Microbiology, vol. 155, no. 7, pp. 587-595.'},{id:"B82",body:'Singh, H. (2006). Mycoremediation: Fungal Bioremediation, Wiley-Interscience, New York, NY, USA.'},{id:"B83",body:'Bogusławska-Was, E., and W. Dąbrowski (2001). “The seasonal variability of yeasts and yeast-like organisms in water and bottom sediment of the Szczecin Lagoon,” International Journal of Hygiene and Environmental Health, vol. 203, no. 5-6, pp. 451-458.'},{id:"B84",body:'Kapoor, A., T. V. (1999). Removal of heavy metals using the fungus Aspergillus niger. Bioresources Technology, 70, 95-104.'},{id:"B85",body:'Wu, T., O. Chellemi, D., J. Martin, K., H. Graham, J., & N. Rosskopf, E. (2007). Discriminating the effects of agricultural land management practices on soil fungal communities. Soil Biology and Biochemistry, 39(5), 1139-1155. doi:https://doi.org/10.1016/j.soilbio.2006.11.024'},{id:"B86",body:'Jirout, J., Šimek, M., & Elhottová, D. (2011). Inputs of nitrogen and organic matter govern the composition of fungal communities in soil disturbed by overwintering cattle. Soil Biology and Biochemistry, 43(3), 647-656.'},{id:"B87",body:'Minoshima, H., L. J.-M. (2007, May 01). soil food webs and carbon dynamics in response to conservation tillage in California. Soil Science Society of America Journal, 71(3), 952-963. doi:https://doi.org/10.2136/sssaj2006.0174'},{id:"B88",body:'Sivapalan, A., W. M. (1993). Monitoring Populations of Soil Microorganisms during a Conversion from a Conventional to an Organic System of Vegetable Growing. Biological Agriculture and Horticulture, 10(1), 9-27. doi:https://doi.org/10.1080/01448765.1993.9754647'},{id:"B89",body:'Fließbach, A., P. M. (2000). Microbial biomass and size-density fractions differ between soils of organic and conventional agricultural systems. Soil Biology & Biochemistry, 757-768.'},{id:"B90",body:'Shannon, D., A. S. (2002). A comparative study of the microbiology of soils managed under organic and conventional regimes. Soil Use & Management, 18, 274-283.'},{id:"B91",body:'Wicklow, D. (1973). Microfungal populations in surface soils of manipulated prairie stands. Ecology, 54, 1302-1310.'},{id:"B92",body:'Martyniuk, S., & Wagner., G. (1978). Quantitative and qualitative examination of soil microflora associated with different management systems. Soil Science, 125, 343-350.'},{id:"B93",body:'Ploetz, R.C., D. M. (1985). Population dynamics of soilborne fungi in a field multicropped to rye and soybeans under reduced tillage in Florida. Phytopathology, 1447-1451.'},{id:"B94",body:'Beare, M., Parmelee, R., Hendrix, P., Cheng, W., Coleman, D., & Crossley, D. (1992). Microbial and Faunal interactions and effects on litter nitrogen and decomposition in agroecosystems. Ecological Monograph, 62, 569-591.'},{id:"B95",body:'Frey, S., Elliott, E., & Paustian, K. (1999). Bacterial and fungal abudance and biomass in conventional and no-tillage agroecosystems along two climatic gradients. Soil Biology & Biochemistry, 31, 573-585.'},{id:"B96",body:'Mazzola, M. (1999). Transformation of soil microbial community structure and Rhizoctonia-suppressive potential in response to apple roots. Phytopathology, 89, 920-927.'},{id:"B97",body:'Hedlund, K. (2002). Soil microbial community structure in relation to vegetation management on former agricultural land. Soil Biology & Biochemistry, 34, 1299-1307.'},{id:"B98",body:'Singh, S., & Rai, J. (2004). Soil microbial population and enzyme activity related to grazing pressure in alpine meadows of Nanda Devi Biosphere Reserve. Journal of Environmental Biology, 25, 103-107.'}],footnotes:[],contributors:[{corresp:"yes",contributorFullName:"Oluwatosin Ayobami Ogunsola",address:"oluwatosinogunsola8@gmail.com",affiliation:'
Department of Crop, Soil and Pest Management, Federal University of Technology Akure, Nigeria
'},{corresp:null,contributorFullName:"Odunayo David Adeniyi",address:null,affiliation:'
Department of Earth and Environmental Sciences, University of Pavia, Italy
Department of Environmental Health Sciences, University of Ibadan, Nigeria
'}],corrections:null},book:{id:"9843",title:"Soil Contamination",subtitle:null,fullTitle:"Soil Contamination",slug:null,publishedDate:null,bookSignature:"Dr. Marcelo L. Larramendy and Dr. Sonia Soloneski",coverURL:"https://cdn.intechopen.com/books/images_new/9843.jpg",licenceType:"CC BY 3.0",editedByType:null,editors:[{id:"14764",title:"Dr.",name:"Marcelo L.",middleName:null,surname:"Larramendy",slug:"marcelo-l.-larramendy",fullName:"Marcelo L. Larramendy"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}}},profile:{item:{id:"110901",title:"Dr.",name:"Angel",middleName:null,surname:"Coronel-Beltrán",email:"acorbel@hotmail.com",fullName:"Angel Coronel-Beltrán",slug:"angel-coronel-beltran",position:null,biography:null,institutionString:null,profilePictureURL:"https://mts.intechopen.com/storage/users/110901/images/2677_n.jpg",totalCites:0,totalChapterViews:"0",outsideEditionCount:0,totalAuthoredChapters:"1",totalEditedBooks:"0",personalWebsiteURL:null,twitterURL:null,linkedinURL:null,institution:{name:"Universidad de Sonora",institutionURL:null,country:{name:"Mexico"}}},booksEdited:[],chaptersAuthored:[{title:"Invariant Nonlinear Correlations via Fourier Transform",slug:"invariant-nonlinear-correlations-via-fourier-transform",abstract:null,signatures:"Angel Coronel-Beltran and Josue Alvarez-Borrego",authors:[{id:"103367",title:"Prof.",name:"Josué",surname:"Álvarez-Borrego",fullName:"Josué Álvarez-Borrego",slug:"josue-alvarez-borrego",email:"josue@cicese.mx"},{id:"110901",title:"Dr.",name:"Angel",surname:"Coronel-Beltrán",fullName:"Angel Coronel-Beltrán",slug:"angel-coronel-beltran",email:"acorbel@hotmail.com"}],book:{title:"Fourier Transform",slug:"fourier-transform-signal-processing",productType:{id:"1",title:"Edited Volume"}}}],collaborators:[{id:"104590",title:"Ph.D.",name:"Omar",surname:"Mustaf",slug:"omar-mustaf",fullName:"Omar Mustaf",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Gulf University",institutionURL:null,country:{name:"Bahrain"}}},{id:"107354",title:"Dr.",name:"Ainhoa",surname:"Cortes",slug:"ainhoa-cortes",fullName:"Ainhoa Cortes",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Centro de Estudios e Investigaciones Técnicas de Gipuzkoa",institutionURL:null,country:{name:"Spain"}}},{id:"107426",title:"Dr.",name:"Lianming",surname:"Sun",slug:"lianming-sun",fullName:"Lianming Sun",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"The University of Kitakyushu",institutionURL:null,country:{name:"Japan"}}},{id:"107618",title:"Prof.",name:"Renbiao",surname:"Wu",slug:"renbiao-wu",fullName:"Renbiao Wu",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Civil Aviation University of China",institutionURL:null,country:{name:"China"}}},{id:"107676",title:"Dr.",name:"Krzysztof",surname:"Duda",slug:"krzysztof-duda",fullName:"Krzysztof Duda",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"AGH University of Science and Technology",institutionURL:null,country:{name:"Poland"}}},{id:"109280",title:"Dr.",name:"Somayeh",surname:"Mohammady",slug:"somayeh-mohammady",fullName:"Somayeh Mohammady",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/109280/images/system/109280.jpg",biography:"Dr. Somayeh Mohammady obtained a Ph.D. in Electrical and Electronic Engineering in 2012 from University Putra Malaysia (UPM). Prior to her current work as a certified lecturer, researcher, and publisher at the Technological University of Dublin (TU Dublin), she worked as a postdoc fellow and design engineer. Dr. Mohammady’s research interests include digital signal processing (DSP), power efficiency improvement algorithms in wireless telecommunication systems, physical layer security improvement, bandpass filter design using optimization algorithms, the Internet of Things (IoT), and robotics and programmable logic control (PLC) automation systems. \n\n\n\nHer hobbies include illustrating, yoga, and swimming. She is skilled in communications, Arduino, and Allen-Bradley automation equipment. She is actively engaged in gender equality in Science, Technology, Engineering, and Mathematics (STEM) activities.",institutionString:"Technological University Dublin",institution:{name:"Technological University Dublin",institutionURL:null,country:{name:"Ireland"}}},{id:"112666",title:"Dr.",name:"Marcelo",surname:"Castelli",slug:"marcelo-castelli",fullName:"Marcelo Castelli",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Universidad de Montevideo",institutionURL:null,country:{name:"Uruguay"}}},{id:"114188",title:"Dr.",name:"Igone",surname:"Velez",slug:"igone-velez",fullName:"Igone Velez",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Centro de Estudios e Investigaciones Técnicas de Gipuzkoa",institutionURL:null,country:{name:"Spain"}}},{id:"114189",title:"Dr.",name:"Juan Francisco",surname:"Sevillano",slug:"juan-francisco-sevillano",fullName:"Juan Francisco Sevillano",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Centro de Estudios e Investigaciones Técnicas de Gipuzkoa",institutionURL:null,country:{name:"Spain"}}},{id:"127891",title:"Ms.",name:"Marta",surname:"Turrillas",slug:"marta-turrillas",fullName:"Marta Turrillas",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null}]},generic:{page:{slug:"partnerships",title:"Partnerships",intro:"
IntechOpen has always supported new and evolving ideas in scholarly publishing. We understand the community we serve, but to provide an even better service for our IntechOpen Authors and Academic Editors, we have partnered with leading companies and associations in the scientific field and beyond.
",metaTitle:"Partnerships",metaDescription:"IntechOpen was built by scientists, for scientists. We understand the community we serve, but to bring an even better service to the table for IntechOpen Authors and Academic Editors, we partnered with the leading companies and associations in the industry and beyond.",metaKeywords:null,canonicalURL:"/page/partnerships",contentRaw:'[{"type":"htmlEditorComponent","content":"
ALPSP
\\n\\n
\\n\\t
The Association of Learned and Professional Society Publishers (ALPSP) is the largest association of scholarly and professional publishers in the world. Its mission is to connect, inform, develop and represent the international scholarly and professional publishing community. IntechOpen has been a member of ALPSP since 2016 and has consequently stayed informed about industry trends through connecting with peers and developing jointly.
\\n
\\n\\n
OASPA
\\n\\n
\\n\\t
The Open Access Scholarly Publishers Association (OASPA) was established in 2008 to represent the interests of Open Access (OA) publishers globally in all scientific, technical and scholarly disciplines. Its mission is carried out through exchange of information, the setting of standards, advancing models, advocacy, education, and the promotion of innovation.
\\n
\\n\\n
STM
\\n\\n
\\n\\t
The International Association of Scientific, Technical and Medical Publishers (STM) is the leading global trade association for academic and professional publishers. As a member, IntechOpen has not only made a commitment to STM's Ethical Principles.
\\n
\\n\\n
COPE
\\n\\n
\\n\\t
The Committee on Publication Ethics (COPE) provides advice to editors and publishers on all aspects of publication ethics and, in particular, how to handle cases of misconduct in research and publication. IntechOpen has been a member of COPE since 2013 and adheres to the COPE Code of Conduct and Best Practice Guidelines, ensuring that we maintain the highest ethical standards.
\\n
\\n\\n
Creative Commons
\\n\\n
\\n\\t
Creative Commons (CC) is a nonprofit organization that enables the sharing and use of creativity and knowledge through free legal tools. IntechOpen uses the CC BY 3.0 license for chapters, meaning Authors retain copyright and their work can be reused and adapted as long as the source is properly cited and Authors are acknowledged.
\\n
\\n\\n
Crossref
\\n\\n
\\n\\t
Crossref is the official Digital Object Identifier (DOI) Registration Agency for scholarly and professional publications with a goal of making scholarly communications more effective. IntechOpen deposits metadata and registers DOIs for all content using the Crossref System. IntechOpen also deposits its references and uses the Crossref Cited-by service that enables researchers to track citation statistics.
\\n
\\n\\n
Altmetric and Dimensions from Digital Science
\\n\\n
\\n\\t
Digital Science is a technology company serving the needs of scientific and research communities at key points along the full cycle of research. They support innovative businesses and technologies that make all parts of the research process more open, efficient and effective. IntechOpen integrates tools such as Altmetric to enable our researchers to track and measure the activity around their academic research and Dimensions, to ease access to the most relevant information and better understand and analyze the global research landscape.
\\n
\\n\\n
CLOCKSS
\\n\\n
\\n\\t
CLOCKSS preserves scholarly publications in original formats, ensuring that they always remain available and openly accessible to everyone.
\\n
\\n\\n
Counter
\\n\\n
\\n\\t
COUNTER provides the Code of Practice that enables publishers and vendors to report usage of their electronic resources in a consistent way. This enables libraries to compare data received from different publishers and vendors.
\\n
\\n\\n
DORA
\\n\\n
\\n\\t
DORA is a worldwide initiative covering all scholarly disciplines which recognizes the need to improve the ways in which the outputs of scholarly research are evaluated and seeks to develop and promote best practice. To date it has been signed by over 1500 organizations and around 14,700 individuals.
\\n
\\n\\n
iThenticate
\\n\\n
\\n\\t
iThenticate is the leading provider of professional plagiarism detection and prevention technology and is used worldwide by scholarly publishers and research institutions to ensure the originality of written work before publication. IntechOpen uses the iThenticate plagiarism software to ensure content originality and the research integrity of our published work.
\\n
\\n\\n
Enago
\\n\\n
\\n\\t
IntechOpen collaborates with Enago, through its sister brand, Ulatus, one of the world’s leading providers of book translation services. Their services are designed to convey the essence of your work to readers from across the globe in the language they understand.
\\n\\t
IntechOpen Authors that wish to use this service will receive a 20% discount on all translation services. To find out more information or obtain a quote, please visit https://www.enago.com/intech
\\n
\\n\\n
SPi Global
\\n\\n
\\n\\t
SPi Global is the market leader in technology-driven solutions for the extraction, enrichment and transformation of content assets. IntechOpen publishing services are designed to meet the unique needs of Authors. As part of our commitment to that objective, we have an ongoing partnership agreement for production solutions.
\\n
\\n\\n
Amazon
\\n\\n
\\n\\t
Amazon is the world’s largest online retailer and cloud services provider. IntechOpen books have been available on Amazon since 2017, guaranteeing more visibility for our Authors and Academic Editors.
\\n
\\n\\n
DHL
\\n\\n
\\n\\t
IntechOpen has partnered with DHL since 2011 to ensure the fastest delivery of Print on Demand books.
The Association of Learned and Professional Society Publishers (ALPSP) is the largest association of scholarly and professional publishers in the world. Its mission is to connect, inform, develop and represent the international scholarly and professional publishing community. IntechOpen has been a member of ALPSP since 2016 and has consequently stayed informed about industry trends through connecting with peers and developing jointly.
\n
\n\n
OASPA
\n\n
\n\t
The Open Access Scholarly Publishers Association (OASPA) was established in 2008 to represent the interests of Open Access (OA) publishers globally in all scientific, technical and scholarly disciplines. Its mission is carried out through exchange of information, the setting of standards, advancing models, advocacy, education, and the promotion of innovation.
\n
\n\n
STM
\n\n
\n\t
The International Association of Scientific, Technical and Medical Publishers (STM) is the leading global trade association for academic and professional publishers. As a member, IntechOpen has not only made a commitment to STM's Ethical Principles.
\n
\n\n
COPE
\n\n
\n\t
The Committee on Publication Ethics (COPE) provides advice to editors and publishers on all aspects of publication ethics and, in particular, how to handle cases of misconduct in research and publication. IntechOpen has been a member of COPE since 2013 and adheres to the COPE Code of Conduct and Best Practice Guidelines, ensuring that we maintain the highest ethical standards.
\n
\n\n
Creative Commons
\n\n
\n\t
Creative Commons (CC) is a nonprofit organization that enables the sharing and use of creativity and knowledge through free legal tools. IntechOpen uses the CC BY 3.0 license for chapters, meaning Authors retain copyright and their work can be reused and adapted as long as the source is properly cited and Authors are acknowledged.
\n
\n\n
Crossref
\n\n
\n\t
Crossref is the official Digital Object Identifier (DOI) Registration Agency for scholarly and professional publications with a goal of making scholarly communications more effective. IntechOpen deposits metadata and registers DOIs for all content using the Crossref System. IntechOpen also deposits its references and uses the Crossref Cited-by service that enables researchers to track citation statistics.
\n
\n\n
Altmetric and Dimensions from Digital Science
\n\n
\n\t
Digital Science is a technology company serving the needs of scientific and research communities at key points along the full cycle of research. They support innovative businesses and technologies that make all parts of the research process more open, efficient and effective. IntechOpen integrates tools such as Altmetric to enable our researchers to track and measure the activity around their academic research and Dimensions, to ease access to the most relevant information and better understand and analyze the global research landscape.
\n
\n\n
CLOCKSS
\n\n
\n\t
CLOCKSS preserves scholarly publications in original formats, ensuring that they always remain available and openly accessible to everyone.
\n
\n\n
Counter
\n\n
\n\t
COUNTER provides the Code of Practice that enables publishers and vendors to report usage of their electronic resources in a consistent way. This enables libraries to compare data received from different publishers and vendors.
\n
\n\n
DORA
\n\n
\n\t
DORA is a worldwide initiative covering all scholarly disciplines which recognizes the need to improve the ways in which the outputs of scholarly research are evaluated and seeks to develop and promote best practice. To date it has been signed by over 1500 organizations and around 14,700 individuals.
\n
\n\n
iThenticate
\n\n
\n\t
iThenticate is the leading provider of professional plagiarism detection and prevention technology and is used worldwide by scholarly publishers and research institutions to ensure the originality of written work before publication. IntechOpen uses the iThenticate plagiarism software to ensure content originality and the research integrity of our published work.
\n
\n\n
Enago
\n\n
\n\t
IntechOpen collaborates with Enago, through its sister brand, Ulatus, one of the world’s leading providers of book translation services. Their services are designed to convey the essence of your work to readers from across the globe in the language they understand.
\n\t
IntechOpen Authors that wish to use this service will receive a 20% discount on all translation services. To find out more information or obtain a quote, please visit https://www.enago.com/intech
\n
\n\n
SPi Global
\n\n
\n\t
SPi Global is the market leader in technology-driven solutions for the extraction, enrichment and transformation of content assets. IntechOpen publishing services are designed to meet the unique needs of Authors. As part of our commitment to that objective, we have an ongoing partnership agreement for production solutions.
\n
\n\n
Amazon
\n\n
\n\t
Amazon is the world’s largest online retailer and cloud services provider. IntechOpen books have been available on Amazon since 2017, guaranteeing more visibility for our Authors and Academic Editors.
\n
\n\n
DHL
\n\n
\n\t
IntechOpen has partnered with DHL since 2011 to ensure the fastest delivery of Print on Demand books.
\n
\n'}]},successStories:{items:[]},authorsAndEditors:{filterParams:{sort:"featured,name"},profiles:[{id:"6700",title:"Dr.",name:"Abbass A.",middleName:null,surname:"Hashim",slug:"abbass-a.-hashim",fullName:"Abbass A. Hashim",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/6700/images/1864_n.jpg",biography:"Currently I am carrying out research in several areas of interest, mainly covering work on chemical and bio-sensors, semiconductor thin film device fabrication and characterisation.\nAt the moment I have very strong interest in radiation environmental pollution and bacteriology treatment. The teams of researchers are working very hard to bring novel results in this field. I am also a member of the team in charge for the supervision of Ph.D. students in the fields of development of silicon based planar waveguide sensor devices, study of inelastic electron tunnelling in planar tunnelling nanostructures for sensing applications and development of organotellurium(IV) compounds for semiconductor applications. I am a specialist in data analysis techniques and nanosurface structure. I have served as the editor for many books, been a member of the editorial board in science journals, have published many papers and hold many patents.",institutionString:null,institution:{name:"Sheffield Hallam University",country:{name:"United Kingdom"}}},{id:"54525",title:"Prof.",name:"Abdul Latif",middleName:null,surname:"Ahmad",slug:"abdul-latif-ahmad",fullName:"Abdul Latif Ahmad",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"20567",title:"Prof.",name:"Ado",middleName:null,surname:"Jorio",slug:"ado-jorio",fullName:"Ado Jorio",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Universidade Federal de Minas Gerais",country:{name:"Brazil"}}},{id:"47940",title:"Dr.",name:"Alberto",middleName:null,surname:"Mantovani",slug:"alberto-mantovani",fullName:"Alberto Mantovani",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"12392",title:"Mr.",name:"Alex",middleName:null,surname:"Lazinica",slug:"alex-lazinica",fullName:"Alex Lazinica",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/12392/images/7282_n.png",biography:"Alex Lazinica is the founder and CEO of IntechOpen. After obtaining a Master's degree in Mechanical Engineering, he continued his PhD studies in Robotics at the Vienna University of Technology. Here he worked as a robotic researcher with the university's Intelligent Manufacturing Systems Group as well as a guest researcher at various European universities, including the Swiss Federal Institute of Technology Lausanne (EPFL). During this time he published more than 20 scientific papers, gave presentations, served as a reviewer for major robotic journals and conferences and most importantly he co-founded and built the International Journal of Advanced Robotic Systems- world's first Open Access journal in the field of robotics. Starting this journal was a pivotal point in his career, since it was a pathway to founding IntechOpen - Open Access publisher focused on addressing academic researchers needs. Alex is a personification of IntechOpen key values being trusted, open and entrepreneurial. Today his focus is on defining the growth and development strategy for the company.",institutionString:null,institution:{name:"TU Wien",country:{name:"Austria"}}},{id:"19816",title:"Prof.",name:"Alexander",middleName:null,surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/19816/images/1607_n.jpg",biography:"Alexander I. Kokorin: born: 1947, Moscow; DSc., PhD; Principal Research Fellow (Research Professor) of Department of Kinetics and Catalysis, N. Semenov Institute of Chemical Physics, Russian Academy of Sciences, Moscow.\r\nArea of research interests: physical chemistry of complex-organized molecular and nanosized systems, including polymer-metal complexes; the surface of doped oxide semiconductors. He is an expert in structural, absorptive, catalytic and photocatalytic properties, in structural organization and dynamic features of ionic liquids, in magnetic interactions between paramagnetic centers. The author or co-author of 3 books, over 200 articles and reviews in scientific journals and books. He is an actual member of the International EPR/ESR Society, European Society on Quantum Solar Energy Conversion, Moscow House of Scientists, of the Board of Moscow Physical Society.",institutionString:null,institution:{name:"Semenov Institute of Chemical Physics",country:{name:"Russia"}}},{id:"62389",title:"PhD.",name:"Ali Demir",middleName:null,surname:"Sezer",slug:"ali-demir-sezer",fullName:"Ali Demir Sezer",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/62389/images/3413_n.jpg",biography:"Dr. Ali Demir Sezer has a Ph.D. from Pharmaceutical Biotechnology at the Faculty of Pharmacy, University of Marmara (Turkey). He is the member of many Pharmaceutical Associations and acts as a reviewer of scientific journals and European projects under different research areas such as: drug delivery systems, nanotechnology and pharmaceutical biotechnology. Dr. Sezer is the author of many scientific publications in peer-reviewed journals and poster communications. Focus of his research activity is drug delivery, physico-chemical characterization and biological evaluation of biopolymers micro and nanoparticles as modified drug delivery system, and colloidal drug carriers (liposomes, nanoparticles etc.).",institutionString:null,institution:{name:"Marmara University",country:{name:"Turkey"}}},{id:"61051",title:"Prof.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"100762",title:"Prof.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"St David's Medical Center",country:{name:"United States of America"}}},{id:"107416",title:"Dr.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Texas Cardiac Arrhythmia",country:{name:"United States of America"}}},{id:"64434",title:"Dr.",name:"Angkoon",middleName:null,surname:"Phinyomark",slug:"angkoon-phinyomark",fullName:"Angkoon Phinyomark",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/64434/images/2619_n.jpg",biography:"My name is Angkoon Phinyomark. I received a B.Eng. degree in Computer Engineering with First Class Honors in 2008 from Prince of Songkla University, Songkhla, Thailand, where I received a Ph.D. degree in Electrical Engineering. My research interests are primarily in the area of biomedical signal processing and classification notably EMG (electromyography signal), EOG (electrooculography signal), and EEG (electroencephalography signal), image analysis notably breast cancer analysis and optical coherence tomography, and rehabilitation engineering. I became a student member of IEEE in 2008. During October 2011-March 2012, I had worked at School of Computer Science and Electronic Engineering, University of Essex, Colchester, Essex, United Kingdom. In addition, during a B.Eng. I had been a visiting research student at Faculty of Computer Science, University of Murcia, Murcia, Spain for three months.\n\nI have published over 40 papers during 5 years in refereed journals, books, and conference proceedings in the areas of electro-physiological signals processing and classification, notably EMG and EOG signals, fractal analysis, wavelet analysis, texture analysis, feature extraction and machine learning algorithms, and assistive and rehabilitative devices. I have several computer programming language certificates, i.e. Sun Certified Programmer for the Java 2 Platform 1.4 (SCJP), Microsoft Certified Professional Developer, Web Developer (MCPD), Microsoft Certified Technology Specialist, .NET Framework 2.0 Web (MCTS). I am a Reviewer for several refereed journals and international conferences, such as IEEE Transactions on Biomedical Engineering, IEEE Transactions on Industrial Electronics, Optic Letters, Measurement Science Review, and also a member of the International Advisory Committee for 2012 IEEE Business Engineering and Industrial Applications and 2012 IEEE Symposium on Business, Engineering and Industrial Applications.",institutionString:null,institution:{name:"Joseph Fourier University",country:{name:"France"}}},{id:"55578",title:"Dr.",name:"Antonio",middleName:null,surname:"Jurado-Navas",slug:"antonio-jurado-navas",fullName:"Antonio Jurado-Navas",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/55578/images/4574_n.png",biography:"Antonio Jurado-Navas received the M.S. degree (2002) and the Ph.D. degree (2009) in Telecommunication Engineering, both from the University of Málaga (Spain). He first worked as a consultant at Vodafone-Spain. From 2004 to 2011, he was a Research Assistant with the Communications Engineering Department at the University of Málaga. In 2011, he became an Assistant Professor in the same department. From 2012 to 2015, he was with Ericsson Spain, where he was working on geo-location\ntools for third generation mobile networks. Since 2015, he is a Marie-Curie fellow at the Denmark Technical University. His current research interests include the areas of mobile communication systems and channel modeling in addition to atmospheric optical communications, adaptive optics and statistics",institutionString:null,institution:{name:"University of Malaga",country:{name:"Spain"}}}],filtersByRegion:[{group:"region",caption:"North America",value:1,count:5775},{group:"region",caption:"Middle and South America",value:2,count:5239},{group:"region",caption:"Africa",value:3,count:1721},{group:"region",caption:"Asia",value:4,count:10411},{group:"region",caption:"Australia and Oceania",value:5,count:897},{group:"region",caption:"Europe",value:6,count:15810}],offset:12,limit:12,total:118378},chapterEmbeded:{data:{}},editorApplication:{success:null,errors:{}},ofsBooks:{filterParams:{topicId:"6"},books:[{type:"book",id:"8977",title:"Protein Kinase - New Opportunities, Challenges and Future Perspectives",subtitle:null,isOpenForSubmission:!0,hash:"6d200cc031706a565b554fdb1c478901",slug:null,bookSignature:"Dr. Rajesh Kumar Singh",coverURL:"https://cdn.intechopen.com/books/images_new/8977.jpg",editedByType:null,editors:[{id:"329385",title:"Dr.",name:"Rajesh",surname:"Singh",slug:"rajesh-singh",fullName:"Rajesh Singh"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9659",title:"Fibroblasts - Advances in Cancer, Autoimmunity and Inflammation",subtitle:null,isOpenForSubmission:!0,hash:"926fa6446f6befbd363fc74971a56de2",slug:null,bookSignature:"Ph.D. Mojca Frank Bertoncelj and Ms. Katja Lakota",coverURL:"https://cdn.intechopen.com/books/images_new/9659.jpg",editedByType:null,editors:[{id:"328755",title:"Ph.D.",name:"Mojca",surname:"Frank Bertoncelj",slug:"mojca-frank-bertoncelj",fullName:"Mojca Frank Bertoncelj"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10741",title:"Synthetic Genomics - From Natural to Synthetic Genomes",subtitle:null,isOpenForSubmission:!0,hash:"eb1cebd0b9c4e7e87427003ff7196f57",slug:null,bookSignature:"Dr. Miguel Fernández-Niño and Dr. Luis H. Reyes",coverURL:"https://cdn.intechopen.com/books/images_new/10741.jpg",editedByType:null,editors:[{id:"158295",title:"Dr.",name:"Miguel",surname:"Fernández-Niño",slug:"miguel-fernandez-nino",fullName:"Miguel Fernández-Niño"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10797",title:"Cell Culture",subtitle:null,isOpenForSubmission:!0,hash:"2c628f4757f9639a4450728d839a7842",slug:null,bookSignature:"Prof. Xianquan Zhan",coverURL:"https://cdn.intechopen.com/books/images_new/10797.jpg",editedByType:null,editors:[{id:"223233",title:"Prof.",name:"Xianquan",surname:"Zhan",slug:"xianquan-zhan",fullName:"Xianquan Zhan"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10799",title:"Phenolic Compounds",subtitle:null,isOpenForSubmission:!0,hash:"339199f254d2987ef3167eef74fb8a38",slug:null,bookSignature:"Prof. Farid A. Badria",coverURL:"https://cdn.intechopen.com/books/images_new/10799.jpg",editedByType:null,editors:[{id:"41865",title:"Prof.",name:"Farid A.",surname:"Badria",slug:"farid-a.-badria",fullName:"Farid A. Badria"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10800",title:"Ligase",subtitle:null,isOpenForSubmission:!0,hash:"1f10ff112edb1fec24379dac85ef3b5b",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10800.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10801",title:"Uric Acid",subtitle:null,isOpenForSubmission:!0,hash:"d947ab87019e69ab11aa597edbacc018",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10801.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10837",title:"Peroxisomes",subtitle:null,isOpenForSubmission:!0,hash:"0014b09d4b35bb4d7f52ca0b3641cda1",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10837.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10838",title:"Ion Channels",subtitle:null,isOpenForSubmission:!0,hash:"048017b227b3bdfd0d33a49bac63c915",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10838.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10840",title:"Benzimidazole",subtitle:null,isOpenForSubmission:!0,hash:"9fe810233f92a9c454c624aec634316f",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10840.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10841",title:"Hydrolases",subtitle:null,isOpenForSubmission:!0,hash:"64617cf21bf1e47170bb2bcf31b1fc37",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10841.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],filtersByTopic:[{group:"topic",caption:"Agricultural and Biological Sciences",value:5,count:18},{group:"topic",caption:"Biochemistry, Genetics and Molecular Biology",value:6,count:5},{group:"topic",caption:"Business, Management and Economics",value:7,count:2},{group:"topic",caption:"Chemistry",value:8,count:8},{group:"topic",caption:"Computer and Information Science",value:9,count:6},{group:"topic",caption:"Earth and Planetary Sciences",value:10,count:7},{group:"topic",caption:"Engineering",value:11,count:20},{group:"topic",caption:"Environmental Sciences",value:12,count:2},{group:"topic",caption:"Immunology and Microbiology",value:13,count:4},{group:"topic",caption:"Materials Science",value:14,count:5},{group:"topic",caption:"Mathematics",value:15,count:1},{group:"topic",caption:"Medicine",value:16,count:25},{group:"topic",caption:"Neuroscience",value:18,count:2},{group:"topic",caption:"Pharmacology, Toxicology and Pharmaceutical Science",value:19,count:3},{group:"topic",caption:"Physics",value:20,count:3},{group:"topic",caption:"Psychology",value:21,count:4},{group:"topic",caption:"Robotics",value:22,count:1},{group:"topic",caption:"Social Sciences",value:23,count:3},{group:"topic",caption:"Technology",value:24,count:1},{group:"topic",caption:"Veterinary Medicine and Science",value:25,count:1}],offset:12,limit:12,total:11},popularBooks:{featuredBooks:[{type:"book",id:"9521",title:"Antimicrobial Resistance",subtitle:"A One Health Perspective",isOpenForSubmission:!1,hash:"30949e78832e1afba5606634b52056ab",slug:"antimicrobial-resistance-a-one-health-perspective",bookSignature:"Mihai Mareș, Swee Hua Erin Lim, Kok-Song Lai and Romeo-Teodor Cristina",coverURL:"https://cdn.intechopen.com/books/images_new/9521.jpg",editors:[{id:"88785",title:"Prof.",name:"Mihai",middleName:null,surname:"Mares",slug:"mihai-mares",fullName:"Mihai Mares"}],equalEditorOne:{id:"190224",title:"Dr.",name:"Swee Hua Erin",middleName:null,surname:"Lim",slug:"swee-hua-erin-lim",fullName:"Swee Hua Erin Lim",profilePictureURL:"https://mts.intechopen.com/storage/users/190224/images/system/190224.png",biography:"Dr. Erin Lim is presently working as an Assistant Professor in the Division of Health Sciences, Abu Dhabi Women\\'s College, Higher Colleges of Technology in Abu Dhabi, United Arab Emirates and is affiliated as an Associate Professor to Perdana University-Royal College of Surgeons in Ireland, Selangor, Malaysia. She obtained her Ph.D. from Universiti Putra Malaysia in 2010 with a National Science Fellowship awarded from the Ministry of Science, Technology and Innovation Malaysia and has been actively involved in research ever since. Her main research interests include analysis of carriage and transmission of multidrug resistant bacteria in non-conventional settings, besides an interest in natural products for antimicrobial testing. She is heavily involved in the elucidation of mechanisms of reversal of resistance in bacteria in addition to investigating the immunological analyses of diseases, development of vaccination and treatment models in animals. She hopes her work will support the discovery of therapeutics in the clinical setting and assist in the combat against the burden of antibiotic resistance.",institutionString:"Abu Dhabi Women’s College",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"3",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"Perdana University",institutionURL:null,country:{name:"Malaysia"}}},equalEditorTwo:{id:"221544",title:"Dr.",name:"Kok-Song",middleName:null,surname:"Lai",slug:"kok-song-lai",fullName:"Kok-Song Lai",profilePictureURL:"https://mts.intechopen.com/storage/users/221544/images/system/221544.jpeg",biography:"Dr. Lai Kok Song is an Assistant Professor in the Division of Health Sciences, Abu Dhabi Women\\'s College, Higher Colleges of Technology in Abu Dhabi, United Arab Emirates. He obtained his Ph.D. in Biological Sciences from Nara Institute of Science and Technology, Japan in 2012. Prior to his academic appointment, Dr. Lai worked as a Senior Scientist at the Ministry of Science, Technology and Innovation, Malaysia. His current research areas include antimicrobial resistance and plant-pathogen interaction. His particular interest lies in the study of the antimicrobial mechanism via membrane disruption of essential oils against multi-drug resistance bacteria through various biochemical, molecular and proteomic approaches. Ultimately, he hopes to uncover and determine novel biomarkers related to antibiotic resistance that can be developed into new therapeutic strategies.",institutionString:"Higher Colleges of Technology",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"8",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"Higher Colleges of Technology",institutionURL:null,country:{name:"United Arab Emirates"}}},equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10020",title:"Operations Management",subtitle:"Emerging Trend in the Digital Era",isOpenForSubmission:!1,hash:"526f0dbdc7e4d85b82ce8383ab894b4c",slug:"operations-management-emerging-trend-in-the-digital-era",bookSignature:"Antonella Petrillo, Fabio De Felice, Germano Lambert-Torres and Erik Bonaldi",coverURL:"https://cdn.intechopen.com/books/images_new/10020.jpg",editors:[{id:"181603",title:"Dr.",name:"Antonella",middleName:null,surname:"Petrillo",slug:"antonella-petrillo",fullName:"Antonella Petrillo"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9560",title:"Creativity",subtitle:"A Force to Innovation",isOpenForSubmission:!1,hash:"58f740bc17807d5d88d647c525857b11",slug:"creativity-a-force-to-innovation",bookSignature:"Pooja Jain",coverURL:"https://cdn.intechopen.com/books/images_new/9560.jpg",editors:[{id:"316765",title:"Dr.",name:"Pooja",middleName:null,surname:"Jain",slug:"pooja-jain",fullName:"Pooja Jain"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10192",title:"Background and Management of Muscular Atrophy",subtitle:null,isOpenForSubmission:!1,hash:"eca24028d89912b5efea56e179dff089",slug:"background-and-management-of-muscular-atrophy",bookSignature:"Julianna Cseri",coverURL:"https://cdn.intechopen.com/books/images_new/10192.jpg",editors:[{id:"135579",title:"Dr.",name:"Julianna",middleName:null,surname:"Cseri",slug:"julianna-cseri",fullName:"Julianna Cseri"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9243",title:"Coastal Environments",subtitle:null,isOpenForSubmission:!1,hash:"8e05e5f631e935eef366980f2e28295d",slug:"coastal-environments",bookSignature:"Yuanzhi Zhang and X. San Liang",coverURL:"https://cdn.intechopen.com/books/images_new/9243.jpg",editors:[{id:"77597",title:"Prof.",name:"Yuanzhi",middleName:null,surname:"Zhang",slug:"yuanzhi-zhang",fullName:"Yuanzhi Zhang"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9385",title:"Renewable Energy",subtitle:"Technologies and Applications",isOpenForSubmission:!1,hash:"a6b446d19166f17f313008e6c056f3d8",slug:"renewable-energy-technologies-and-applications",bookSignature:"Tolga Taner, Archana Tiwari and Taha Selim Ustun",coverURL:"https://cdn.intechopen.com/books/images_new/9385.jpg",editors:[{id:"197240",title:"Associate Prof.",name:"Tolga",middleName:null,surname:"Taner",slug:"tolga-taner",fullName:"Tolga Taner"}],equalEditorOne:{id:"186791",title:"Dr.",name:"Archana",middleName:null,surname:"Tiwari",slug:"archana-tiwari",fullName:"Archana Tiwari",profilePictureURL:"https://mts.intechopen.com/storage/users/186791/images/system/186791.jpg",biography:"Dr. Archana Tiwari is Associate Professor at Amity University, India. Her research interests include renewable sources of energy from microalgae and further utilizing the residual biomass for the generation of value-added products, bioremediation through microalgae and microbial consortium, antioxidative enzymes and stress, and nutraceuticals from microalgae. She has been working on algal biotechnology for the last two decades. She has published her research in many international journals and has authored many books and chapters with renowned publishing houses. She has also delivered talks as an invited speaker at many national and international conferences. Dr. Tiwari is the recipient of several awards including Researcher of the Year and Distinguished Scientist.",institutionString:"Amity University",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"3",totalChapterViews:"0",totalEditedBooks:"1",institution:{name:"Amity University",institutionURL:null,country:{name:"India"}}},equalEditorTwo:{id:"197609",title:"Prof.",name:"Taha Selim",middleName:null,surname:"Ustun",slug:"taha-selim-ustun",fullName:"Taha Selim Ustun",profilePictureURL:"https://mts.intechopen.com/storage/users/197609/images/system/197609.jpeg",biography:"Dr. Taha Selim Ustun received a Ph.D. in Electrical Engineering from Victoria University, Melbourne, Australia. He is a researcher with the Fukushima Renewable Energy Institute, AIST (FREA), where he leads the Smart Grid Cybersecurity Laboratory. Prior to that, he was a faculty member with the School of Electrical and Computer Engineering, Carnegie Mellon University, Pittsburgh, PA, USA. His current research interests include power systems protection, communication in power networks, distributed generation, microgrids, electric vehicle integration, and cybersecurity in smart grids. He serves on the editorial boards of IEEE Access, IEEE Transactions on Industrial Informatics, Energies, Electronics, Electricity, World Electric Vehicle and Information journals. Dr. Ustun is a member of the IEEE 2004 and 2800, IEC Renewable Energy Management WG 8, and IEC TC 57 WG17. He has been invited to run specialist courses in Africa, India, and China. He has delivered talks for the Qatar Foundation, the World Energy Council, the Waterloo Global Science Initiative, and the European Union Energy Initiative (EUEI). His research has attracted funding from prestigious programs in Japan, Australia, the European Union, and North America.",institutionString:"Fukushima Renewable Energy Institute, AIST (FREA)",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"1",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"National Institute of Advanced Industrial Science and Technology",institutionURL:null,country:{name:"Japan"}}},equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8985",title:"Natural Resources Management and Biological Sciences",subtitle:null,isOpenForSubmission:!1,hash:"5c2e219a6c021a40b5a20c041dea88c4",slug:"natural-resources-management-and-biological-sciences",bookSignature:"Edward R. Rhodes and Humood Naser",coverURL:"https://cdn.intechopen.com/books/images_new/8985.jpg",editors:[{id:"280886",title:"Prof.",name:"Edward R",middleName:null,surname:"Rhodes",slug:"edward-r-rhodes",fullName:"Edward R Rhodes"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10065",title:"Wavelet Theory",subtitle:null,isOpenForSubmission:!1,hash:"d8868e332169597ba2182d9b004d60de",slug:"wavelet-theory",bookSignature:"Somayeh Mohammady",coverURL:"https://cdn.intechopen.com/books/images_new/10065.jpg",editors:[{id:"109280",title:"Dr.",name:"Somayeh",middleName:null,surname:"Mohammady",slug:"somayeh-mohammady",fullName:"Somayeh Mohammady"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9644",title:"Glaciers and the Polar Environment",subtitle:null,isOpenForSubmission:!1,hash:"e8cfdc161794e3753ced54e6ff30873b",slug:"glaciers-and-the-polar-environment",bookSignature:"Masaki Kanao, Danilo Godone and Niccolò Dematteis",coverURL:"https://cdn.intechopen.com/books/images_new/9644.jpg",editors:[{id:"51959",title:"Dr.",name:"Masaki",middleName:null,surname:"Kanao",slug:"masaki-kanao",fullName:"Masaki Kanao"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9550",title:"Entrepreneurship",subtitle:"Contemporary Issues",isOpenForSubmission:!1,hash:"9b4ac1ee5b743abf6f88495452b1e5e7",slug:"entrepreneurship-contemporary-issues",bookSignature:"Mladen Turuk",coverURL:"https://cdn.intechopen.com/books/images_new/9550.jpg",editors:[{id:"319755",title:"Prof.",name:"Mladen",middleName:null,surname:"Turuk",slug:"mladen-turuk",fullName:"Mladen Turuk"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9027",title:"Human Blood Group Systems and Haemoglobinopathies",subtitle:null,isOpenForSubmission:!1,hash:"d00d8e40b11cfb2547d1122866531c7e",slug:"human-blood-group-systems-and-haemoglobinopathies",bookSignature:"Osaro Erhabor and Anjana Munshi",coverURL:"https://cdn.intechopen.com/books/images_new/9027.jpg",editors:[{id:"35140",title:null,name:"Osaro",middleName:null,surname:"Erhabor",slug:"osaro-erhabor",fullName:"Osaro Erhabor"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8558",title:"Aerodynamics",subtitle:null,isOpenForSubmission:!1,hash:"db7263fc198dfb539073ba0260a7f1aa",slug:"aerodynamics",bookSignature:"Mofid Gorji-Bandpy and Aly-Mousaad Aly",coverURL:"https://cdn.intechopen.com/books/images_new/8558.jpg",editors:[{id:"35542",title:"Prof.",name:"Mofid",middleName:null,surname:"Gorji-Bandpy",slug:"mofid-gorji-bandpy",fullName:"Mofid Gorji-Bandpy"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],offset:12,limit:12,total:5249},hotBookTopics:{hotBooks:[],offset:0,limit:12,total:null},publish:{},publishingProposal:{success:null,errors:{}},books:{featuredBooks:[{type:"book",id:"9521",title:"Antimicrobial Resistance",subtitle:"A One Health Perspective",isOpenForSubmission:!1,hash:"30949e78832e1afba5606634b52056ab",slug:"antimicrobial-resistance-a-one-health-perspective",bookSignature:"Mihai Mareș, Swee Hua Erin Lim, Kok-Song Lai and Romeo-Teodor Cristina",coverURL:"https://cdn.intechopen.com/books/images_new/9521.jpg",editors:[{id:"88785",title:"Prof.",name:"Mihai",middleName:null,surname:"Mares",slug:"mihai-mares",fullName:"Mihai Mares"}],equalEditorOne:{id:"190224",title:"Dr.",name:"Swee Hua Erin",middleName:null,surname:"Lim",slug:"swee-hua-erin-lim",fullName:"Swee Hua Erin Lim",profilePictureURL:"https://mts.intechopen.com/storage/users/190224/images/system/190224.png",biography:"Dr. Erin Lim is presently working as an Assistant Professor in the Division of Health Sciences, Abu Dhabi Women\\'s College, Higher Colleges of Technology in Abu Dhabi, United Arab Emirates and is affiliated as an Associate Professor to Perdana University-Royal College of Surgeons in Ireland, Selangor, Malaysia. She obtained her Ph.D. from Universiti Putra Malaysia in 2010 with a National Science Fellowship awarded from the Ministry of Science, Technology and Innovation Malaysia and has been actively involved in research ever since. Her main research interests include analysis of carriage and transmission of multidrug resistant bacteria in non-conventional settings, besides an interest in natural products for antimicrobial testing. She is heavily involved in the elucidation of mechanisms of reversal of resistance in bacteria in addition to investigating the immunological analyses of diseases, development of vaccination and treatment models in animals. She hopes her work will support the discovery of therapeutics in the clinical setting and assist in the combat against the burden of antibiotic resistance.",institutionString:"Abu Dhabi Women’s College",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"3",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"Perdana University",institutionURL:null,country:{name:"Malaysia"}}},equalEditorTwo:{id:"221544",title:"Dr.",name:"Kok-Song",middleName:null,surname:"Lai",slug:"kok-song-lai",fullName:"Kok-Song Lai",profilePictureURL:"https://mts.intechopen.com/storage/users/221544/images/system/221544.jpeg",biography:"Dr. Lai Kok Song is an Assistant Professor in the Division of Health Sciences, Abu Dhabi Women\\'s College, Higher Colleges of Technology in Abu Dhabi, United Arab Emirates. He obtained his Ph.D. in Biological Sciences from Nara Institute of Science and Technology, Japan in 2012. Prior to his academic appointment, Dr. Lai worked as a Senior Scientist at the Ministry of Science, Technology and Innovation, Malaysia. His current research areas include antimicrobial resistance and plant-pathogen interaction. His particular interest lies in the study of the antimicrobial mechanism via membrane disruption of essential oils against multi-drug resistance bacteria through various biochemical, molecular and proteomic approaches. Ultimately, he hopes to uncover and determine novel biomarkers related to antibiotic resistance that can be developed into new therapeutic strategies.",institutionString:"Higher Colleges of Technology",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"8",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"Higher Colleges of Technology",institutionURL:null,country:{name:"United Arab Emirates"}}},equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10020",title:"Operations Management",subtitle:"Emerging Trend in the Digital Era",isOpenForSubmission:!1,hash:"526f0dbdc7e4d85b82ce8383ab894b4c",slug:"operations-management-emerging-trend-in-the-digital-era",bookSignature:"Antonella Petrillo, Fabio De Felice, Germano Lambert-Torres and Erik Bonaldi",coverURL:"https://cdn.intechopen.com/books/images_new/10020.jpg",editors:[{id:"181603",title:"Dr.",name:"Antonella",middleName:null,surname:"Petrillo",slug:"antonella-petrillo",fullName:"Antonella Petrillo"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9560",title:"Creativity",subtitle:"A Force to Innovation",isOpenForSubmission:!1,hash:"58f740bc17807d5d88d647c525857b11",slug:"creativity-a-force-to-innovation",bookSignature:"Pooja Jain",coverURL:"https://cdn.intechopen.com/books/images_new/9560.jpg",editors:[{id:"316765",title:"Dr.",name:"Pooja",middleName:null,surname:"Jain",slug:"pooja-jain",fullName:"Pooja Jain"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10192",title:"Background and Management of Muscular Atrophy",subtitle:null,isOpenForSubmission:!1,hash:"eca24028d89912b5efea56e179dff089",slug:"background-and-management-of-muscular-atrophy",bookSignature:"Julianna Cseri",coverURL:"https://cdn.intechopen.com/books/images_new/10192.jpg",editors:[{id:"135579",title:"Dr.",name:"Julianna",middleName:null,surname:"Cseri",slug:"julianna-cseri",fullName:"Julianna Cseri"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9243",title:"Coastal Environments",subtitle:null,isOpenForSubmission:!1,hash:"8e05e5f631e935eef366980f2e28295d",slug:"coastal-environments",bookSignature:"Yuanzhi Zhang and X. San Liang",coverURL:"https://cdn.intechopen.com/books/images_new/9243.jpg",editors:[{id:"77597",title:"Prof.",name:"Yuanzhi",middleName:null,surname:"Zhang",slug:"yuanzhi-zhang",fullName:"Yuanzhi Zhang"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9385",title:"Renewable Energy",subtitle:"Technologies and Applications",isOpenForSubmission:!1,hash:"a6b446d19166f17f313008e6c056f3d8",slug:"renewable-energy-technologies-and-applications",bookSignature:"Tolga Taner, Archana Tiwari and Taha Selim Ustun",coverURL:"https://cdn.intechopen.com/books/images_new/9385.jpg",editors:[{id:"197240",title:"Associate Prof.",name:"Tolga",middleName:null,surname:"Taner",slug:"tolga-taner",fullName:"Tolga Taner"}],equalEditorOne:{id:"186791",title:"Dr.",name:"Archana",middleName:null,surname:"Tiwari",slug:"archana-tiwari",fullName:"Archana Tiwari",profilePictureURL:"https://mts.intechopen.com/storage/users/186791/images/system/186791.jpg",biography:"Dr. Archana Tiwari is Associate Professor at Amity University, India. Her research interests include renewable sources of energy from microalgae and further utilizing the residual biomass for the generation of value-added products, bioremediation through microalgae and microbial consortium, antioxidative enzymes and stress, and nutraceuticals from microalgae. She has been working on algal biotechnology for the last two decades. She has published her research in many international journals and has authored many books and chapters with renowned publishing houses. She has also delivered talks as an invited speaker at many national and international conferences. Dr. Tiwari is the recipient of several awards including Researcher of the Year and Distinguished Scientist.",institutionString:"Amity University",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"3",totalChapterViews:"0",totalEditedBooks:"1",institution:{name:"Amity University",institutionURL:null,country:{name:"India"}}},equalEditorTwo:{id:"197609",title:"Prof.",name:"Taha Selim",middleName:null,surname:"Ustun",slug:"taha-selim-ustun",fullName:"Taha Selim Ustun",profilePictureURL:"https://mts.intechopen.com/storage/users/197609/images/system/197609.jpeg",biography:"Dr. Taha Selim Ustun received a Ph.D. in Electrical Engineering from Victoria University, Melbourne, Australia. He is a researcher with the Fukushima Renewable Energy Institute, AIST (FREA), where he leads the Smart Grid Cybersecurity Laboratory. Prior to that, he was a faculty member with the School of Electrical and Computer Engineering, Carnegie Mellon University, Pittsburgh, PA, USA. His current research interests include power systems protection, communication in power networks, distributed generation, microgrids, electric vehicle integration, and cybersecurity in smart grids. He serves on the editorial boards of IEEE Access, IEEE Transactions on Industrial Informatics, Energies, Electronics, Electricity, World Electric Vehicle and Information journals. Dr. Ustun is a member of the IEEE 2004 and 2800, IEC Renewable Energy Management WG 8, and IEC TC 57 WG17. He has been invited to run specialist courses in Africa, India, and China. He has delivered talks for the Qatar Foundation, the World Energy Council, the Waterloo Global Science Initiative, and the European Union Energy Initiative (EUEI). His research has attracted funding from prestigious programs in Japan, Australia, the European Union, and North America.",institutionString:"Fukushima Renewable Energy Institute, AIST (FREA)",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"1",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"National Institute of Advanced Industrial Science and Technology",institutionURL:null,country:{name:"Japan"}}},equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8985",title:"Natural Resources Management and Biological Sciences",subtitle:null,isOpenForSubmission:!1,hash:"5c2e219a6c021a40b5a20c041dea88c4",slug:"natural-resources-management-and-biological-sciences",bookSignature:"Edward R. Rhodes and Humood Naser",coverURL:"https://cdn.intechopen.com/books/images_new/8985.jpg",editors:[{id:"280886",title:"Prof.",name:"Edward R",middleName:null,surname:"Rhodes",slug:"edward-r-rhodes",fullName:"Edward R Rhodes"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10065",title:"Wavelet Theory",subtitle:null,isOpenForSubmission:!1,hash:"d8868e332169597ba2182d9b004d60de",slug:"wavelet-theory",bookSignature:"Somayeh Mohammady",coverURL:"https://cdn.intechopen.com/books/images_new/10065.jpg",editors:[{id:"109280",title:"Dr.",name:"Somayeh",middleName:null,surname:"Mohammady",slug:"somayeh-mohammady",fullName:"Somayeh Mohammady"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9644",title:"Glaciers and the Polar Environment",subtitle:null,isOpenForSubmission:!1,hash:"e8cfdc161794e3753ced54e6ff30873b",slug:"glaciers-and-the-polar-environment",bookSignature:"Masaki Kanao, Danilo Godone and Niccolò Dematteis",coverURL:"https://cdn.intechopen.com/books/images_new/9644.jpg",editors:[{id:"51959",title:"Dr.",name:"Masaki",middleName:null,surname:"Kanao",slug:"masaki-kanao",fullName:"Masaki Kanao"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9550",title:"Entrepreneurship",subtitle:"Contemporary Issues",isOpenForSubmission:!1,hash:"9b4ac1ee5b743abf6f88495452b1e5e7",slug:"entrepreneurship-contemporary-issues",bookSignature:"Mladen Turuk",coverURL:"https://cdn.intechopen.com/books/images_new/9550.jpg",editors:[{id:"319755",title:"Prof.",name:"Mladen",middleName:null,surname:"Turuk",slug:"mladen-turuk",fullName:"Mladen Turuk"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],latestBooks:[{type:"book",id:"9243",title:"Coastal Environments",subtitle:null,isOpenForSubmission:!1,hash:"8e05e5f631e935eef366980f2e28295d",slug:"coastal-environments",bookSignature:"Yuanzhi Zhang and X. San Liang",coverURL:"https://cdn.intechopen.com/books/images_new/9243.jpg",editedByType:"Edited by",editors:[{id:"77597",title:"Prof.",name:"Yuanzhi",middleName:null,surname:"Zhang",slug:"yuanzhi-zhang",fullName:"Yuanzhi Zhang"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10020",title:"Operations Management",subtitle:"Emerging Trend in the Digital Era",isOpenForSubmission:!1,hash:"526f0dbdc7e4d85b82ce8383ab894b4c",slug:"operations-management-emerging-trend-in-the-digital-era",bookSignature:"Antonella Petrillo, Fabio De Felice, Germano Lambert-Torres and Erik Bonaldi",coverURL:"https://cdn.intechopen.com/books/images_new/10020.jpg",editedByType:"Edited by",editors:[{id:"181603",title:"Dr.",name:"Antonella",middleName:null,surname:"Petrillo",slug:"antonella-petrillo",fullName:"Antonella Petrillo"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9521",title:"Antimicrobial Resistance",subtitle:"A One Health Perspective",isOpenForSubmission:!1,hash:"30949e78832e1afba5606634b52056ab",slug:"antimicrobial-resistance-a-one-health-perspective",bookSignature:"Mihai Mareș, Swee Hua Erin Lim, Kok-Song Lai and Romeo-Teodor Cristina",coverURL:"https://cdn.intechopen.com/books/images_new/9521.jpg",editedByType:"Edited by",editors:[{id:"88785",title:"Prof.",name:"Mihai",middleName:null,surname:"Mares",slug:"mihai-mares",fullName:"Mihai Mares"}],equalEditorOne:{id:"190224",title:"Dr.",name:"Swee Hua Erin",middleName:null,surname:"Lim",slug:"swee-hua-erin-lim",fullName:"Swee Hua Erin Lim",profilePictureURL:"https://mts.intechopen.com/storage/users/190224/images/system/190224.png",biography:"Dr. Erin Lim is presently working as an Assistant Professor in the Division of Health Sciences, Abu Dhabi Women\\'s College, Higher Colleges of Technology in Abu Dhabi, United Arab Emirates and is affiliated as an Associate Professor to Perdana University-Royal College of Surgeons in Ireland, Selangor, Malaysia. She obtained her Ph.D. from Universiti Putra Malaysia in 2010 with a National Science Fellowship awarded from the Ministry of Science, Technology and Innovation Malaysia and has been actively involved in research ever since. Her main research interests include analysis of carriage and transmission of multidrug resistant bacteria in non-conventional settings, besides an interest in natural products for antimicrobial testing. She is heavily involved in the elucidation of mechanisms of reversal of resistance in bacteria in addition to investigating the immunological analyses of diseases, development of vaccination and treatment models in animals. She hopes her work will support the discovery of therapeutics in the clinical setting and assist in the combat against the burden of antibiotic resistance.",institutionString:"Abu Dhabi Women’s College",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"3",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"Perdana University",institutionURL:null,country:{name:"Malaysia"}}},equalEditorTwo:{id:"221544",title:"Dr.",name:"Kok-Song",middleName:null,surname:"Lai",slug:"kok-song-lai",fullName:"Kok-Song Lai",profilePictureURL:"https://mts.intechopen.com/storage/users/221544/images/system/221544.jpeg",biography:"Dr. Lai Kok Song is an Assistant Professor in the Division of Health Sciences, Abu Dhabi Women\\'s College, Higher Colleges of Technology in Abu Dhabi, United Arab Emirates. He obtained his Ph.D. in Biological Sciences from Nara Institute of Science and Technology, Japan in 2012. Prior to his academic appointment, Dr. Lai worked as a Senior Scientist at the Ministry of Science, Technology and Innovation, Malaysia. His current research areas include antimicrobial resistance and plant-pathogen interaction. His particular interest lies in the study of the antimicrobial mechanism via membrane disruption of essential oils against multi-drug resistance bacteria through various biochemical, molecular and proteomic approaches. Ultimately, he hopes to uncover and determine novel biomarkers related to antibiotic resistance that can be developed into new therapeutic strategies.",institutionString:"Higher Colleges of Technology",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"8",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"Higher Colleges of Technology",institutionURL:null,country:{name:"United Arab Emirates"}}},equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9560",title:"Creativity",subtitle:"A Force to Innovation",isOpenForSubmission:!1,hash:"58f740bc17807d5d88d647c525857b11",slug:"creativity-a-force-to-innovation",bookSignature:"Pooja Jain",coverURL:"https://cdn.intechopen.com/books/images_new/9560.jpg",editedByType:"Edited by",editors:[{id:"316765",title:"Dr.",name:"Pooja",middleName:null,surname:"Jain",slug:"pooja-jain",fullName:"Pooja Jain"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9669",title:"Recent Advances in Rice Research",subtitle:null,isOpenForSubmission:!1,hash:"12b06cc73e89af1e104399321cc16a75",slug:"recent-advances-in-rice-research",bookSignature:"Mahmood-ur- Rahman Ansari",coverURL:"https://cdn.intechopen.com/books/images_new/9669.jpg",editedByType:"Edited by",editors:[{id:"185476",title:"Dr.",name:"Mahmood-Ur-",middleName:null,surname:"Rahman Ansari",slug:"mahmood-ur-rahman-ansari",fullName:"Mahmood-Ur- Rahman Ansari"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10192",title:"Background and Management of Muscular Atrophy",subtitle:null,isOpenForSubmission:!1,hash:"eca24028d89912b5efea56e179dff089",slug:"background-and-management-of-muscular-atrophy",bookSignature:"Julianna Cseri",coverURL:"https://cdn.intechopen.com/books/images_new/10192.jpg",editedByType:"Edited by",editors:[{id:"135579",title:"Dr.",name:"Julianna",middleName:null,surname:"Cseri",slug:"julianna-cseri",fullName:"Julianna Cseri"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9550",title:"Entrepreneurship",subtitle:"Contemporary Issues",isOpenForSubmission:!1,hash:"9b4ac1ee5b743abf6f88495452b1e5e7",slug:"entrepreneurship-contemporary-issues",bookSignature:"Mladen Turuk",coverURL:"https://cdn.intechopen.com/books/images_new/9550.jpg",editedByType:"Edited by",editors:[{id:"319755",title:"Prof.",name:"Mladen",middleName:null,surname:"Turuk",slug:"mladen-turuk",fullName:"Mladen Turuk"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10065",title:"Wavelet Theory",subtitle:null,isOpenForSubmission:!1,hash:"d8868e332169597ba2182d9b004d60de",slug:"wavelet-theory",bookSignature:"Somayeh Mohammady",coverURL:"https://cdn.intechopen.com/books/images_new/10065.jpg",editedByType:"Edited by",editors:[{id:"109280",title:"Dr.",name:"Somayeh",middleName:null,surname:"Mohammady",slug:"somayeh-mohammady",fullName:"Somayeh Mohammady"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9313",title:"Clay Science and Technology",subtitle:null,isOpenForSubmission:!1,hash:"6fa7e70396ff10620e032bb6cfa6fb72",slug:"clay-science-and-technology",bookSignature:"Gustavo Morari Do Nascimento",coverURL:"https://cdn.intechopen.com/books/images_new/9313.jpg",editedByType:"Edited by",editors:[{id:"7153",title:"Prof.",name:"Gustavo",middleName:null,surname:"Morari Do Nascimento",slug:"gustavo-morari-do-nascimento",fullName:"Gustavo Morari Do Nascimento"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9888",title:"Nuclear Power Plants",subtitle:"The Processes from the Cradle to the Grave",isOpenForSubmission:!1,hash:"c2c8773e586f62155ab8221ebb72a849",slug:"nuclear-power-plants-the-processes-from-the-cradle-to-the-grave",bookSignature:"Nasser Awwad",coverURL:"https://cdn.intechopen.com/books/images_new/9888.jpg",editedByType:"Edited by",editors:[{id:"145209",title:"Prof.",name:"Nasser",middleName:"S",surname:"Awwad",slug:"nasser-awwad",fullName:"Nasser Awwad"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},subject:{topic:{id:"994",title:"Traumatology",slug:"traumatology",parent:{title:"Critical Care Medicine",slug:"critical-care-medicine"},numberOfBooks:5,numberOfAuthorsAndEditors:132,numberOfWosCitations:55,numberOfCrossrefCitations:44,numberOfDimensionsCitations:101,videoUrl:null,fallbackUrl:null,description:null},booksByTopicFilter:{topicSlug:"traumatology",sort:"-publishedDate",limit:12,offset:0},booksByTopicCollection:[{type:"book",id:"9066",title:"Wound Healing",subtitle:null,isOpenForSubmission:!1,hash:"a293ecd8c2655a402321dc30e0ffbf9a",slug:"wound-healing",bookSignature:"Muhammad Ahmad",coverURL:"https://cdn.intechopen.com/books/images_new/9066.jpg",editedByType:"Edited by",editors:[{id:"204257",title:"Dr.",name:"Muhammad",middleName:null,surname:"Ahmad",slug:"muhammad-ahmad",fullName:"Muhammad Ahmad"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7046",title:"Wound Healing",subtitle:"Current Perspectives",isOpenForSubmission:!1,hash:"fa7b870ad29ce1dfcf6faeafdc060309",slug:"wound-healing-current-perspectives",bookSignature:"Kamil Hakan Dogan",coverURL:"https://cdn.intechopen.com/books/images_new/7046.jpg",editedByType:"Edited by",editors:[{id:"30612",title:"Prof.",name:"Kamil Hakan",middleName:null,surname:"Dogan",slug:"kamil-hakan-dogan",fullName:"Kamil Hakan Dogan"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6662",title:"Trauma Surgery",subtitle:null,isOpenForSubmission:!1,hash:"9721b9ac98bf237058cafd0a0303bdbc",slug:"trauma-surgery",bookSignature:"Ozgur Karcioglu and Hakan Topacoglu",coverURL:"https://cdn.intechopen.com/books/images_new/6662.jpg",editedByType:"Edited by",editors:[{id:"221195",title:"Dr.",name:"Ozgur",middleName:null,surname:"Karcioglu",slug:"ozgur-karcioglu",fullName:"Ozgur Karcioglu"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6069",title:"Essentials of Spinal Cord Injury Medicine",subtitle:null,isOpenForSubmission:!1,hash:"f0a49e24ebfbb9ed7d02f7daab9b30f6",slug:"essentials-of-spinal-cord-injury-medicine",bookSignature:"Yannis Dionyssiotis",coverURL:"https://cdn.intechopen.com/books/images_new/6069.jpg",editedByType:"Edited by",editors:[{id:"76883",title:"PhD.",name:"Yannis",middleName:null,surname:"Dionyssiotis",slug:"yannis-dionyssiotis",fullName:"Yannis Dionyssiotis"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"5290",title:"Wound Healing",subtitle:"New insights into Ancient Challenges",isOpenForSubmission:!1,hash:"a6c479ab3fea0a9b7051d2a8478c91c3",slug:"wound-healing-new-insights-into-ancient-challenges",bookSignature:"Vlad Adrian Alexandrescu",coverURL:"https://cdn.intechopen.com/books/images_new/5290.jpg",editedByType:"Edited by",editors:[{id:"66358",title:"Ph.D.",name:"Vlad",middleName:"Adrian",surname:"Alexandrescu",slug:"vlad-alexandrescu",fullName:"Vlad Alexandrescu"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],booksByTopicTotal:5,mostCitedChapters:[{id:"50983",doi:"10.5772/63961",title:"Antimicrobial Dressings for Improving Wound Healing",slug:"antimicrobial-dressings-for-improving-wound-healing",totalDownloads:3705,totalCrossrefCites:5,totalDimensionsCites:21,book:{slug:"wound-healing-new-insights-into-ancient-challenges",title:"Wound Healing",fullTitle:"Wound Healing - New insights into Ancient Challenges"},signatures:"Omar Sarheed, Asif Ahmed, Douha Shouqair and Joshua Boateng",authors:[{id:"183108",title:"Dr.",name:"Joshua",middleName:null,surname:"Boateng",slug:"joshua-boateng",fullName:"Joshua Boateng"},{id:"183399",title:"Dr.",name:"Omar",middleName:null,surname:"Sarheed",slug:"omar-sarheed",fullName:"Omar Sarheed"},{id:"188082",title:"Mr.",name:"Asif",middleName:null,surname:"Ahmed",slug:"asif-ahmed",fullName:"Asif Ahmed"},{id:"188083",title:"Ms.",name:"Douha",middleName:null,surname:"Shouqair",slug:"douha-shouqair",fullName:"Douha Shouqair"}]},{id:"51825",doi:"10.5772/64611",title:"Roles of Matrix Metalloproteinases in Cutaneous Wound Healing",slug:"roles-of-matrix-metalloproteinases-in-cutaneous-wound-healing",totalDownloads:2740,totalCrossrefCites:8,totalDimensionsCites:14,book:{slug:"wound-healing-new-insights-into-ancient-challenges",title:"Wound Healing",fullTitle:"Wound Healing - New insights into Ancient Challenges"},signatures:"Trung T. Nguyen, Shahriar Mobashery and Mayland Chang",authors:[{id:"183405",title:"Prof.",name:"Mayland",middleName:null,surname:"Chang",slug:"mayland-chang",fullName:"Mayland Chang"},{id:"191152",title:"Mr.",name:"Trung",middleName:null,surname:"Nguyen",slug:"trung-nguyen",fullName:"Trung Nguyen"},{id:"191153",title:"Prof.",name:"Shahriar",middleName:null,surname:"Mobashery",slug:"shahriar-mobashery",fullName:"Shahriar Mobashery"}]},{id:"63675",doi:"10.5772/intechopen.81208",title:"Wound Healing: Contributions from Plant Secondary Metabolite Antioxidants",slug:"wound-healing-contributions-from-plant-secondary-metabolite-antioxidants",totalDownloads:685,totalCrossrefCites:1,totalDimensionsCites:6,book:{slug:"wound-healing-current-perspectives",title:"Wound Healing",fullTitle:"Wound Healing - Current Perspectives"},signatures:"Victor Y.A. Barku",authors:[{id:"261027",title:"Prof.",name:"Victor Y. A.",middleName:null,surname:"Barku",slug:"victor-y.-a.-barku",fullName:"Victor Y. A. Barku"}]}],mostDownloadedChaptersLast30Days:[{id:"60520",title:"Maxillofacial Fractures: From Diagnosis to Treatment",slug:"maxillofacial-fractures-from-diagnosis-to-treatment",totalDownloads:1791,totalCrossrefCites:0,totalDimensionsCites:0,book:{slug:"trauma-surgery",title:"Trauma Surgery",fullTitle:"Trauma Surgery"},signatures:"Mohammad Esmaeelinejad",authors:[{id:"172188",title:"Dr.",name:"Mohammad",middleName:null,surname:"Esmaeelinejad",slug:"mohammad-esmaeelinejad",fullName:"Mohammad Esmaeelinejad"}]},{id:"51825",title:"Roles of Matrix Metalloproteinases in Cutaneous Wound Healing",slug:"roles-of-matrix-metalloproteinases-in-cutaneous-wound-healing",totalDownloads:2743,totalCrossrefCites:8,totalDimensionsCites:15,book:{slug:"wound-healing-new-insights-into-ancient-challenges",title:"Wound Healing",fullTitle:"Wound Healing - New insights into Ancient Challenges"},signatures:"Trung T. Nguyen, Shahriar Mobashery and Mayland Chang",authors:[{id:"183405",title:"Prof.",name:"Mayland",middleName:null,surname:"Chang",slug:"mayland-chang",fullName:"Mayland Chang"},{id:"191152",title:"Mr.",name:"Trung",middleName:null,surname:"Nguyen",slug:"trung-nguyen",fullName:"Trung Nguyen"},{id:"191153",title:"Prof.",name:"Shahriar",middleName:null,surname:"Mobashery",slug:"shahriar-mobashery",fullName:"Shahriar Mobashery"}]},{id:"51223",title:"Medicinal Plants and Natural Products with Demonstrated Wound Healing Properties",slug:"medicinal-plants-and-natural-products-with-demonstrated-wound-healing-properties",totalDownloads:2807,totalCrossrefCites:1,totalDimensionsCites:3,book:{slug:"wound-healing-new-insights-into-ancient-challenges",title:"Wound Healing",fullTitle:"Wound Healing - New insights into Ancient Challenges"},signatures:"Christian Agyare, Emelia Oppong Bekoe, Yaw Duah Boakye,\nSusanna Oteng Dapaah, Theresa Appiah and Samuel Oppong\nBekoe",authors:[{id:"182058",title:"Dr.",name:"Christian",middleName:null,surname:"Agyare",slug:"christian-agyare",fullName:"Christian Agyare"},{id:"186987",title:"Dr.",name:"Yaw Duah",middleName:null,surname:"Boakye",slug:"yaw-duah-boakye",fullName:"Yaw Duah Boakye"},{id:"186988",title:"Ms.",name:"Susanna Oteng",middleName:null,surname:"Dapaah",slug:"susanna-oteng-dapaah",fullName:"Susanna Oteng Dapaah"},{id:"186989",title:"MSc.",name:"Theresa",middleName:null,surname:"Appiah",slug:"theresa-appiah",fullName:"Theresa Appiah"},{id:"186990",title:"Dr.",name:"Samuel Oppong",middleName:null,surname:"Bekoe",slug:"samuel-oppong-bekoe",fullName:"Samuel Oppong Bekoe"},{id:"186992",title:"Dr.",name:"Emelia Oppong",middleName:null,surname:"Bekoe",slug:"emelia-oppong-bekoe",fullName:"Emelia Oppong Bekoe"}]},{id:"63086",title:"Medicinal Plants in Wound Healing",slug:"medicinal-plants-in-wound-healing",totalDownloads:1701,totalCrossrefCites:0,totalDimensionsCites:2,book:{slug:"wound-healing-current-perspectives",title:"Wound Healing",fullTitle:"Wound Healing - Current Perspectives"},signatures:"Mohammad Reza Farahpour",authors:[{id:"253340",title:"Prof.",name:"Mohammadreza",middleName:null,surname:"Farahpour",slug:"mohammadreza-farahpour",fullName:"Mohammadreza Farahpour"}]},{id:"62998",title:"Biomarkers of Wound Healing",slug:"biomarkers-of-wound-healing",totalDownloads:890,totalCrossrefCites:0,totalDimensionsCites:0,book:{slug:"wound-healing-current-perspectives",title:"Wound Healing",fullTitle:"Wound Healing - Current Perspectives"},signatures:"Christian Agyare, Newman Osafo and Yaw Duah Boakye",authors:[{id:"182058",title:"Dr.",name:"Christian",middleName:null,surname:"Agyare",slug:"christian-agyare",fullName:"Christian Agyare"},{id:"196452",title:"Dr.",name:"Newman",middleName:null,surname:"Osafo",slug:"newman-osafo",fullName:"Newman Osafo"},{id:"252789",title:"Dr.",name:"Yaw Duah",middleName:null,surname:"Boakye",slug:"yaw-duah-boakye",fullName:"Yaw Duah Boakye"}]},{id:"63082",title:"Abdominal Trauma",slug:"abdominal-trauma",totalDownloads:631,totalCrossrefCites:0,totalDimensionsCites:0,book:{slug:"trauma-surgery",title:"Trauma Surgery",fullTitle:"Trauma Surgery"},signatures:"Göksu Afacan",authors:[{id:"236854",title:"M.D.",name:"Göksu",middleName:null,surname:"Afacan",slug:"goksu-afacan",fullName:"Göksu Afacan"}]},{id:"63308",title:"Autologous Platelet-Rich Plasma and Mesenchymal Stem Cells for the Treatment of Chronic Wounds",slug:"autologous-platelet-rich-plasma-and-mesenchymal-stem-cells-for-the-treatment-of-chronic-wounds",totalDownloads:1153,totalCrossrefCites:1,totalDimensionsCites:3,book:{slug:"wound-healing-current-perspectives",title:"Wound Healing",fullTitle:"Wound Healing - Current Perspectives"},signatures:"Peter A. Everts",authors:[{id:"256306",title:"Ph.D.",name:"Peter A.",middleName:null,surname:"Everts",slug:"peter-a.-everts",fullName:"Peter A. Everts"}]},{id:"66286",title:"From Tissue Repair to Tissue Regeneration",slug:"from-tissue-repair-to-tissue-regeneration",totalDownloads:1052,totalCrossrefCites:2,totalDimensionsCites:2,book:{slug:"wound-healing-current-perspectives",title:"Wound Healing",fullTitle:"Wound Healing - Current Perspectives"},signatures:"Aragona Salvatore Emanuele, Mereghetti Giada, Ferrari Alessio and\nGiorgio Ciprandi",authors:[{id:"247667",title:"Prof.",name:"Emanuele Salvatore",middleName:null,surname:"Aragona",slug:"emanuele-salvatore-aragona",fullName:"Emanuele Salvatore Aragona"}]},{id:"71904",title:"Modulation of Inflammatory Dynamics by Insulin to Promote Wound Recovery of Diabetic Ulcers",slug:"modulation-of-inflammatory-dynamics-by-insulin-to-promote-wound-recovery-of-diabetic-ulcers",totalDownloads:274,totalCrossrefCites:0,totalDimensionsCites:0,book:{slug:"wound-healing",title:"Wound Healing",fullTitle:"Wound Healing"},signatures:"Pawandeep Kaur and Diptiman Choudhury",authors:null},{id:"51068",title:"A Potential Mechanism for Diabetic Wound Healing: Cutaneous Environmental Disorders",slug:"a-potential-mechanism-for-diabetic-wound-healing-cutaneous-environmental-disorders",totalDownloads:1432,totalCrossrefCites:0,totalDimensionsCites:0,book:{slug:"wound-healing-new-insights-into-ancient-challenges",title:"Wound Healing",fullTitle:"Wound Healing - New insights into Ancient Challenges"},signatures:"Junna Ye, Ting Xie, Yiwen Niu, Liang Qiao, Ming Tian, Chun Qing\nand Shuliang Lu",authors:[{id:"182332",title:"Dr.",name:"Junna",middleName:null,surname:"Ye",slug:"junna-ye",fullName:"Junna Ye"}]}],onlineFirstChaptersFilter:{topicSlug:"traumatology",limit:3,offset:0},onlineFirstChaptersCollection:[],onlineFirstChaptersTotal:0},preDownload:{success:null,errors:{}},aboutIntechopen:{},privacyPolicy:{},peerReviewing:{},howOpenAccessPublishingWithIntechopenWorks:{},sponsorshipBooks:{sponsorshipBooks:[{type:"book",id:"10176",title:"Microgrids and Local Energy Systems",subtitle:null,isOpenForSubmission:!0,hash:"c32b4a5351a88f263074b0d0ca813a9c",slug:null,bookSignature:"Prof. Nick Jenkins",coverURL:"https://cdn.intechopen.com/books/images_new/10176.jpg",editedByType:null,editors:[{id:"55219",title:"Prof.",name:"Nick",middleName:null,surname:"Jenkins",slug:"nick-jenkins",fullName:"Nick Jenkins"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],offset:8,limit:8,total:1},route:{name:"profile.detail",path:"/profiles/110901/angel-coronel-beltran",hash:"",query:{},params:{id:"110901",slug:"angel-coronel-beltran"},fullPath:"/profiles/110901/angel-coronel-beltran",meta:{},from:{name:null,path:"/",hash:"",query:{},params:{},fullPath:"/",meta:{}}}},function(){var e;(e=document.currentScript||document.scripts[document.scripts.length-1]).parentNode.removeChild(e)}()